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ABSTRACT
BIOENERGETIC MECHANISMS OF AGE-RELATED DIFFERENCES IN MUSCLE
FATIGUE
FEBRUARY 2020
LIAM F. FITZGERALD, BSc (Hons)., UNIVERSITY OF WORCESTER, UK
M.S., BALL STATE UNIVERSITY, IN, USA
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST, USA
Directed by: Professor Jane A. Kent, Ph.D.

Muscle fatigue is defined as the reduced capacity to produce torque or power in
response to contractile activity. Previous work has observed greater fatigue in older than
young adults in response to high-velocity contractions, but similar fatigue with age in
response to moderate-velocity contractions. The mechanisms for these age-related
differences is not clear. One potential explanation is a greater accumulation of putative
agents of fatigue (e.g., Pi, H2PO4-, and H+) in older than young muscle during high- but
not moderate-velocity contractions. Older muscle may accumulate these metabolites to
greater extent because of deficits in muscle metabolic economy (ME). This dissertation
sought to address these knowledge gaps using 31P-MRS to evaluate the role of
bioenergetics in two studies: 1) age-related differences in knee extensor muscle fatigue in
response to two distinct bouts of contractions chosen to permit high- (MVDC20%; 20%
MVIC) and moderate-velocity (MVDC120; 120°.s-1) contractions, and 2) in vivo muscle
ME during three 24-s bouts of maximal isometric, isokinetic or isotonic contractions
(MVIC, MVDCIsoK, MVDCIsoT). We observed similar fatigue in young and older adults
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in response to the MVDC20% protocol. Surprisingly, this was coincident with lower pH
and greater [H2PO4-] in young than older muscle. In response to the MVDC120 protocol,
fatigue, [Pi], and [H2PO4-] were greater, and pH lower, in young than older muscle.
During both protocols, oxidative ATP production increased from baseline to the end of
the fatiguing contractions in older, but not young, muscle. Collectively, these results
indicate relatively greater oxidative ATP production in older than young quadriceps
during in vivo contractions at two different loads (20% MVIC (MVDC20%) versus ~50%
(young) and 35% MVIC (older) at the start of the MVDC120 task). Further, these results
suggest the contractile machinery is more sensitive to changes in pH in older than young
muscle in vivo. In Study 2, we observed similar in vivo muscle ME during the MVIC, but
lower ME in older than young muscle during the MVDCIsoK and MVDCIsoT tasks. These
results show an age-related deficit in ME that is evident only during dynamic
contractions, potentially due to the higher energy demand of these contractions.

vii

PREFACE
Chapters 1 through 3 include the dissertation proposal as submitted to the
Graduate School in December 2017. During pilot testing, some of the methods used were
modified. These changes are outlined in the addendum to Chapter 3. Chapters 4 and 5
correspond to Study 1 and 2, respectively, and Chapter 6 provides an overall summary of
this work.
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CHAPTER 1
INTRODUCTION

Age-Related Changes in Muscle Structure & Function
Maximal force and power production are lower in older (≥65 years) compared
with young (≤40 years) adults (23,24,45,48-50,132,190,234). Myriad factors may
contribute to these age-related decrements in force and power, including a loss of muscle
mass (24,115,141), slower maximal contraction velocity (48,50,132,232), and slowed
crossbridge kinetics (164). The loss of maximal contraction velocity may be due to
selective atrophy of type II muscle fibers (142,143,175), caused by a loss of highthreshold motor neurons (62,63,119,158,230). However, the loss of high-threshold motor
neurons that occurs during the denervation-reinnervation process is most notable beyond
approximately 75 years of age (87,193). Slowed crossbridge kinetics, on the other hand,
are apparent in 65-75 year olds (164), and provide an additional molecular explanation
for the loss of the skeletal muscle power before the age of 75. This age-related loss of
muscular strength and power has significant consequences for older adults by increasing
their likelihood of falling, and placing them at risk for injuries and a loss of independence
(169,196).
The reductions in torque production and contractile velocity with age are evident
in the downward shift in the torque-velocity curve, as illustrated in Figure 1.1
(24,132,228,232). Indeed, these deficits in older muscle combine to shift the power-load
or power-velocity curve down- and left-ward (132,157,184,228). Cross-sectional studies
suggest that the loss in muscular power with age occurs prior to the reduction in maximal
force production (157,159). Additionally, specific power (peak power per unit cross1

sectional area) declines at a faster rate than specific strength (maximal torque per unit
cross-sectional area) with age, suggesting the primary culprit for the age-related decline
in power may be slowed contractile velocity, independent of the age-related decline in
maximal force (157).

Figure 1.1. The effect of age on the torque-velocity curve in human knee extensors. Adapted
from Callahan et al. (24).

The fall in maximal force and power production with age may be explained, at
least in part, by changes in the muscle’s architecture (pennation angle and fascicle
length). Because pennation angle reflects the number of sarcomeres in parallel, a larger
pennation angle enables greater maximal force production (146). On the other hand,
muscles with longer fascicles are capable of producing more force at a given contraction
velocity due to an increased number of sarcomeres in series (146). The greater force
produced by long fascicles at high velocities is likely due to the reduced sarcomeric
shortening required for a given whole-fiber shortening (19). The pennation angle and
fascicle length of the vastus lateralis have been shown to decrease with age by 3-6° (~1530%) and 5-12 mm (~6-11%), respectively (124,191). Because pennation angle and
2

fascicle length are determined by their geometric arrangement within a muscle, as
illustrated in Figure 1.2, these architectural parameters are intrinsically affected by the
muscle thickness or cross-sectional area (19). As such, the changes in muscle
architecture with age appear to be due to the age-related decline in muscle mass (170).

Figure 1.2. An overview of muscle architecture. Adapted from Blazevich. (19).

In order to generate movement, the force produced by muscular contraction is
transmitted to the skeleton via connective tissues such as tendons and aponeuroses.
These load-bearing connective tissues also act as biological springs, capable of storing
and releasing elastic energy (14,95). During cyclical contractions, such as those
occurring during walking, force contributions from passive-elastic energy help minimize
the energy cost of movements (208).
Muscle-tendon unit stiffness has been measured using several different methods,
including a quick release technique (61,177,178) and ultrasound imaging combined with
dynamometry measures of force (84,219). The quick release technique models stiffness
as the frequency response of a perturbed system. With this technique, some studies have
shown an increase in stiffness with age (177,178), while others demonstrate no agerelated differences (61). Because the proposed study will measure muscle-tendon unit
stiffness using the ultrasound and dynamometry technique, this literature review only
focuses on that technique.
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To assess muscle-tendon unit stiffness with ultrasound and dynamometry, the
elongation of the aponeurosis is tracked, using ultrasonography, while simultaneous
measures of force are obtained during a ramped isometric contraction (i.e., a contraction
that increases in intensity over a period of time). The change in length and force can be
plotted, and the slope of this relationship used as an index of muscle-tendon unit stiffness.
Using this approach, several studies have demonstrated a decrease in muscle-tendon unit
stiffness with age (125,150,219). However, other studies have shown no effect of age on
muscle-tendon unit stiffness (84,217).
Theoretically a stiffer muscle-tendon unit is capable of storing and releasing more
elastic energy. As such, force and power production might be lower in older compared
with young adults, especially during rapid muscular contractions, because of age-related
differences in muscle-tendon unit stiffness. Additionally, if the muscle-tendon unit is
more compliant in older compared with young adults, the metabolic economy may be
lower with age. If true, muscle-tendon unit stiffness may provide a structural rationale
for age-related differences in metabolic economy.
Age-Related Differences in Muscle Fatigue
Muscle fatigue is defined as the reduced ability of a muscle to produce torque or
power in response to a period of contractile activity (112). Because activities of daily
living, such as climbing stairs or walking, require repeated dynamic contractions (184),
the ability to resist muscle fatigue may be especially important for older adults to
maintain their quality of life (227). Numerous studies have reported less fatigue in older
(≥65 years) compared with young muscle (≤40 years) in response to isometric
contractions (28,35,60,114,130). Conversely, when completing dynamic contractions,
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especially at high velocities (e.g., 270°.s-1 in the knee extensors), older muscle fatigues to
a greater extent than young muscle (9,24,48,49,159). This crossover from less to greater
fatigue in older compared with young muscle is illustrated in Figure 1.3.

Figure 1.3. Illustration of the fatigue paradox in aging knee extensors. Fatigue was quantified
under different conditions and defined by the decline in torque or power, as follows: isometric
(torque), moderate velocity dynamic contractions (power), or high velocity dynamic contractions
(power). MVIC, maximal voluntary isometric contraction; MVDC, maximal voluntary dynamic
contraction; int, intermediate velocity; hi, high velocity. *indicates group differences in fatigue
(p<0.05). Adapted from Callahan & Kent-Braun (24).

When contractions are performed at slow or moderate velocities (e.g., ≤120°.s-1 in
the knee extensors), similar fatigue is observed in young and older muscle
(23,24,49,147). Callahan & Kent-Braun reported strong associations between torquevelocity characteristics at baseline and knee extensor fatigue in both young (r = -0.63)
and older (r = -0.72) women (24). However, no associations were observed between their
measure of the torque-velocity curve (V50; the velocity associated with 50% maximal
isometric torque) and fatigue induced by isometric or high velocity contractions (24).
Because contractile velocity is an important factor in power loss at baseline
(49,157,159,184), maximal contraction velocity might be a better predictor of fatigue
during high-velocity contractions than V50. Despite repeated observations of these age5

related differences in muscle fatigue, the mechanisms for greater fatigue in older
compared with young muscle in response to high-velocity contractions remain poorly
understood.

Figure 1.4. The pathway of force production. An illustration of the events leading to force
production in the myocyte, beginning with: 1) cortical excitation, 2) motor unit activation, 3)
release of acetylcholine, depolarization of the sarcolemma, and subsequent calcium release from
the sarcoplasmic reticulum, and 4) the crossbridge cycle, which is 5) powered by energy (ATP).
Adapted from Kent-Braun et al. (112).

Because of the multi-faceted nature of force and power production, identifying the
exact cause(s) of muscle fatigue is challenging. Indeed, fatigue can originate at myriad
sites along the pathway of force production (Figure 1.4). The initial signals to produce
force are generated in the motor cortex of the brain in the form of nerve action potentials
(Figure 1.4, point 1). These nerve action potentials propagate along the corticospinal
tract to alpha motor neurons in the spinal cord. Each axon of a motor neuron innervates
numerous skeletal muscle fibers (Figure 1.4, point 2). Collectively, a motor unit consists
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of a motor neuron and all of the skeletal muscle fibers innervated by that motor neuron.
Once the nerve action potential reaches the neuromuscular junction, acetylcholine is
released into the synaptic cleft, the sarcolemma is depolarized which generates a muscle
action potential that travels through the T-tubular system, and calcium (Ca2+) is released
from the sarcoplasmic reticulum (SR) into the cytosol (Figure 1.4, point 3). Once in the
cytosol, Ca2+ binds with troponin-C to uncover myosin binding sites on actin. Myosin
will continue to bind with, displace, and detach from actin in accordance with the
crossbridge cycle of muscular contraction (Figure 1.4, point 4). The process in which the
electrical signal (i.e., muscle action potential) is transformed into a mechanical movement
(i.e., displacement of actin and generation of force) is known as excitation-contraction
coupling (ECC) (65).
Mechanisms of Muscle Fatigue
Although the causes of muscle fatigue can be numerous (Figure 1.4), broadly
speaking fatigue can occur as a result of changes in neural activation (central fatigue;
numbers 1 and 2 in Figure 1.4) and changes within the muscle’s local environment
(peripheral fatigue; numbers 3, 4, and 5 in Figure 1.4). The use of electrical stimulation
permits the evaluation of central activation by comparing the torque produced during a
maximal voluntary contraction (MVC) with that obtained during a superimposed tetanic
stimulus (116). Likewise, fatigue-induced changes in the ratio of peak torques obtained
during a MVC and an electrically-stimulated tetanic train can be used to indicate failure
of central activation (18,116). Most studies suggest that central activation failure does
not contribute to age-related differences in muscle fatigue in response to isometric or
dynamic contractions (23,131); although this finding is not always supported (216). To
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date, only one study has examined age-related differences in central activation in
response to high-velocity contractions (49). Because the electromyographic (EMG)
signal was unaltered in young and older men in response to high-velocity dynamic
contractions of the knee extensors, Dalton et al. concluded that failure of neuromuscular
activation was not an important factor in the age-related differences in muscle fatigue
(49).
Peripheral causes of muscle fatigue include failure of ECC and metabolic
inhibition of the crossbridge cycle (112). Failure of ECC can be detected in vivo as a
decrease in the ratio of peak torques elicited by low- and high-frequency electrical
stimulations (67). Blunted torque production in response to a low-frequency stimulus is
thought to be due to impaired Ca2+ release (30). Indeed, ECC failure generally occurs in
response to prolonged muscular activity (7); although intermittent submaximal isometric
contractions have also been shown to elicit low-frequency fatigue in young and older
men (4).
In unfatigued muscle, the time required for force to fall by 50% from its peak
(T1/2) following an electrically-stimulated contraction is generally longer in older than
young adults (24,35,114,131), potentially as a result of greater type I fiber numbers or
area in older muscle (143). In young and older muscle, the T1/2 typically becomes
prolonged in response to fatiguing muscular activity (114,131), presumably due to
slowed Ca2+ release from troponin or uptake by the sarcoplasmic reticulum (1). During
fatiguing isometric contractions, reported changes in T1/2 are varied, with some authors
reporting a greater increase in T1/2 only in young muscle (131) and others reporting
similar slowing of T1/2 in young and older muscle (114). In contrast, Dalton et al.
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reported a greater slowing of muscular relaxation in older compared with young muscle
in response to moderate- and high-, but not slow-velocity contractions (49).
The lesser fatigue of older compared with young muscle in response to isometric
contractions is thought to arise from the greater proportion of ATP produced via
oxidative phosphorylation (ATPOX) in older compared with young muscle (128).
Because of this greater reliance on oxidative phosphorylation, concentrations of the
metabolic by-products of non-oxidative ATP production (e.g., proton, H+; inorganic
phosphate, Pi; and diprotonated phosphate, H2PO4-) known to inhibit crossbridge kinetics
(57,59,176) were lower in older compared with young muscle (114,128). The authors of
one of these studies suggest the decreased reliance on ATP production from the creatine
kinase reaction (ATPCK) and glycolysis (ATPGLY) with age is greater than would be
predicted by the modest decrease in type II fiber area (128). The accumulation of H+
slows ADP release from the actin-myosin complex and thus reduces contractile velocity
(57,58,123). The accumulation of Pi and H2PO4- causes myosin to dissociate from actin
after its powerstroke, reducing total force production, because ADP is still attached to the
dissociated myosin molecule (56,59). Additionally, elevated [H+] and [Pi] decrease the
muscle’s sensitivity to Ca2+ (59,181), directly interfering with crossbridge formation.
Overall, the literature indicates that the capacity for producing ATP via oxidative
phosphorylation declines with age in the knee extensor muscles (73). Coupled with the
higher ATP demand of dynamic compared with isometric contractions (205), the deficit
in oxidative capacity may require older muscle to rely more on phosphocreatine (PCr)
breakdown and non-oxidative glycolysis for ATP production than young muscle. If true,
H+, Pi, and H2PO4- would accumulate more in older compared with young muscle,
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providing a metabolic basis for the crossover to greater fatigue in older muscle during
high-velocity dynamic contractions. Further, because ATP consumption increases with
contractions of short duration (13,89) as the production of force is more costly than the
maintenance of force (202), the energetic demands of moderate-velocity contractions
may be sufficiently low to prevent older muscle from relying on PCr breakdown and
glycolysis to a greater extent than young muscle. These hypotheses remain to be tested.
There are 3 main sites of ATP consumption within skeletal muscle; i) myosin
ATPase, ii) SERCA pump (Ca2+ ATPase), and iii) Na2+/K+ ATPase. The latter 2 are
commonly referred to as pumps because they work against the concentration gradient of
the ions they are moving. The Na2+/K+ pump is located on the sarcolemma and is
responsible for the ATP-consuming process of pumping both sodium and potassium
against their concentration gradients in order to restore the resting membrane potential
following activation (37). The Ca2+ ATPase, located on the SR, pumps Ca2+ from the
cytosol back into the SR after activation; a necessary process for force relaxation.
Approximately 30-50% of the total ATP cost of contraction is associated with the
Na2+/K+ and Ca2+ ATPases, the majority of which is attributed to SERCA pump activity
(8). The remaining 50-70% of ATP consumption is used by myosin ATPase in the
crossbridge cycle (8).
Use of phosphorus magnetic resonance spectroscopy (31P-MRS) allows noninvasive measurement of ATP production rates during muscle contractions in vivo (20).
Because [ATP] is maintained until extreme levels of fatigue (226), the rate of ATP
production is equal to its rate of consumption (128,226). In studies comparing agerelated differences in ATP consumption rates, accounting for the decline in muscle mass
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with age by examining the metabolic economy of muscle (ME; mass-normalized torque
produced per unit ATP consumed) is required. During an MVIC sustained for 120s,
Boska et al. observed no change in ME, suggesting that ME does not change with muscle
fatigue (20).
Only a few studies have examined age-related differences in ME
(31,130,137,139). Some authors have reported higher (130) or similar (31) ME in older
compared with young muscle during maximal isometric contractions. Conversely, Layec
et al. have observed lower ME in older than young muscle during dynamic contractions
(137,139). However, these studies varied in methodology and the muscle studied, which
further confuses the issue at this time. Thus, whether age-related changes in ME are
velocity-dependent and can provide a metabolic rationale for the crossover in muscle
fatigue is currently unclear.
Summary and Statement of the Problem
Old age is associated with a reduction in maximal force, power, and contraction
velocity in the unfatigued state. These age-related deficits in muscle function are likely
due to reductions in muscle mass, slowed crossbridge kinetics, shifts in muscle fiber type,
muscle-tendon unit stiffness, and pennation angle and fascicle length (i.e., muscle
architecture) in older compared with young adults. The extent to which the differences in
muscle architecture contribute to age-related differences in fatigue is unclear at this time.
Older muscle fatigues less than young muscle in response to isometric
contractions (33). This age-related difference in muscle fatigue can be explained by a
greater proportion of ATPOX in older compared with young muscle during isometric
contractions (31,114,128,130). Paradoxically, older muscle fatigues to a greater extent
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than young muscle in response to high-velocity contractions (24,49), and age-related
differences in muscle fatigue are abolished when contractions are performed at moderate
velocities (23,24,49). The mechanism(s) of this “fatigue paradox” in which older muscle
transitions from less to greater fatigue than young are not known.
Age-related differences in fatigue induced by maximal isometric and moderatevelocity dynamic contractions are generally not associated with deficits in central
activation (23,49,131), failure of ECC (4), or slowing of contractile properties (114,131).
However, fatigue elicited by contractions performed at higher velocities may result in
age-related deficits in these measures. Likewise, this greater fatigue in older muscle
might be related to a lower baseline maximal contraction velocity in older muscle
(48,50,132,232), as a result of changes in fiber type composition (142,143,175) and
slowed crossbridge kinetics with age (164). Any deficit in baseline maximal contraction
velocity would cause older muscle to operate at a higher relative velocity during these
dynamic protocols.
The capacity for ATP production via oxidative phosphorylation is impaired in the
knee extensors of older compared with young adults (73). This deficit could result in
older muscle relying on the glycolytic pathway to a greater extent than young muscle
when the energetic demands are sufficiently high, such as during high-velocity dynamic
contractions. Additionally, ME might be lower in older knee extensor muscles compared
with young, which could exacerbate fatigue if the energetic demand outweighs its supply.
An age-related decline in muscle-tendon unit stiffness may worsen ME with age during
high-velocity contractions, because less energy is returned from elastic structures to the
muscle to amplify power production. Although logical, a metabolic basis for the greater
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fatigue in older muscle in response to high-velocity contractions has not been evaluated.
This dissertation has the potential to elucidate the causes of exacerbated muscle fatigue in
response to high-velocity contractions in older compared with young adults.

Age-Related Differences in Knee Extensor Muscle Fatigue: The Role of
Bioenergetics and Muscle-Tendon Unit Stiffness
The primary aim of this study is to determine the extent to which differences in
intracellular energy metabolism explain the age-related differences in muscle fatigue due
to moderate- (e.g., 120°.s-1) and high-velocity (e.g., 240°.s-1) maximal voluntary
contractions. The secondary aim of this study is to investigate the role of contraction
velocity on potential age-related differences in ATP demand during isometric, moderateand high-velocity contractions of the unfatigued muscles.

Figure 1.5. Overview of the measures to be collected at each visit.

Groups of young (21-40 years; n=20, 10 men) and older (65-80 years; n=20, 10
men) sedentary-to-recreationally active adults will be matched for habitual physical
activity, using accelerometry (23,24,131). This study will require 3 visits, 1 to the
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Human Testing Center (HTC) and 2 to the Human Magnetic Resonance Center (hMRC)
at the University of Massachusetts Amherst. The total time commitment for this study is
approximately 3-4 hours. Visit 1 will involve measures of mobility, muscle-tendon unit
stiffness, and familiarization with the fatigue protocols to be completed at Visits 2 and 3.
Measures of muscle contractile and non-contractile volumes, intracellular bioenergetics,
and fatigue (1st of 2 protocols) will be made at Visit 2. Lastly, measures of oxidative
capacity, intracellular bioenergetics, and fatigue (2nd of 2 protocols) will be made at Visit
3. An overview of the measures to be made at each visit is illustrated in Figure 1.5.
The primary outcome variables for the study include oxidative capacity, [H+],
[Pi], and [H2PO4-] during both fatigue trials, the ME of isometric and dynamic
contractions at 120°.s-1 and 240°.s-1, and muscle-tendon unit stiffness. Group descriptive
characteristics will include age, height, body mass, blood pressure, timed up-and-go
(TUG), and an advanced version of the short physical performance battery (SPPB-A).
The conceptual framework for this study is shown in Figure 1.6.

Figure 1.6. Conceptual framework for this dissertation. Muscle fatigue is caused by the
concentrations of H+, Pi, and H2PO4-, which increase when ATP demand is greater than
oxidative ATP production. The dashed lines represent the possible links between contraction
velocity, muscle-tendon unit stiffness, and metabolic economy.
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Aim 1: To determine whether there is a bioenergetic basis for the paradoxical
relationship between muscle fatigue and aging
H 1a: Baseline oxidative capacity of the vastus lateralis will be higher in young
than older adults.
If supported, this would indicate a deficit in the ability of older compared with
young muscle to produce ATP via oxidative phosphorylation.
H 1b: Cytosolic [H+], [Pi] and [H2PO4-] will increase to a greater extent in older
than young muscle during the high velocity (240°.s-1) fatigue trial.
This result would provide novel evidence for the role of these metabolites in the
age-related difference in high-velocity muscle fatigue.
H 1c: Neither fatigue nor cytosolic [H+], [Pi] and [H2PO4-] will differ between
age groups during the moderate velocity (120°.s-1) fatigue trial.
If true, this would support the concept that the muscles of healthy older adults can
meet the energy demands imposed by moderate contraction velocities, and thus
fatigue does not exceed that of young adults.
H 1d: The proportion of ATP derived from oxidative phosphorylation will be
lower in older than young muscle during the high velocity (240°.s-1) fatigue trial,
but not between groups during moderate velocity (120°.s-1) fatigue trial.
If supported, this would indicate that the energy demands of high- but not
moderate-velocity contractions forces older muscle to rely on non-oxidative ATP
production more than young muscle.
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Aim 2: To determine the impact of contraction velocity on muscle metabolic economy in
the unfatigued muscles of young and older adults
H 2a: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be higher in older
compared with young muscle during a 24s isometric contraction.
If true, this would support the notion that isometric contractions are less
energetically costly in older compared with young muscle when not fatigued, and
provide support for the metabolic cause of less fatigue in older compared with
young muscle in response to isometric contractions.
H 2b: Metabolic economy (Nm.s.cm-3.mM ATP-1) will not be different between
age-groups during contractions at 120°.s-1.
If supported, this would provide a mechanism to support the observation that
young and older muscle fatigue to a similar extent in response to moderatevelocity contractions.
H 2c: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be lower in older
compared with young muscle during contractions at 240°.s-1.
This result would indicate that older muscle is at an energetic disadvantage when
performing high-velocity contractions, even when not fatigued, and provide
additional support for a metabolic cause of the greater fatigue in older compared
with young muscle in response to high-velocity contractions.

Exploratory Aim 1: To examine age-related differences in muscle-tendon unit stiffness
and how those differences may be related to muscle fatigue
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EH 1a: Muscle-tendon unit stiffness of the vastus lateralis will be greater in
young compared with older adults.
If true, this may provide support for a structural mechanism to explain the agerelated differences in metabolic economy and muscle fatigue.
EH 1b: Muscle-tendon unit stiffness will be positively associated with fatigue
(defined as % initial power) induced by high-velocity contractions (240°.s-1).
If these two variables are positively associated, it would suggest that muscletendon unit plays an important role in the age-related differences in muscle
fatigue, potentially by exacerbating poor metabolic economy in older muscles.

Successful completion of the proposed work will advance the field by providing
novel insight into energetic flux, metabolite concentrations, and metabolic economy
during moderate- and high-velocity muscle contractions in vivo. Additionally, this work
will evaluate age-related differences in MTU stiffness and examine the role of those
differences in muscle fatigue. To date, no studies have examined age-related differences
in bioenergetic flux during contractions where velocity is controlled, the proposed study
will yield new information regarding the potential causes of age-related differences in
muscle fatigue. Because activities of daily living, such as stair climbing and walking,
require repeated dynamic contractions, the ability to resist muscle fatigue may be
important for maintaining quality of life into old age. As such, the new information
gained by the proposed study may be helpful for identifying targets to extend the
healthspan of older adults. Overall the proposed study will improve our understanding of
the age-related changes in muscle structure and function.
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CHAPTER 2
LITERATURE REVIEW
Age-Related Changes in the Neuromuscular System
Sarcopenia refers to the progressive loss of skeletal muscle mass and function
associated with age (71), and affects approximately 30% and 50% of individuals over 60
and 80 years of age, respectively (10). The effects of sarcopenia include a loss of
mobility and quality of life as well as an increased risk of hospitalization (71,97). Indeed,
the estimated financial cost of these effects is significant, totaling 18.5 billion dollars in
the United States in 2000 (98). Therefore, there is compelling rationale to investigate
age-related changes in neuromuscular system structure and function.
Nervous System
Beyond the age of 60 years there is a decline in the number of motor neurons in
humans (158,230). Because of this loss of motor neurons, muscle fibers undergo a
denervation-reinnervation process whereby the motor neurons innervating type II muscle
fibers may be lost and replaced with slower motor neurons (87). This denervationreinnervation process can result in a selective atrophy of type II fibers and a greater
proportion of type I muscle fibers in older compared with young adults (141-143,175).
However, this fiber-type shift with aging is generally small in magnitude (<10%) and is
not always observed (39,193). In contrast with the reports of a fast-to-slow shift in
muscle fiber composition, a longitudinal study observed an increase in the percentage of
type II muscle fibers in the vastus lateralis of healthy, sedentary men at 12 year follow-up
(75).
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At the neural level, muscular force production is modulated by 2 factors:
recruitment and rate coding. Motor unit recruitment describes the number of activated
motor units, which occurs in accordance with the size principle (i.e., smallest to largest)
as the force produced increases (86,165). Rate coding of motor units refers to the motor
unit discharge rate (MUDR), with faster MUDRs resulting in greater force production
(103,167).
The inability to completely activate a muscle during maximal contractions is
termed central activation failure, and can be caused by a failure to recruit all of the
available motor units or a decline in the maximal MUDR (110). Central activation can be
assessed indirectly by combining maximal voluntary and electrically stimulated
contractions. One approach to assess central activation involves delivering a tetanic
stimulus during an MVIC, with an increase in torque reflecting central activation failure
(110). An alternative method to quantify if central activation failure is present following
a fatiguing bout of contractions is to compare the peak torques obtained during maximal
voluntary and electrically stimulated contractions (18). Using these techniques, similar
central activation has been observed in the dorsiflexors (113,114,120,131) and knee
extensors (23,24) of young and older adults. In contrast with these studies, Stackhouse et
al. reported failure to completely activate the knee extensors in ~50% of the older adults
in their study (216). Similarly, incomplete activation of the knee extensors was observed
in very old (85-97 years) adults and was unaltered by 12 weeks of resistance exercise
training (81).
There is some evidence of lower MUDRs in older compared with young adults
during maximal and submaximal contractions of several muscle groups, including the
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first dorsal interosseous (104), dorsiflexors (42), and knee extensors (103). However, a
lack of age-related differences in MUDRs have also been reported during maximal and
submaximal contractions of the knee extensors (199) and plantar flexors (47,118).
Because maximal MUDRs increase with short-term training (32), these discrepant
findings may be due to differences in participants’ physical activity status across studies.
Despite lower MUDRs resulting in less force production (212,233), any decline in
MUDRs with age may be offset by a leftward shift in the force-frequency relationship
(Figure 2.1), such that older muscle produces maximal force at a lower activation
frequency (3,172,174).

Figure 2.1. Age-related changes in the force-frequency relationship of the quadriceps. Data for
young (filled circles) and older (open circles) are Mean±SE. Adapted from Allman & Rice (3)

Changes in muscular co-activation, defined as concomitant activation of agonist
and antagonist muscles, with age are somewhat equivocal. An increase in muscle coactivation might mechanically oppose force production. Greater co-activation in older
compared with young shanks was shown in one (91) but not another study (183). When
performing isolated knee extension and flexion, greater co-activation was only present
during contractions of the extensors (149). However, increased co-activation of the
quadriceps and hamstrings with age is not associated with contraction velocity (36).
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Other changes occur within the nervous system with age, such as decreased
conduction velocity of motor neurons due to a loss of myelinated neurons (160).
Additionally, declines in cortical excitability and atrophy of the primary motor cortex
have been shown in older compared with young adults (179,206).
Muscle Size, Force, and Power
Whole muscle cross-sectional area, quantified by magnetic resonance imaging
(MRI), declines in multiple muscle groups with age. Kent-Braun et al. reported a 12%
decline in the contractile area of the tibialis anterior in old compared with young men and
women (115). Using a similar technique, McNeil et al. reported no significant
differences in the size of dorsiflexor muscles in 25, 65, and 85 year old men (157).
However, the cross-sectional area of the knee extensors has been consistently shown to
decline by ~27% with age (24,90,231). Callahan & Kent-Braun reported a decline in
knee extensor size of ~28% in older compared with young women (24). More recently,
Hogrel et al. observed a greater decline in the size of the rectus femoris (35%) than the
vastus intermedius (25%), vastus lateralis (28%), and vastus medialis (19%) in older
compared with young adults (90). However this observation is in contrast with that of
Trappe et al. who reported similar atrophy across all knee extensor muscle in older
compared with young adults (231).
Differences in the age-related decline in muscle size between muscle groups
might be related to altered patterns of use in old compared with young muscle (122). In
addition to the decline in muscle size with age, there is a concomitant increase in noncontractile content of muscle in older compared with young adults (24,115).
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Accompanying the decline in muscle size, maximal voluntary force production
declines with age (79,172). In a 10 year longitudinal study of 120 adults (age 46-78
years), Hughes et al. reported 14 and 16% reductions in knee extensor and flexor
strength, respectively (93). To account for the decrease in muscle mass with age, many
researchers report specific strength (force per unit muscle cross-sectional area). Despite
lower absolute strength in older compared with young men, Kent-Braun & Ng reported
no age-related difference in specific strength of the dorsiflexors in males and females
(113). However, McNeil et al. demonstrated specific strength to be reduced in very old
adults (~85 years) compared with young (~25 years) and older (~65 years) men (157).
Callahan & Kent-Braun observed no differences in specific strength of the quadriceps in
young and older women (ref). However, Jubrias et al. reported the decline in quadriceps
cross-sectional area with age only accounted for 50% of the age-related reduction in
maximal force production (101).
Muscular power is lower in multiple muscle groups of older compared with young
adults (24,132,157,159,164). Reid et al. reported a ~9% loss in knee extensor power, but
no change in maximal isometric strength, over a 3 year period in healthy older adults
(197). Additionally, in a study of young (~26 years), old (~64 years), and very old (~84
years) men, maximal isometric strength was preserved in old, but not very old muscle
(159). However, contractile velocity and power at 20% MVIC were lower in old and
very old compared with young men. In old age (>65 years), specific power (power per
unit muscle cross-sectional area) declines at a faster rate than specific force (157).
Maximal contraction velocity declines in multiple muscle groups with age (50,132,232).
The deficits in maximal torque production and contractile velocity with age result in a
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downward shift in the torque-velocity curve (24,132,228,232) as illustrated in Figure 1.1,
and a down- and left-ward shift in the power-load or power-velocity curve
(132,157,184,228,232).
Muscle Architecture
The elegant microscopic structure of skeletal muscle fibers is well established.
However, less is known about skeletal muscle architecture, which refers to the orientation
of muscle fiber bundles (fascicles) relative to the axis of force generation, the length of
those fascicles, and the thickness of the muscle (146). The architecture of a muscle can
be characterized in vivo, using ultrasonography, by two variables: pennation angle (i.e.,
the fascicle angle relative to the axis of force generation) and fascicle length (173). In
general, muscles with large pennation angles (e.g., vastus lateralis) have a greater number
of sarcomeres in parallel and are capable of generating high forces (19). On the other
hand, muscles with longer fascicles (e.g., biceps femoris) have a greater number of
sarcomeres in series and are suited to high shortening velocities (19). Figure 2.2
illustrates the theoretical difference between a long and short fascicle on the forcevelocity curve (146).

Figure 2.2. Effect of fascicle length on the torque-velocity relationship. Adapted from Lieber and
Fridén (146).
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Several studies have shown a decrease in pennation angle and fascicle length of
the human vastus lateralis (125,191) and triceps surae (170,173,218) with age. Power et
al. reported pennation angle and fascicle length of the vastus lateralis to be ~25% and
~12% smaller and shorter, respectively, in older compared with young men (191). Kubo
et al. observed an age-related decline in the fascicle length of the vastus lateralis in men
but not women (124). Thom et al. reported fascicle length of the medial gastrocnemius to
account for ~58% of the difference in maximal contraction velocity in young and older
men (228). However, Fitzgerald et al. (unpublished observation) found that neither
muscle thickness nor fascicle length of the vastus lateralis were associated with maximal
voluntary isometric torque, maximal power at 240°.s-1, or maximal contraction velocity in
young or older women (r2≤0.261, p≥0.241). Moreover, these architectural variables were
not associated with muscle fatigue in young or older women (r2≤0.147, p≥0.397).
Muscle-Tendon Unit Stiffness
The force produced by muscular contraction is transmitted to the skeleton via
connective tissues, such as tendons and aponeuroses, to generate movement. These
connective tissues act as ‘biological springs’, which are capable of storing and releasing
elastic energy (14,95). During cyclical contractions, such as those occurring during
walking, force contributions from these ‘biological springs’ help to minimize the energy
cost of movements (208).
Theoretically, a stiffer muscle-tendon unit is capable of storing and releasing
more elastic energy. As such, force and power production could be lower in older
compared with young adults, especially during rapid muscular contractions, if there exists
an age-related difference in muscle-tendon unit stiffness. Additionally, if the muscle24

tendon unit is more compliant in older compared with young adults, metabolic economy
may be lower with age. If true, muscle-tendon unit stiffness may provide a structural
rationale for age-related differences in metabolic economy.
Muscle-tendon unit stiffness has been measured using several different methods,
including a quick release technique (61,177,178) and a technique which combines
ultrasound imaging with dynamometry measures of force (84,219). The quick release
technique models stiffness as the frequency response of a perturbed system. With this
technique, some studies have shown an increase in stiffness with age (177,178), while
others demonstrate no age-related differences (61). Because the proposed study will
measure muscle-tendon unit stiffness using the technique which combines ultrasound
imaging and dynamometry measures of force, the remainder of this literature review only
focuses on that technique.

Figure 2.3. In vivo assessment of muscle-tendon unit stiffness. Panel A shows the torque tracing
during a ramped maximal voluntary isometric contraction. Panel B shows the force-extension
relationship of the human dorsiflexor muscle. Adapted from (84).

To assess muscle-tendon unit stiffness with ultrasound imaging and
dynamometry, the elongation of the aponeurosis is visualized using ultrasonography, and
tracked using software, while simultaneous measures of force are obtained during a
ramped isometric contraction (i.e., a contraction that increases in intensity over a period
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of time). The change in length and force can be plotted, and the polynomial slope of this
relationship used as an index of muscle-tendon unit stiffness, as shown in Figure 2.3.
Using this technique, Kubo et al. reported a significant age-related decrease in
muscle-tendon unit stiffness of the vastus lateralis (a knee extensor muscle) in women
(125). Moreover, Kubo et al. observed no change in muscle-tendon unit stiffness in older
and middle-aged women in response to 6 months of low-load resistance training (e.g.,
body weight squats). An age-related decrease in muscle-tendon unit stiffness has also
been reported in the plantar flexors (150,218). Conversely, others have reported no effect
of age on muscle-tendon unit stiffness in the plantar flexors (217) or dorsiflexors (84).
Mademli et al. demonstrated that muscle fatigue induced by isokinetic contractions of the
plantar flexors at 60°.s-1 until volitional fatigue elicited no change in muscle-tendon unit
stiffness in older men (151). This finding suggests that the mechanical properties of the
muscle-tendon unit are unaffected by muscle fatigue.
Contractile Properties
The T1/2 (time required for force to fall by 50% from its peak following an
electrically-stimulated contraction) tends to be longer in older than young muscle
(24,35,50,94,114,131,189). This slowing of force relaxation has been observed in
multiple muscle groups including the dorsiflexors (35,114,131,189), knee extensors
(24,94), and plantar flexors (50). McNeil et al. reported that T1/2 of the dorsiflexors was
only longer in very old (~84 years) and not old (~65 years) compared with young (~26
years) muscle (157). Other studies have observed no age-related differences in the T1/2
(23,47,49).
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Theoretically, slowed muscular relaxation following an electrically imposed
stimulus could be caused by reduced Ca2+ uptake into the SR or a slower rate of Ca2+
dissociation from troponin (66). Because Ca2+ uptake is powered by an ATPase, slowed
muscle relaxation in older compared with young adults may be due to a reduction in the
concentration of Ca2+-ATPase with age (66). Hunter et al. investigated the cause of agerelated differences in T1/2 and reported slower relaxation times, decreased Ca2+ uptake
and Ca2+-ATPase activity in older compared with young muscle (94). However, after 12
weeks of resistance training, Ca2+ uptake and Ca2+-ATPase activity increased in older
muscle while relaxation time was unchanged (94). Based on these findings, Ca2+ uptake
by the SR is not the cause of slower muscular relaxation in older compared with young
muscle. Hunter et al. suggested that other factors affecting muscle relaxation, including
Ca2+ uptake by cytosolic buffers, the rate of Ca2+ dissociation from troponin-C,
crossbridge kinetics, and muscle-tendon unit stiffness must explain the age-related
slowing of T1/2 (94).
Muscle Fatigue and Aging
During repeated contractile activity, the force- and power-generating capacity of
muscle declines; a process known as muscle fatigue (72). In response to isometric
contractions, the literature supports relatively less fatigue in older compared with young
muscle (23,24,28,35,60,114,130,131,201,204). Callahan et al. observed a greater decline
in knee extensor MVIC in young compared with older adults (43±3% and 29±3%,
respectively) following 4min of intermittent isometric contractions (23). Using the same
protocol, Callahan & Kent-Braun reported a greater decrease in knee extensor MVIC in
young (59.8±2.5% initial MVIC) compared with older (71.1±3.7% initial MVIC) women
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(24). These 2 studies highlight the reproducibility of the observation that older adults
experience less fatigue than young adults in response to isometric contractions.
Conversely, the literature supports greater muscle fatigue in older compared with
young muscle in response to dynamic contractions, especially at high velocities (9,24,4850,159,184,189,234). One of the first studies to highlight this was conducted by Petrella
et al. who demonstrated greater fatigue, defined as the decline in peak velocity during
isotonic contractions, in older compared with young adults in response to 10 maximal
contractions of the knee extensors using a load equal to 40% MVIC (184). Recently,
Dalton et al. examined age-related differences in muscle fatigue in response to isokinetic
or isotonic contractions performed at the velocity or load, associated with peak power,
respectively (48). In that study, fatigue was defined as the number of contractions
performed until peak power declined to 40% of that achieved at baseline. The authors
reported no age-related differences in muscle fatigue in response to the isokinetic task,
but greater muscle fatigue in older compared with young in response to the isotonic task,
and suggested that age-related differences in muscle fatigue may be masked when the
contraction velocity is constrained (48). However, if the contraction velocity is
sufficiently high (e.g., 270°.s-1), older muscle has been shown to experience greater
fatigue compared with young muscle (24).
Fatigue in response to slow- and moderate-velocity contractions is similar
between age groups (23,24,49,147). Dalton et al. investigated the effect of contraction
velocity on age-related differences in muscle fatigue using 3 different knee extension
protocols (slow, 60°.s-1; moderate, 180°.s-1; and fast, isotonic at 20% MVIC) in young
and older men (49). The authors reported a similar decline in power between groups in
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response to slow (old: 53%, young 53%) and moderate (old: 45%, young 38%) velocities,
but not in response to fast contraction protocol (old: 35%, young: 23%). This study is
particularly useful for highlighting the fatigue paradox because all 3 protocols were
performed by the same participants. Combined, these studies indicate that older muscle
transitions from less fatigue in response to isometric contractions to greater fatigue in
response to high-velocity contractions.
Callahan & Kent-Braun reported strong associations between V50 (the velocity
associated with 50% MVIC) at baseline and knee extensor fatigue, induced by
intermittent contractions at V50, in both young (r = -0.63) and older (r = -0.72) women
(24). However, no associations were observed between V50 and fatigue induced by
intermittent isometric or high-velocity (270°.s-1) contractions (24). Because contractile
velocity is an important factor in power loss at baseline (49,157,159,184), maximal
contraction velocity might be a better predictor of fatigue during high-velocity
contractions than V50. Pilot data from our lab (young, n=6; older, n=4, women) indicates
that maximal contraction velocity, measured as the peak velocity during an isokinetic
contraction at 500°.s-1, explains 41% of the variance in muscle fatigue (defined as the %
initial power) following high-velocity contractions of the knee extensors (Figure 2.4).
Thus, inherently faster muscles appear to experience less fatigue in response to highvelocity contractions. Although the observation of greater fatigue in older compared with
young muscle has been observed repeatedly, the mechanisms to explain this crossover in
fatigue are not well understood.
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Figure 2.4. Relationship between maximal contraction velocity of the knee extensors and muscle
fatigue. Data are unpublished observations reported by Fitzgerald et al. 2019.

Mechanisms of Muscle Fatigue
Muscle fatigue can result from changes at any site along the pathway of force
production (Figure 1.4). Typically, the etiology of fatigue is classified as occurring due
to central (central or peripheral nervous system) or peripheral (within the muscle) factors
(112).
Bigland-Ritchie demonstrated central activation failure in response to a sustained
60s MVIC of the knee extensors in some, but not all, participants who varied in age from
25-50 years (18). In response to intermittent submaximal isometric contractions of the
knee extensors, the decline in voluntary and electrically-stimulated contractions was
shown to be markedly similar; suggesting that fatigue induced by this contraction mode
may be entirely due to failure within the muscle itself (17). Studies examining agerelated differences in central activation failure in response to isometric (4,23,35,114,131)
and dynamic (23,131) contractions generally support these early observations. However,
a few studies have reported the presence of central activation failure in response to
isometric contractions, although in these studies the magnitude of the decline in central
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activation was similar in magnitude in young and older adults (46,204). To our
knowledge, only one study has shown greater central activation failure in older compared
with young adults in response to isometric contractions (216). Thus, central activation
failure does not appear to explain the age-related differences in muscle fatigue in
response to isometric contractions. Recently, Fitzgerald et al. (unpublished observations)
reported greater muscle fatigue in older compared with young women in response to
4min of intermittent maximal voluntary dynamic contractions of the knee extensors at
240°.s-1, with no evidence of central fatigue (ratio of MVIC:80Hz peak torque) in either
group (p≥0.35).
Maximal MUDRs have been shown to decline in response to sustained MVICs
(15,16,34,46,201). The literature generally supports a similar decline in MUDRs in
response to isometric contractions with age (34,46,190). Dalton et al. reported a ~44%
decline in MUDR in young and older men in response to a sustained contraction at 75%
MVIC (46).
Peripherally, fatigue may be caused by changes within the myocellular
environment. Changes in ECC, from depolarization of the sarcolemma to Ca2+ binding to
troponin-C may contribute to muscle fatigue. In vivo, failure of ECC can be examined by
comparing the change in a muscle’s force response to electrically-evoked contractions at
low and high frequencies (67). During fatigue, the force produced by a low-frequency
stimulation may decrease (low frequency fatigue) while the force produced by a highfrequency stimulation does not decrease as much because of force summation (Figure
2.5). The decrease in force elicited by a low-frequency stimulus is likely caused by
impaired Ca2+ release from the SR (30,67,144). By comparing the ratio of torque elicited
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by low- and high-frequencies, several studies have shown that ECC is impaired with
muscle fatigue (4,7,190,203). However, the fatigue-induced decline in the ratio of lowto high-frequency force production appears to be similar in young and older adults in
response to isometric contractions (4,35). In response to 4min of intermittent maximal
voluntary dynamic contractions of the knee extensors, Fitzgerald et al. (unpublished
observations) found failure of ECC in both young and older women (p≤0.021), although
the magnitude of ECC failure was similar in young and older women (p≥0.361). These
findings suggest that ECC failure cannot explain the age-related differences in muscle
fatigue induced by high-velocity contractions.

Figure 2.5. Force responses to electrically-stimulated contractions during fatigue. Adapted from
Edwards et al. (67).

Following repeated isometric (35) and dynamic (49) contractions, the T1/2
increases in duration, likely due to a slowing of Ca2+ ATPase activity (144). However,
other factors which affect muscular relaxation may also cause this slowing, including
reduced Ca2+ uptake by cytosolic buffers, impaired Ca2+ dissociation from troponin-C,
slowed crossbridge kinetics, and decreased muscle-tendon unit stiffness.
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While some studies report a greater decrease in the T1/2 in older compared with
young muscle (49,121), this finding is not consistent across the literature (23,35). Dalton
et al. reported a longer T1/2 in older compared with young men in response to moderateand high-velocity contractions (49). The authors further reported no age-related
differences in T1/2 in response to slow-velocity contractions of the knee extensors.
Recently, Fitzgerald et al. (unpublished observations) observed slower force relaxation at
baseline in older compared with young women (p=0.003). In that study, participants
completed 4min of intermittent, high-velocity contractions of the knee extensors, which
elicited greater muscle fatigue in older compared with young women (p=0.005). In
response to fatigue, there was a similar slowing of T1/2 in young and older women
(p=0.500). Moreover, baseline T1/2 was associated with muscle fatigue in older
(r2=0.589, p=0.04) but not young women (r2=0.105, p=0.479). These findings suggest
that slower baseline contractile characteristics with age explains a significant portion of
the greater muscle fatigue in older compared with young women.
In vivo experiments have shown the loss of force during isometric contractions is
strongly associated with [H+], [Pi], and [H2PO4-] (54,238). At the molecular level,
elevated [H+], [Pi], and [H2PO4-] have been shown to impair force production and
unloaded shortening velocity (58). In vitro experiments in which [H+] is elevated to
levels observed during fatigue in vivo have shown ADP-release from the actin-myosin
complex is slowed under these conditions (57,58,123). The slowing of ADP-release
caused a reduction in contractile velocity in those experiments (57,58). Similar studies
have investigated the effects of high [Pi] and [H2PO4-] on crossbridge kinetics. Elevated
[Pi] and [H2PO4-] appear to cause myosin, with ADP still bound, to dissociate from the
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actin filament after its powerstroke, which reduces force production (56,59). However,
when [H+] and [Pi] are both present in the in vitro milieu, the effect of [H+] on contractile
velocity is attenuated (58). An additional result of high [H+] and [Pi] is a decrease in
muscles sensitivity to Ca2+ (59,181). Any reduction in the Ca2+ sensitivity during fatigue
exacerbates force loss because less Ca2+ is released from the SR in the fatigued state
(140,144). Together, the increase in [H+], [Pi], and [H2PO4-] with fatigue impair force
and power production.
The greater fatigue in young compared with older muscle in response to isometric
contractions is associated with an accumulation of the metabolic by-products of nonoxidative ATP production ([H+], [Pi], and [H2PO4-]) in young muscle (114,130). Indeed,
during a sustained 60s MVIC, ATPOX is relatively greater in older than young muscle, as
shown in Figure 2.6 (128). Lanza et al. used cuff-ischemia to test the hypothesis that
glycolytic ATP production is impaired in older muscle and found that when oxygen
supply is compromised, older muscle can upregulate its glycolytic ATP production to
similar levels observed in young muscle (130).

Figure 2.6. Relative contributions from each bioenergetic pathway to total ATP production.
ATPgly, glycolytic ATP production; ATPOX, oxidative ATP production; ATPCK, ATP derived via
the creatine kinase reaction. Adapted from Lanza et al. (128).
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Muscle oxidative capacity can be defined in vivo as the maximal rate at which a
muscle can consume oxygen under conditions in which delivery of oxygen and substrate
are not limited (29). This rate reflects the maximal rate of oxidative phosphorylation
within the muscle under study. Following a brief contraction in which intracellular pH is
relatively unchanged, the kinetics of PCr recovery follow a mono-exponential curve
which is strictly attributable to mitochondrial ATP production (6,162,194). The rate
constant of this curve (kPCr, s-1) can be determined, as illustrated in Figure 2.7, and used
as an index of muscle oxidative capacity (117). This technique for measuring oxidative
capacity is highly reliable and well correlated with in vitro respirometry measures of
mitochondrial capacity (129) and oxidative enzyme activities (134,156). Because muscle
oxidative capacity is higher in active compared with sedentary older adults, matching
groups for physical activity when examining age-related differences in muscle energetics
is an important methodological consideration (133).

Figure 2.7. Mono-exponential recovery of PCr reflects in vivo muscle oxidative capacity.
Adapted from Kent & Fitzgerald (111).
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Our recent systematic review and meta-analysis revealed older adults have
impaired oxidative capacity of the knee extensors compared with young adults (73). This
finding is illustrated by the negative standardized effect in Figure 2.8. Coupled with the
higher ATP demand of dynamic compared with isometric contractions (205), this deficit
in oxidative capacity may require older muscle to rely more on phosphocreatine (PCr)
breakdown and non-oxidative glycolysis for ATP production than young muscle. If true,
[H+], [Pi], and [H2PO4-] would increase more in older compared with young muscle,
providing a metabolic basis for the crossover to greater fatigue in older muscle during
high-velocity dynamic contractions. Additionally, an in vitro study, which used a
fluorescence-linked assay, demonstrated rat diaphragm muscles shortening at peak power
output consumed ~3x more ATP compared with that consumed during an isometric
contraction (209). Further, because ATP consumption increases with contractions of
short duration (13,89), as the production of force is more costly than the maintenance of
force (202), the energetic demands of moderate-velocity contractions may be sufficiently
low to prevent older muscle from relying on PCr breakdown and glycolysis to a greater
extent than young muscle. However, these hypotheses remain to be tested.

36

Figure 2.8. Age-related changes in muscle oxidative capacity. Data are Standardized Effects ±
Standard Error. Positive standardized effects indicate greater muscle oxidative capacity in older
compared with young adults. *indicates a significant of age (p<0.05). Adapted from Fitzgerald et
al. (73).

There are 3 main sites of ATP consumption within skeletal muscle; i) myosin
ATPase, ii) Ca2+ ATPase, and iii) Na2+/K+ ATPase. The latter 2 are commonly referred
to as pumps because they work against the concentration gradient of the ions they are
moving. The Na2+/K+ pump is located on the sarcolemma and is responsible for the
ATP-consuming process of pumping both sodium and potassium against their
concentration gradients in order to restore the resting membrane potential following
activation (37). The Ca2+ ATPase, located on the SR, pumps Ca2+ from the cytosol back
into the SR after activation; a necessary process for force relaxation. Approximately 3050% of the total ATP cost of contraction is associated with the Na2+/K+ and Ca2+
ATPases. The majority of this energy cost is attributed to Ca2+ ATPase activity (8). The
remaining 50-70% of ATP consumption is used by myosin ATPase in the crossbridge
cycle (8).
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Use of phosphorus magnetic resonance spectroscopy (31P-MRS) allows noninvasive measurement of ATP production rates during muscle contractions in vivo (20).
In 1986, Taylor et al. used 31P-MRS to examine the effect of low- and high-intensity
contractions of the forearm on [ATP] (226). The authors demonstrated that [ATP] is well
maintained during low-intensity contractions (~30% MVIC, 1 contraction every 2s for
5min), but decreased by ~45% during high-intensity contractions (100% MVIC, 1
contraction every 2s until exhaustion) in some, but not all participants. Thus, because
[ATP] is maintained until extreme levels of fatigue (226), the rate of ATP production is
equal to its rate of consumption (128,226). In studies comparing age-related differences
in ATP consumption rates, accounting for the decline in muscle mass with age by
examining the metabolic economy of muscle (ME; mass-normalized torque produced per
unit ATP consumed) is required. The few studies conducted to date suggest ME is higher
(130) or similar (31) in older compared with young muscle during maximal isometric
contractions. Christie et al. evaluated ME in the dorsiflexors of young, older, and older
mobility-impaired adults and reported no age-related differences during a sustained 12s
MVIC (31). Layec et al. also reported no age-related difference in ME in the knee
extensors of older compared with young adults during a sustained 24s MVIC (136).
However, the authors of that study did report lower ME in older compared with young
adults during intermittent contractions of the knee extensors. The latter finding suggests
there is an age-related increase in the cost of developing but not maintaining force.
To date, 2 studies have examined age-related differences in ME during dynamic
contractions (137,139). Layec et al. determined the maximal power output during an
incremental knee extension protocol and subsequently quantified ME over 5 min of knee
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extensions at 40% of each participant’s maximal work rate (139). The authors reported
significantly higher ME in young compared with older muscle.
The studies which have evaluated age-related differences in ME of human
skeletal muscle have varied considerably in methodology and the muscle studied, which
precludes a consensus being reached at this time. If ME is lower in older knee extensor
muscles compared with young during high-velocity contractions, fatigue may be
exacerbated because the energetic demand outweighs its supply. However, whether agerelated changes in ME are velocity-dependent and can provide a metabolic rationale for
the crossover in muscle fatigue is currently unclear.
Summary
In summary, fatigue is greater in older compared with young muscle in response
to high-velocity contractions. However, the mechanisms to explain this age-related
difference in muscle fatigue remain unclear at this time. Preliminary findings from
Fitzgerald et al. (unpublished observations) indicate neither central activation nor ECC
failure can explain these age-related differences in muscle fatigue. These preliminary
results do, however, suggest that slowed contractile properties at baseline can explain a
significant portion of the age-related differences in muscle fatigue in response to highvelocity contractions. However, it is unclear how these slowed contractile properties at
baseline might affect bioenergetic flux during high-velocity contractions.
Several knowledge gaps have been identified. Firstly, the extent to which deficits
in muscle oxidative capacity affect the contribution from the 3 bioenergetic pathways
during moderate- and high-velocity dynamic contractions has not been addressed.
Secondly, changes in ME may be age- and velocity-dependent and thus provide a
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metabolic rationale for the age-related differences in muscle fatigue. Lastly, age-related
differences in muscle-tendon unit stiffness may provide a structural mechanism for the
greater loss of muscular power in older compared with young adults in response to highvelocity contractions.
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CHAPTER 3
METHODS
Age-Related Differences in Muscle Fatigue: The Role of Bioenergetics
Participants
For this study, 20 young (25-40 years; 10 men) and 20 older (65-80 years; 10
men) adults will be recruited. Participants will be recruited from Amherst and the
surrounding communities using flyers, word of mouth, and mailing lists. Individuals who
have participated in previous studies and indicated their desire to participate in future
studies will be contacted via email or telephone to assess their interest in the study.
Table 3.1 shows the sample size estimates, which were calculated to detect
significant differences with 80% power, an alpha level of 0.05, and an equal number of
participants in young and older groups (GPower v3.1; (70)). Although the sample size
estimates for detecting age-related differences in ME during isometric and dynamic
contractions indicate total group sizes of 44 and 46 participants would be required,
respectively, the decision to include 20 young and 20 older adults was made due to the
financial constraints of testing additional participants. Further, the scant data available on
age-related differences in ME precludes a comprehensive estimate of the required sample
size. On the whole, the sample size estimates indicate that the recruitment of 40
participants will provide adequate statistical power to detect differences in the main
outcome variables (i.e., muscle fatigue, oxidative capacity, ME, and MTU stiffness).
Upon completion of this study, participants will receive a $30 gift card to a local store in
compensation for their time and effort.
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Table 3.1. Sample size estimates for outcome variables

Aim 1
Aim 1
H2.1a
H2.1a
H2.1a
H2.2a
H2.2a
H2.2b
Aim 3

Variable
(units)
Hi-Vel fatigue
(% initial)
Mod-Vel fatigue
(pre:post MVIC)
Oxidative capacity
(Qmax, mM ATP.s-1)
Oxidative capacity
(KPCr, s)
Oxidative capacity
(Qmax, mM ATP.s-1)
Isometric ME
(mM.min-1.Nm-1)
Dynamic ME
(mM.min-1.W-1)
ME peak power
(mM.min-1.W-1)
MTU stiffness
(kN/strain)

Ref

Muscle

Young

Older

Total
n

(24)

KE

52.1±20.7

28.0±12.3

14

(23)

KE

0.43±0.12

0.44±0.11

3280

(100)

VL

0.77±0.04

0.64±0.05

6

(133)

VL

(133)

VL

1.11±0.3

0.88±0.2

32

(136)

VL

0.06±0.02

0.10±0.07

44

(137)

PF

3.7±1.7

5.1±2.0

46

(139)

PF

2.4±1.9

7.2±4.1

14

(105)

VL

57.9±10.6

46.1±15.5

34

0.029±0.008 0.024±0.006
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Values are Mean±SD. Hi-Vel, high-velocity; Mod-Vel, moderate-velocity; T1/2, time for PCr
to recover to 50% of baseline [PCr]; Qmax, theoretical maximal rate of oxidative ATP
synthesis; kPCr, rate constant for PCr recovery; mM, millimolar; min, minute; Nm, Newton
meter; W, Watt; kN, kilo Newtons; strain, aponeurosis elongation; KE, knee extensors; VL,
vastus lateralis; PF, plantar flexors.

Except for the informed consent (Appendix A), telephone screening form
(Appendix B), Magnetic Resonance (MR) safety form (Appendix C), all documents
(paper and electronic) will be labeled with a participant code instead of the individual’s
name. All informed consent documents and the list identifying each participant’s code
number will be kept separate from documents containing the participant code and stored
in a locked cabinet. All electronic data will be kept on a password-protected computer in
a locked office, and this computer will be kept offline. Those steps will be taken to
ensure participant confidentiality.
42

Inclusion Criteria:


Young (25-40 years old) or older (65-80 years old) men or women



Relatively healthy (see exclusion criteria)

Exclusion Criteria:


Diagnosis of cardiovascular, pulmonary, musculoskeletal, neurological, or
metabolic disease



More than two 30 min bouts of moderate intensity exercise per week, as
determined by self-report during the telephone screening



Use of medications that may affect physical function or fatigue (e.g., betablockers, calcium channel blockers, sedatives, tranquilizers, etc.)



Current smoker or smoking cessation within the previous year



Clinically significant arthritis in the lower extremities



History of muscle cramps or pain



History of dyspnea, cramping, light-headedness, or other symptoms upon
exertion



Pregnant



Metal implants or unable to undergo an MRI exam (e.g., claustrophobia)

Young and older groups will be matched for habitual physical activity, which will
be measured using a uniaxial accelerometer (ActiGraph GT3X, Pensacola, FL). To help
in the recruitment of sedentary-to-recreationally active individuals, participants will be
asked about their current phyiscal activity habits during the initial phone screening.
Those who report completing more than two 30 min bouts of exercise per week will be
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excluded. Similar physical activity criteria have been used in studies examining agerelated differences in muscle fatigue in our lab (23,24,131). Visits 2 and 3 will be
separated by at least 3 days to prevent any effect of fatigue at Visit 2 affecting the
measures taken at Visit 3.
Procedures
This study will require 3 visits, all of which will take place at the University of
Massachusetts Amherst. Visit 1 will take place at the human testing center (HTC), which
is located within the Institute for Applied Life Sciences. Visits 2 and 3 will take place in
the human magnetic resonance center (hMRC), which is also located within the Institute
for Applied Life Sciences. The total time commitment for the study is approximately 3
hours. Visit 1 will involve consenting, measures of mobility and muscle-tendon unit
stiffness, and familiarization with the fatigue protocols to be completed at Visits 2 and 3.
Measures of muscle contractile and non-contractile volumes, intracellular bioenergetics,
and fatigue (1st of 2 protocols) will be made at Visit 2. Lastly, measures of oxidative
capacity, intracellular bioenergetics, and fatigue (2nd of 2 protocols) will be made at Visit
3.
At the beginning of Visit 1, the participant will read and sign an informed consent
document, as approved by the Institutional Review Board at the University of
Massachusetts Amherst, and in accordance with the Declaraction of Helsinki. With the
exception of this informed consent document and the MR safety form (Appendix C), all
participant information will be de-identified. All individuals in the older group will be
asked to sign a letter requesting their physician’s clearance to participate in Visits 2 and
3. Once their physician has reviewed the study information and given their approval, the
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older participant will be scheduled for their second and third visits. If their physician
does not approve the individual to participate in Visits 2 and 3, we will not schedule any
further visits for that participant. A conceptual framework for the study is shown in
Figure 1.6.
Paperwork and Anthropometrics
Each participant will complete 3 documents, including the MR safety form
(Appendix C), medical history form (Appendix D), and Physical Activity Readiness
questionnaire (Appendix E). After completing the paperwork, the participant’s height,
body mass, and seated blood pressure will be measured using standardized procedures
(23,24,131,132).
Mobility Measures
In order to facilitate comparisons with previous studies, two common metrics of
mobility will be completed to help characterize the participant’s physical function. First,
the participant will complete the Timed-Up-and-Go (TUG) test, which is measured as the
time a participant takes to stand up from a seated position, walk 3m, return to the chair
and sit down (188). This test will be completed twice with 1 min of rest between each
trial, and the fastest of the 2 trials will be used to characterize the participant’s mobility.
Participants will be instructed to complete the TUG at their usual walking speed (188).
Next, the participant will complete the Advanced Short Physical Performance Battery
(SPPB-A) which includes 3 parts that combine measures of chair rise time, balance time
in 3 different positions, and gait speed over a 4m path (210). The time required to
completely stand up and sit back down 10 times in a standardized chair (seat height =
45cm) will be recorded with a stopwatch. For the chair rise task, the participant will be
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instructed to fold their arms across their chest and complete the task as fast as possible.
For the balance tasks, the participant will stand with their feet in 3 different positions
(side-by-side, semi-tandem, and tandem) for as long as possible, up to a maximum of 30s.
If the participant loses their balance and reaches out for the wall or the research assistant,
the trial will be stopped and the time the participant was able to hold the balance position
will be recorded. Next, the participant will walk along a straight, 4m path at a casual
speed as though they were walking along the street. This test will be repeated twice with
1 min between trials. The time to walk 4m will be recorded using a stopwatch, and the
fastest time will be used for analysis. This walking test will then be completed, with the
same instructions, while the participant tries to walk within a 20cm path. Each measure
of the SPPB-A will be scored, from 0-4, and summed to facilitate comparisons with other
studies (210). For both mobility tests, a research assistant will be present to provide
support and guard against falls, as necessary. The principal investigator will initiate each
task verbally and record the duration of timed tasks using a stopwatch.
Muscle-Tendon Unit Stiffness
After completing the mobility tests, the participant’s thigh, shank, and total leg
length will be obtained using a tape measure. A small mark will be made with indelible
ink at the midpoint between the lateral femoral condyle and greater trochanter of the
femur. Next, the participant will perform 5 min of unloaded cycling on a recumbent
cycle ergometer (Schwinn, Nautilus, Inc., Vancouver, Washington), in order to “warm
up.” The participant’s dominant leg will then be determined by asking “which leg would
you use to kick a ball?” This leg will be used for all measures of muscle tendon-unit
stiffness. The participant will be seated on an Biodex 4 dynamometer (Biodex Medical
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Systems, Shirley, NY) in an upright position with their hips at 90° and a starting knee
angle of 100° extension (180° = full extension). Next, the participant will complete 2
maximal isometric voluntary contractions, with 1 min rest between each contraction to
prevent muscle fatigue. These isometric contractions will be completed at a knee angle
of 100°, and each contraction will be held for ~3-4s. If peak torque differs by greater
than 10%, an additional maximal voluntary isometric contraction. Once baseline
isometric torque is determined, the participant’s vastus lateralis will be visualized using
an ultrasound system (Affiniti 70, Philips Healthcare, Bothell, WA). Specifically, Bmode ultrasound will be obtained using a linear array transducer (Philips model: L12-5)
and an insonation angle of 60° (191). The transducer will be placed over the midpoint of
the vastus lateralis, identified as 50% of the length between the greater trochanter and
lateral epicondyle, and adjusted as necessary to obtain the best visualization of the muscle
fascicles, and superficial and deep aponeuroses. Next, participants will complete 5
ramped isometric contractions (i.e., contractions which increase in intensity over time)
while an ultrasound video of the participant’s vastus lateralis is obtained concurrently.
Force feedback will be provided throughout these ramped contractions, and participants
will be asked to match a visual target. The duration of these ramped isometric
contractions will be determined during pilot testing, but will be between 10 and 30s. The
displacement of the deep aponeurosis will be tracked using an automated, custom-written
MatLab program, and plotted against the increase in torque from the ramped isometric
contraction. The slope of this relationship will be fit with a 2nd order polynomial to
determine the muscle-tendon unit stiffness (84).
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Familiarization: Fatigue Trials
While still seated on the Biodex 4 dynamometer, the participant will complete
two 40-s trials of dynamic contractions with their dominant leg to familiarize them with
the fatigue trials to be performed at Visits 2 and 3. Specifically, the participant will
complete 40s of maximal voluntary dynamic contractions at 120°.s-1 and 240°.s-1, with 1
contraction completed every 2s. Each contraction will be cued by an audible beep, and
all dynamic contractions will be completed over a 35° range of motion (105-140°) for
each velocity tested. For all contractions, the participant will be asked to fold their arms
across their chest and “kick out their leg as hard and fast as possible.” Visual feedback
regarding torque will be provided using an LED box for all contractions.
Habitual Physical Activity
At the end of Visit 1, the participant will be given an accelerometer and activity
log (Appendix F), and asked to wear the device for a 7 day period. The participant will
be instructed to wear the accelerometer at their right hip, and data will be recorded with a
60s epoch. A minimum of 10 hours of accelerometry data will be required per day to be
included in the analysis, and data will be required for a minimum of 4 complete days (3
weekdays and 1 weekend day). These criteria have been demonstrated to provide good
reliability for quantifying overall, light, and moderate-to-vigorous physical activity
(153,154). To assist with capturing activities not detectable by this accelerometer (e.g.,
swimming, cycling, etc.), the participants will also be given an activity log and asked to
record their daily activities, sleep schedule, times the accelerometer was removed, and
activities which they consider to be atypical for them. ActiLife v6.13 software
(ActiGraph, Pensacola, FL) will be used to calculate average daily activity counts as well
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as minutes spent in moderate-to-vigorous physical activity, using established cutpoint
thresholds for uniaxial ActiGraph accelerometers (74).
Muscle Cross-Sectional Area
Upon arriving for Visit 2, the participant will be asked to remove all jewelry and
any other metallic objects on their person. To ensure their safety, participants will also
walk through an upright metal detector, and have a hand-held metal detector passed over
their body. Next, they will be positioned supine inside a MR scanner (Skyra 3T, Siemens
Medical Systems, Erlangen, Germany) while T1-weighted images of the thigh of their
dominant leg, determined at Visit 1, are obtained using an 18 channel phased-array coil.
The acquisition parameters for these images will be: turbo spin echo sequence, echo time
= 8.1ms, matrix = 192x192, field of view = 230x230mm, slice thickness = 6mm with no
gaps. An example of the T1-weighted images to be obtained is shown in Figure 3.1.
A custom-written MatLab program (MathWorks, Natick, MA) will be used to
quantify the fat-free muscle cross-sectional area (CSA, cm2) of the knee extensors, as
previously done in our lab (24). This MatLab program will parse intramuscular fat from
muscle tissue, which is particularly useful in studies of aging because intramuscular fat
content increases with age (24,90). The program achieves this by analyzing the signal
intensity of pixels within a region of interest, selected by the investigator, and producing
a histogram of those signal intensities. The histogram displays 3 peaks corresponding to
the signal intensity from bone and connective tissue, muscle, and fat. By selecting the
outer boundaries of the peak from muscle, thresholds are assigned for the signal intensity
from muscle. Next, the muscle perimeter will be manually traced, avoiding any
subcutaneous fat, and the MatLab program will compute the muscle CSA (cm2) and fat
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CSA (% total) for each slice. Muscle volume will be calculated as the sum of CSAs for
the knee extensor muscles. To eliminate the possibility of inter-investigator error, the
same investigator will analyze all MR images.
Intracellular Bioenergetics
After the images have been obtained, participants will be removed from the MR
scanner and a dual-tuned (proton and phophorus; 10 × 8cm) copper coil will be affixed
over the vastus lateralis of their dominant leg using athletic wrap and tape. The
participant will then be re-positioned inside the scanner. The knee and ankle of the leg
will be strapped to a custom-made knee extension ergometer using Velcro straps (Figure
3.2). Additionally, an inelastic stap will be fastened over their hips to prevent unwanted
movement. This ergometer is capable of imposing and recording isometric, isokinetic
and isotonic contractions of the knee extensor muscles (96).
Gradient-echo scout images will be obtained to ensure the vastus lateralis of the
participant’s dominant thigh is positioned within the isocenter of the magnet. The
homogeneity of the magnetic field will be optimized by localized shimming on the proton
signal of tissue water. The participant will then complete either a moderate- or highvelocity fatigue protocol (see Fatigue Protocols), the order of which will be randomized
across Visits 2 and 3. Cytosolic pH and concentrations of phosphorus-containing
compounds will be continuously and noninvasively obtained using 31P-MRS. These
measures will be acquired for 90s before, during, and 10 min after completion of the
fatigue protocol at Visits 2 and 3. The acquisition parameters for these spectra will be:
hard pulse, 60° flip angle, 2000ms repetition time, 2048 complex points, 4000Hz spectral
width, 465 total acquisitions.
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The MRS free induction decays will be analyzed using jMRUI v6.0beta. For Aim
1, spectra will be averaged to achieve 90s and 20s resolution at rest and during the fatigue
protocol, respectively. For the recovery period, the time resolution will be 8s and 30s
during the first and last 5 min, respectively. This time resolution will yield better signalto-noise than if no averaging is performed, and will provide better time resolution than
previous investigations examining age-related differences in muscle fatigue using 31PMRS (114).
Once averaged, spectra will be zero-filled (2,048 points) and Fourier-transformed.
A 1Hz Lorentzian filter will be applied and the spectra will be manually phased. After
setting the PCr peak to 0 parts per million, the spectra will be line-fit using the AMARES
algorithm and the area under the peaks corresponding to phosphomonoesters, Pi,
phosphodiesters, PCr, and gamma ATP quantified (Figure 3.3, panel A). The
concentrations of Pi and PCr will be calculated assuming that [Pi] + [PCr] = 42.5mM in
resting muscle (161). Intracellular pH will be calculated based on the chemical shift (σ)
of Pi relative to PCr (168). Because broadening and splitting of the Pi peak can occur
due to distinct pH pools during contractions (180), 2 curves will be used to fit Pi and the
weighted average of the 2 peaks will be used when Pi splitting is evident as described in
[Eq. 3.8]. The concentration of H2PO4- will be calculated as (127):

H PO

1
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Pi
10

[Eq. 3.1]
.

Fatigue Protocols
Once positioned inside the MR scanner at Visits 2 and 3, and with the dual-tuned
coil affixed over the participant’s vastus lateralis, the participant will complete 2 MVICs
with 1 min of rest between each, to determine peak torque at baseline. If the 2 peak
values differ by more than 10%, 1 additional MVIC will be performed. Participants will
then perform 2 sets of 3 MVDCs, with 1 min of rest between sets to prevent muscle
fatigue, to determine peak power at baseline. Because of the physical constraints of the
MR scanner’s bore, the range of motion for all dynamic contractions will be limited to
30° with a starting knee angle of ~110° (180° = full extension). The velocity of these
dynamic contractions will be matched to the velocity of the fatigue trial (i.e., 120°.s-1 or
240°.s-1) the participant will perform at this visit.
After baseline measures of maximal torque and power have been obtained, the
participant will complete a fatigue trial consisting of 4 min of MVDCs at one of 2
velocities. The moderate-velocity fatigue protocol will consist of MVDCs at 120°.s-1.
Because each contraction will last ~0.3s and participants will complete 1 contraction
every 2s, the duty cycle will be ~13%. The high-velocity fatigue protocol will consist of
1 MVDC every 2s at 240°.s-1, providing a duty cycle of ~7.5%.
Participants will be cued for each contraction with an auditory tone and verbal
encouragement will be provided by a research assistant. Visual feedback will also be
provided using a large screen visible to the participant. Measures of torque, velocity, and
knee angle will be collected at 500Hz using a custom-written MatLab user interface for
all isometric and dynamic contractions. Peak torque during each dynamic contraction
will be identified during the isovelocity phase. The peak power produced during each
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contraction will be calculated as the product of peak torque and the corresponding
velocity observed at that time, as illustrated in Figure 3.4. The peak power achieved
during the 2 sets of 3 baseline MVDCs will be used to provide a visual target, which
participants will be able to view real-time throughout the fatigue trial. To determine the
relative decline in peak power, fatigue during the moderate- and high-velocity protocols
will be calculated as (24):

average peak power over final 5 contractions
average peak power at baseline and during fatigue trial

100

[Eq. 3.2]

Muscle Oxidative Capacity
Upon arrival at hMRC for Visit 3, the participant will be safety screened,
positioned inside the MR scanner with the dual-tuned coil fastened over the vastus
lateralis of their leg, and their knee and ankle strapped to the ergometer using the same
procedures as at Visit 2. Gradient scout images will be obtained to ensure the participant
is correctly positioned inside the MR scanner and the magnetic field will be optimized
using the same method as Visit 2. The participant will then perform a sustained 24s
MVIC of their knee extensors. The duration of this contraction has been demonstrated to
deplete PCr in the vastus lateralis muscle by ~50% from resting concentration with little
change in pH (133). Concentrations of phosphorus-containing compounds will be
acquired for 90s before, during, and 10min following the contraction using the same
parameters as those described for Visit 2. This procedure will be completed prior to the
fatigue trial.
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All free induction decays will be analyzed using jMRUI v6.0beta. Spectra will be
zero-filled (2,048 points) and Fourier-transformed. A 1Hz Lorentzian filter will be
applied and the spectra will be manually phased. After setting the PCr peak to 0 parts per
million, the spectra will be line-fit using the AMARES algorithm and the area under the
peaks corresponding to phosphomonoesters, Pi, phosphodiesters, PCr, and gamma ATP
quantified (Figure 3.3, panel A). The concentrations of Pi and PCr will be calculated
assuming that [Pi] + [PCr] = 42.5mM in resting muscle (161). Intracellular pH will be
calculated based on the chemical shift (σ) of Pi relative to PCr (168).
Once pH and the concentrations of PCr, Pi and ATP have been determined, the
repletion of PCr during the 10 min recovery period will be fit with a monoexponential
function and the rate constant (kPCr) determined, as shown in equation [3.3]. Examples of
a 31P spectrum and monoexponential recovery of PCr are illustrated in Figure 3.3. In
equation [3.3], PCrex is [PCr] at the end of the contraction, and ΔPCr = (PCrrest – PCrex),
where PCrrest is [PCr] at rest. The rate constant of PCr recovery, kPCr (s-1), reflects the
capacity for oxidative phosphorylation under these conditions. This measure is highly
reliable and well correlated with respirometry measures of maximally stimulated in vitro
(i.e., state 3) respiration (129) and oxidative enzyme activities (134,156).

PCr t

∆PCr 1

e

PCr

[Eq. 3.3]

ATP Cost of Contraction
Under conditions where there is no net change in [ATP], ATP production can be
assumed to be equal to ATP consumption (20,226). As a result, the rates of ATPCK,
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ATPGLY, and ATPOX can be calculated during contractions. These measures will be made
during the 24s MVIC used to determine oxidative capacity, as well as during the first 24s
of the moderate- and high-velocity fatigue protocols to address Aim 2.
The MRS free induction decays will be analyzed using jMRUI v6.0beta. For Aim
2, spectra will be averaged to achieve 90s and 4s resolution at rest and during the first 24s
of the fatigue protocol, respectively. This time resolution was chosen to yield adequate
signal-to-noise for calculating the bioenergetic flux calculations (128).
Once averaged, spectra will be zero-filled (2,048 points) and Fourier-transformed.
A 1Hz Lorentzian filter will be applied and the spectra will be manually phased. After
setting the PCr peak to 0 parts per million, the spectra will be line-fit using the AMARES
algorithm and the area under the peaks corresponding to phosphomonoesters, Pi,
phosphodiesters, PCr, and gamma ATP quantified (Figure 3.3, panel A). The
concentrations of Pi and PCr will be calculated assuming that [Pi] + [PCr] = 42.5mM in
resting muscle (161). Intracellular pH will be calculated based on the chemical shift (σ)
of Pi relative to PCr (168).
The rate of PCr breakdown by the CK reaction will be established by the rate of
decline in PCr at each 4s time point during the 3 contraction protocols (i.e., 24s MVIC,
120°.s-1, and 240°.s-1), as follows:

∆PCr
∆t

ATP
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[Eq. 3.4]

Oxidative ATP synthesis will be quantified under the assumptions that the resting
concentration of ATP is equal to 8.2mM (82), and the phosphorylation potential
([Pi][ADP]/[ATP]) is regulated with a Km of 0.11 (235), as follows:

ATP Pi
K PCr

ADP

[Eq. 3.5]

where [Pi] and [PCr] will be averaged every 4s during the contractions. The equilibrium
constant of the CK reaction, KCK, will be corrected for pH, as follows:

K

1.66

10

.

[Eq. 3.6]

Intracellular pH will be calculated based on the chemical shift (σ) of Pi relative to
PCr, in parts per million, as follows (168):

pH

6.75

log

σ 3.27
5.69 σ

[Eq. 3.7]

If Pi splitting is evident, the pH pH corresponding to each Pi pool will be calculated
separately (based on the linefit of each of 2 Pi peaks), and the weighted average will be
determined as follows (128):

pH

pH

area Pi
total Pi area
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pH

area Pi
total Pi area

[Eq. 3.8]

Glycolytic ATP synthesis will be calculated based on changes in pH and PCr during each
24s contraction, using linear regression for the rate of change. Proton consumption by
the CK reaction, buffering, and oxidative proton production will also be taken into
account, as follows:

ATP

1.5

β

∆pH
∆t

θ

∆PCr
∆t

𝑚ATP

[Eq. 3.9]

where β represents the total buffering capacity, which will be calculated as the sum of
inherent buffering, and buffering from bicarbonate and Pi (108). Proton production by
oxidative phosphorylation is represented as m (108). The proton stoichiometry of the CK
reaction coupled with ATP hydrolysis, θ, will be calculated, as follows:

θ

1
1

10

.

[Eq. 3.10]

The total rate of ATP production (mM.s-1) will be calculated as the sum of ATP
flux through the CK reaction, non-oxidative glycolysis, and oxidative phosphorylation
(31). Absolute quantities of ATP production (mM) will be determined by multiplying the
total rate of ATP production (mM.s-1) by the duration of the contraction (i.e., 24 s). To
evaluate age-related differences in ME for each condition (i.e., isometric, 120°.s-1, and
240°.s-1), the torque-time integral will be normalized to muscle volume and ATP
production (Nm.s.cm-3.mM ATP-1), as previously reported by our lab (31).
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Outcome Variables and Statistical Analyses
The primary outcome variables for this dissertation include oxidative capacity
(kPCr), [H+], [Pi], and [H2PO4-] during both fatigue trials, peak power (W), and the ME
(Nm.cm-3.mM ATP-1) for isometric and dynamic contractions at 120°.s-1 and 240°.s-1.
Group descriptive characteristics will include age, height, body mass, blood pressure,
TUG, and SPPB-A. All statistical analyses will be performed using SPSS v24.0 (SPSS
Inc., Chicago, IL). Significance will be accepted at the p≤0.05 level. Exact p values,
95% confidence intervals for the differences in group means, as well as mean±SE will be
reported. All data will be checked for violations of statistical assumptions (e.g.,
normality) and non-parametric alternatives will be performed where appropriate.
Differences in group descriptive characteristics will be analyzed using independent ttests. Prior to hypothesis testing, all variables will be evaluated for differences by sex,
and sex-by-age interactions. In the event differences or interactions are detected, the
statistical plan will be adjusted accordingly.
Hypotheses
Aim 1:
H 1a: Baseline oxidative capacity of the vastus lateralis will be higher in young
than older adults.
H 1b: Cytosolic [H+], [Pi] and [H2PO4-] will increase to a greater extent in older
than young muscle during the high velocity (240°.s-1) fatigue trial.
H 1c: Neither fatigue nor cytosolic [H+], [Pi] and [H2PO4-] will differ between
age groups during the moderate velocity (120°.s-1) fatigue trial.
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H 1d: The proportion of ATP derived from oxidative phosphorylation will be
lower in older than young muscle during the high velocity (240°.s-1) fatigue trial, but not
between groups during moderate velocity (120°.s-1) fatigue trial.
Aim 2:
H 2a: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be higher in older
compared with young muscle during a 24s isometric contraction.
H 2b: Metabolic economy (Nm.s.cm-3.mM ATP-1) will not be different between
age-groups during contractions at 120°.s-1.
H 2c: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be lower in older
compared with young muscle during contractions at 240°.s-1.
Exploratory Aim:
EH 1a: Muscle-tendon unit stiffness of the vastus laterlis will be greater in young
compared with older adults.
EH 1b: Muscle-tendon unit stiffness will be positively associated with fatigue
(defined as % initial power) induced by high-velocity contractions (240°.s-1).

Hypothesis 1a will be tested by comparing oxidative capacity (kPCr) between
young and older groups using an independent t-test. Hypotheses 1b will be tested by
comparing [H+], [Pi], and [H2PO4-] using 2-way MIXED procedure repeated measures
ANOVA’s (group × time). For this analysis, metabolite concentrations over each 20s
time period during the high velocity (240°.s-1) fatigue trial (i.e., 12 time points) will be
used. Hypothesis 1c will be tested in the same way as hypothesis 1b, but using the data
from the moderate velocity (120°.s-1) fatigue trial. Hypothesis 1d will be tested by
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comparing group differences in the proportion of ATP derived from oxidative
phosphorylation (ATPOX/ATPTOTAL) using 2-way MIXED procedure repeated measures
ANOVA’s (group × time) for each fatigue trial. If significant differences are found for
hypotheses 1b-d and the null hypotheses are rejected, post-hoc testing on the differences
between groups will be evaluated.
Hypothesis 2a will be tested by comparing group differences in metabolic
economy (Nm.cm-3.mM ATP-1) using a 2-way MIXED procedure repeated measures
ANOVA (group × time) during the 24s MVIC. Hypothesis 2b will be tested by
comparing group differences in metabolic economy (Nm.cm-3.mM ATP-1) using a 2-way
MIXED procedure repeated measures ANOVA (group × time) during the first 24s of the
moderate velocity fatigue protocol. Hypothesis 2c will be tested by comparing group
differences in metabolic economy (Nm.cm-3.mM ATP-1) using a 2-way MIXED
procedure repeated measures ANOVA (group × time) during the first 24s of the high
velocity fatigue protocol.
Exploratory hypothesis 1a will be tested by comparing group differences in
muscle-tendon unit stiffness using an independent t-test. The second exploratory
hypothesis (1b) will be tested using a linear regression analysis to examine the
relationship between muscle-tendon unit stiffness and muscle fatigue in response to the
high velocity (240°.s-1) fatigue trial.
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Figure 3.1. Example MRI of the thigh musculature. The image shown was obtained from 1 young
male.

Figure 3.2. Overview of the MR-compatible ergometer. Adapted from Jaber (96).
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Figure 3.3. 31Phosphorus spectrum and oxidative capacity from one young woman. Panel A
shows a resting 31P Spectrum. Panel B shows the rate constant of PCr recovery obtained from 1
young woman. PME, phosphomonoesters; Pi, inorganic phosphate; PDE, phosphodiesters; ɣATP, gamma ATP peak; α-ATP, alpha ATP peak; β ATP peak.
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Figure 3.4. Representative torque and velocity trace during a maximal voluntary dynamic
contraction. Peak torque was generated while velocity was constant at 240°.s-1.

Chapter 3: Addendum
Following the proposal of this dissertation in July 2017, several methodological
amendments were made. First of these was that we were unable to collect data on 20
young (10 men) and 20 older (10 men) adults due to budget constraints. As such, we
recruited and collected data from 10 young (6 men) and 10 older (5 men) adults. Pilot
testing necessitated changes to the MR imaging sequence, high-velocity fatigue protocol,
and MTU stiffness measurement. Amendments from the originally proposed methods are
outlined below, along with a rationale for those changes.
Magnetic Resonance Imaging
The original proposal included the collection of T1-weighted MR images of the
thigh musculature. Pilot testing revealed a significant dielectric effect in the T1-weighted
MRI’s using our Skyra 3T scanner (Siemens Medical Systems, Erlangen, Germany), as
shown in upper panel of Figure 3.5. This dielectric effect precluded accurate separation
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of muscle and fat during offline quantification. So that muscle and fat could be
accurately quantified in all participants in the studies composing this dissertation, we
used a 6-pt Dixon imaging technique (51,145). A representative image collected using
the 6-pt Dixon technique is shown in bottom panel of Figure 3.5. To accurately quantify
muscle and fat from these images, a custom MatLab (Mathworks, Natick, MA) program
was written. All images were analyzed by the same investigator.

Figure 3.5. Representative T1-weighted and Dixon magnetic resonance images. A T1-weighted
image with artefacts is shown in the upper panel. Note the difference in pixel intensity between
muscle in left vs. right hand side of the image. A representative 6-point Dixon in-phase, oppositephase, and fat image are shown in the bottom panel. This technique allowed for more accurate
quantification of contractile volume and fat deposition within the muscle at 3T. Data are from 1
young man.

High-Velocity Fatigue Protocol
For Study 1, we proposed 2 fatigue protocols; 4 min of dynamic contractions (1
every 2s) at either a moderate or a high velocity. All participants were able to
successfully attain 120°.s-1, and were therefore able to complete the moderate-velocity
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contractions. However, the older adults were unable to achieve the target velocity
(240°.s-1) required for the proposed high-velocity contractions (Figure 3.6). Notably,
there was no isovelocity period during these contractions. Because of this, the torque and
velocity varied throughout each contraction which would have resulted in a different
fatigue protocol for the young and older adults. To solve this issue, the high-velocity
fatigue protocol was changed to 4min of dynamic contractions (1 every 2 s) at a load
equivalent to 20% maximal isometric torque. This protocol has been used to evaluate
age-related differences in muscle fatigue during contractions inside the MR-environment
(223).

Figure 3.6. Representative torque and velocity traces at the beginning of the proposed highvelocity fatigue trial. Torque (A) and velocity (B) are from 1 older woman. Note there is no
isovelocity period during the contractions and peak velocity is substantially below the target of
240°.s-1.
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MTU Stiffness Measurement
In Study 1, we planned to quantify in vivo muscle-tendon unit stiffness of the
knee extensors by combining isometric dynamometry and real-time ultrasound imaging.
Synchronization of the Biodex system 4 dynamometer (Biodex Medical Systems, Shirley,
NY) and ultrasound imaging system (Affiniti 70, Philips Healthcare, Bothell, WA) was
not straightforward. To synchronize the equipment, raw torque, velocity, and position
signals from the Biodex 4 dynamometer were streamed wirelessly, along with an EMG
signal from the rectus femoris, to an offline PC using a ±5 V anaolg adapter (Trigno,
Delsys Inc., Natick, MA). These data were recorded in EMGWorks (Delsys Inc., Natick,
MA).
The torque signal was calibrated across the range of torques expected (14-points)
by hanging weights off the Biodex lever arm. The velocity signal was calibrated between
-300 and 300°.s-1 (14-points) during pilot work. Briefly, one young male volunteered to
perform dynamic contractions at distinct velocities (60, 120, 180, 240, 300°.s-1 flexion
and extension). An additional calibration point (0°.s-1) was sampled while the
dynamometers lever arm was stationary. Lastly, the position signal was calibrated using
14-points which captured the range of positions achieved during the familiarization trials.
Torque, position, and velocity signals were sampled at 148 Hz due to the hardware
constraints of the ±5 V anaolg adapter.
Because real-time force-feedback was not possible within the EMGWorks
software, real-time feedback was provided based on the RMS EMG signal, which was
scaled from 0-100% based on the RMS EMG signal during the 3-5 s MVIC at baseline.
The RMS EMG signal was sampled at baseline and over a 0.25 s period covering the

66

peak isometric torque during the 3-5 s MVIC trials. The maximum RMS EMG signal
and offset (i.e., baseline RMS EMG signal) was used to scale visual feedback during the
30-s ramped isometric trials, which was clearly displayed on a 27 inch LED monitor
positioned in front of the participant at eye-level. After the deep and superficial
aponeuroses were visualized on the ultrasound screen, a 5 V pulse was sent from the
ultrasound system to EMGWorks via a trigger (Delsys Inc., Natick, MA), which initiated
the 30-s ramped isometric contraction. Real-time feedback was provided based on the
RMS EMG signal, which was scaled to the maximal RMS EMG from the 3-5 s MVICs.
Ultrasound videos and torque signals were saved for offline analysis.
The sampling frequency of the ultrasound videos varied, depending on the depth
of the acquired images (range: 26.3 to 41.8 Hz). Because the sampling frequency was not
identical to that of the torque signal, the torque data were downsampled to match the
sampling frequency of the corresponding torque data using a piecewise cubic hermite
interpolating polynomial function in MatLab (MathWorks, Natick, MA). The
EMGWorks software, which recorded the torque signals, was triggered to begin
recording on the negative edge of the 5 V synchronization pulse. Using an A/D board,
we discovered that the time delay between the recording of the ultrasound and torque
signals was 1-s. To account for this, the ultrasound and torque signals were synchronized
by removing the first 1-s data from the ultrasound signal.
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CHAPTER 4
ROLE OF BIOENERGETICS IN AGE-RELATED DIFFERENCES IN KNEE
EXTENSOR MUSCLE FATIGUE
Abstract
In response to a period of contractile activity, the capacity to produce torque or power is
reduced; a phenomenon known as muscle fatigue. Previous work has shown muscle
fatigue is generally greater in older than young adults in response to high-velocity
contractions, but similar between age groups in response to moderate-velocity
contractions. The purpose of this study was to evaluate whether age-related differences
in muscle fatigue in response to two distinct bouts of contractions are due to differences
in the accumulation of putative agents of fatigue (i.e., inorganic phosphate (Pi),
diprotonated phosphate (H2PO4-), and pH). We hypothesized in vivo oxidative capacity
of the vastus lateralis would be lower in older compared with young adults in the
unfatigued state. We further hypothesized that fatigue would be greater in older than
young adults in response to 4 min of isotonic contractions against a load equivalent to
20% maximal isometric torque (MVDC20%), and that this would be accompanied by
greater [Pi] and [H2PO4-], and a lower pH in older muscle. Conversely, we expected to
observe no age-related differences in fatigue, [Pi], [H2PO4-], or pH in response to 4 min
of isokinetic contractions performed at 120°.s-1. Lastly, we hypothesized that the
proportion of ATP derived from oxidative phosphorylation would be lower in older
compared with young muscle during the MVDC20% bout of contractions, but not different
between age groups during the MVDC120 protocol. Phosphorus magnetic resonance
spectroscopy (31P-MRS) was used to quantify [Pi], pH, and [H2PO4-] in the knee extensor
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muscles in 10 young (YA; 27.5±1.2 yrs, 6 men) and 10 older (OA; 71.2±1.6 yrs, 5 men)
healthy adults, matched for habitual physical activity, throughout both fatigue protocols.
Muscle oxidative capacity, measured as the rate constant of PCr recovery following 24 s
of maximal voluntary dynamic contractions at 120°.s-1 (1 every 2 s) was not different
between groups (YA: 0.021±0.001 vs. OA: 0.022±0.001 s-1, p=0.632). Fatigue (% initial
power-time integral) was not different between groups in response to the MVDC20%
protocol (YA: 69.6±3.4% initial, OA: 69.7±6.5%, p=0.546), despite a lower pH and
greater [H2PO4-] in YA compared with OA muscle (main effects of group: p≤0.001).
Coincident with these observations, ATP flux through non-oxidative glycolysis was
higher in YA than OA during the MVDC20% protocol (main effect of group: p=0.032),
and the initial velocity of PCr resynthesis (Vi[PCr]: a measure of oxidative ATP flux)
increased from baseline to the end of the MVDC20% in OA (p=0.01) but not YA
(p=0.577). In contrast, fatigue was greater in YA than OA in response to the MVDC120
protocol (40.8±3.0 vs. 60.8±5.7%, p=0.007), and accompanied by greater [Pi] and
[H2PO4-], and lower pH in YA compared with OA (main effects of group: p≤0.001).
There was a main effect of group on non-oxidative glycolytic ATP flux (p=0.001) during
the MVDC120 protocol, such that it was higher in YA than OA. Oxidative ATP
production, measured as Vi[PCr], increased from baseline to the end of the MVDC120
protocol in OA (p=0.025) but not YA (p=0.512). Collectively, these results support a
preponderance for oxidative ATP production during in vivo contractions of the knee
extensor muscles, at two distinct loads, in OA compared with YA. Further, these results
suggest the contractile machinery may be more sensitive to changes in pH in older
compared with young muscle.
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Introduction
Muscle fatigue can be defined as the reduced capacity of a muscle to produce
torque or power in response to a period of contractile activity (112). Because activities of
daily living, such as climbing stairs or walking, require repeated dynamic contractions
(184), the ability to resist muscle fatigue may be especially important for older adults in
order to maintain their quality of life (227). Numerous studies have reported less fatigue
in older (≥ 65 years) compared with young adults (≤ 40 years) in response to isometric
contractions (28,35,60,114,130). Conversely, greater fatigue has been observed
repeatedly in older compared with young adults in response to high-velocity contractions
(9,24,48,49,159). This observation has been made in studies using both isokinetic and
isotonic dynamic contractions (24,48,49,222). Notably, fatigue is similar in young and
older adults in response to contractions at slow or moderate velocities (e.g., ≤120°.s-1 in
the knee extensor muscles (23,24,49,147).
The relative fatigue resistance of older compared with young adults during
isometric contractions is thought to arise from the greater proportion of ATP produced
via oxidative phosphorylation (ATPOX) in older adults (25,128). Because of this greater
reliance on oxidative phosphorylation, inorganic phosphate (Pi), proton (H+), and
diprotonated phosphate (H2PO4-), which are known to inhibit crossbridge kinetics
(57,59,176), accumulate to a lesser extent in older compared with young muscle

70

(114,128). Indeed, a computational model examining the etiology of age-related
differences in muscle fatigue supported the notion that fatigue resistance during isometric
contractions is due to a lower reliance on glycolytic ATP production (25). However, the
mechanisms responsible for age-related differences in fatigue during dynamic
contractions are less well established.
Recent work in our lab demonstrated that the greater muscle fatigue in older
compared with young women in response to 4 min of high-velocity (240°.s-1) contractions
of the quadriceps muscles was not due to greater deficits in voluntary activation or
excitation-contraction coupling with age (Appendix G). Others have also shown greater
fatigue in older than young adults in response to high-velocity contractions of the knee
extensor and plantar flexor muscles, and that this fatigue was not due to age-related
deficits in voluntary activation (50,222). Rather, Sundberg et al. reported that fatigueinduced changes in the electrically-evoked twitch amplitude were strongly associated
with fatigue in response to voluntary contractions, which was greater in older compared
with young adults (222). Collectively, these results suggest the age-related differences in
fatigue are due to mechanisms localized within the muscle.
One mechanism that does not appear responsible for the greater fatigue with age
during high-velocity contractions is an increased myofiber sensitivity to [Pi] or [H+]. In
isolated myofibers from the vastus lateralis of young and older men, force, velocity, and
power were reduced to a similar extent when exposed to a fatigue-mimicking solution
(pH 6.2 and 30 mM Pi) (221). Although these data suggest that increased fatigue with
age was not due to an increased myofilament sensitivity to [Pi] and [H+], these
experiments were conducted in vitro and under saturating [Ca2+]; conditions which are
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likely not present during fatigue in vivo because high [Pi] decreases Ca2+ release from the
sarcoplasmic reticulum (236).
Most investigators have reported lower oxidative capacity in the knee extensor
muscles of older compared with young adults (41,100,133,136,213), while others have
found no difference (223). Overall, our systematic review and meta-analysis found the
capacity for producing ATP via oxidative phosphorylation in the knee extensor muscles
declines with age (73). Coupled with the higher ATP demand of dynamic compared with
isometric contractions (205), the deficit in oxidative capacity may require older muscle to
rely more on non-oxidative ATP production than young muscle during dynamic
contractions. As a result of this reliance on non-oxidative ATP production, Pi, H+, and
H2PO4- could accumulate more in older compared with young muscle, providing a
metabolic basis for the greater fatigue in older muscle during high-velocity contractions.
Because ATP consumption increases with contractions of short duration (13,89), due to
the production of force being more costly than its maintenance (202), the energetic
demands of moderate-velocity contractions may be sufficiently lower than that of highvelocity contractions to prevent a greater reliance on non-oxidative ATP production in
older compared with young muscle, and thus result in similar fatigue in young and older
muscle in response to moderate-velocity contractions. This hypothesis has not yet been
tested.
Therefore, the purpose of this study was to determine the extent to which
differences in intracellular energy metabolism explain age-related differences in muscle
fatigue in response to two distinct bouts of maximal voluntary dynamic contractions
(MVDCs) of the knee extensor muscles. We hypothesized that in vivo oxidative capacity
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of the vastus lateralis, measured using the PCr recovery method in an unfatigued state,
would be lower in older compared with young adults. Further, we hypothesized that
fatigue would be greater in older compared with young adults in response to 4 min of
isotonic contractions against a load equivalent to 20% maximal isometric torque
(MVDC20%), and that this fatigue would be accompanied by greater [Pi] and [H2PO4-],
and lower pH in older than young muscle. Conversely, we expected to observe no agerelated differences in muscle fatigue, [Pi], [H2PO4-], or pH in response to 4 min of
isokinetic contractions at 120°.s-1 (MVDC120). Lastly, we hypothesized that the
proportion of ATP derived from oxidative phosphorylation would be lower in older
compared with young muscle during the MVDC20%, but not different between age groups
during the MVDC120 protocol.

Methods
Participants
Ten young (24-35 yrs; n=6 men) and 10 older (66-80 yrs; n=5 men) adults were
studied. Prior to enrollment, each participant gave their written informed consent, as
approved by the University of Massachusetts Amherst, and in accordance with the
Declaration of Helsinki. Physician’s consent to participate was obtained for all of the
older volunteers prior to data collection. Participants were sedentary by self-report,
defined as completing less than two 30 min sessions of structured exercise per week.
They also reported being healthy, as evaluated by a health-history questionnaire, and
were not taking any medications known to affect physical function or muscle fatigue
(e.g., beta-blockers, calcium channel blockers, sedatives). Participants with significant
arthritis in their lower extremities, cardiovascular symptoms upon exertion, metal
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implants, or who were claustrophobic were excluded from the study prior to enrollment.
Participants who answered ‘no’ to all questions on the Physical Activity Readiness
Questionnaire (229) were enrolled.
Experimental Design
Participants reported to the University of Massachusetts Amherst for 3 visits. At
visit 1, physical function and muscle-tendon unit stiffness were measured, and
participants were familiarized with the high- and moderate-velocity contraction protocols
to be completed at visits 2 and 3. At the beginning of visit 2, magnetic resonance (MR)
images of the entire thigh were obtained and participants completed 1 of 2 fatigue
protocols while supine inside the MR scanner. The second fatigue protocol was
completed at visit 3, which was at least 3 days following visit 2. Prior to the fatigue
protocol at either visit 2 or 3, participants completed a rest-contraction-recovery protocol
to quantify in vivo muscle oxidative capacity. The order of the fatigue protocols and
measurement of oxidative capacity were randomized between visits 2 and 3.
Physical Function and Physical Activity
Measures of mobility and physical activity were obtained in order to characterize
the study groups. Mobility was measured using the Timed-Up-and-Go (TUG; (188)) and
advanced short physical performance battery (SPPB-A; (210)). For the TUG test,
participants were asked to stand up from a seated position, walk 3 m, return to the chair
and sit down (188). Participants completed this test twice at their usual walking speed,
with 1 min of rest between each trial. The fastest of the 2 trials was used for analysis.
Participants also completed the SPPB-A, which combines chair rise time, standing
balance time with 3 different foot positions, and gait speed over a 4 m path (210). For the
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chair rise task, participants were instructed to fold their arms across their chest and
completely stand up and sit back down again 10 times, as fast as possible, in a standard
chair (seat height = 45 cm). For the balance tasks, participants stood with their feet in 3
different positions (semi-tandem, tandem, and on one leg) for as long as possible, up to a
maximum of 30 s. The time taken to walk a straight, 4 m path was recorded as a measure
of gait speed. Participants completed this walking task twice, with 1 min of rest between
trials. They were instructed to walk at their preferred speed and the fastest trial was used
for analysis. The walking test was then repeated, with the participant instructed to stay
within a 20 cm wide path, which was marked on the floor. The time taken to complete
each mobility test was recorded with a stopwatch and the SPPB-A was calculated as
reported elsewhere (210).
At the end of visit 1, participants were asked to wear a uniaxial accelerometer
(Actigraph GT3X, Pensacola, FL) for 7 days. Accelerometers were worn over the right
hip, and data were recorded with a 60 s epoch. Participants wore the accelerometer for a
minimum of 10 hours per day on at least 4 days (3 weekdays and 1 weekend day). These
criteria have been shown to provide good reliability (>80%) for quantifying overall, light,
and moderate-to-vigorous physical activity (153,154). Average daily activity counts and
minutes of moderate-to-vigorous physical activity were determined using ActiLife v6.13
software (ActiGraph, Pensacola, FL) with established cutpoints (74).
Muscle-Tendon Unit Stiffness
Muscle-tendon unit stiffness reflects the series elasticity of multiple structures in
vivo, and is characterized by the torque-extension relationship (84). A less compliant
muscle-tendon unit is theoretically advantageous for producing torque rapidly. As such,
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the lower power produced by older compared with young muscle may have a structural
basis. The literature is equivocal with regard to age-related differences in muscle-tendon
unit stiffness; some studies have demonstrated a decrease in muscle-tendon unit stiffness
with age (125,150,219), while others have shown no effect of age (84,217). We sought to
quantify age-related differences in stiffness of the quadriceps muscle-tendon unit in vivo
to explore the relationships between age, stiffness, and muscle fatigue.
The length of the dominant thigh was determined using a tape measure and a
small mark was made with indelible ink at the midpoint between the lateral femoral
condyle and greater trochanter of the femur. The participant’s dominant leg was
determined by asking “which leg would you use to kick a ball?” Participants were then
seated on a Biodex 4 dynamometer (Biodex Medical Systems, Shirley, NY) in an upright
position with hip and knee angles of 90° and 100°, respectively. Next, the skin over the
muscle belly of the rectus femoris was shaved and cleaned with 70% ethanol and a
surface EMG electrode (Trigno, Delsys Inc., Natick, MA) was adhered to the skin. The
EMG signal was sampled at 2,000 Hz and recorded using EMGWorks (Delsys Inc.,
Natick, MA). Torque, velocity, and position signals from the Biodex 4 dynamometer
were streamed wirelessly to EMGWorks software for synchronization with the EMG
signal using a ±5 V anaolg adapter (Trigno, Delsys Inc., Natick, MA). The torque signal
was calibrated across the range of torques expected (14 points) by hanging weights off
the Biodex lever arm. The velocity signal was calibrated between -300 and 300°.s-1
(specifically: 60, 120, 180, 240, 300°.s-1 flexion and extension) during pilot work. An
additional calibration point (0°.s-1) was sampled while the dynamometer lever arm was
stationary. Lastly, the position signal was calibrated using 14 points that captured the
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range of positions achieved during the familiarization trials. Torque, position, and
velocity signals were sampled at 148 Hz due to the hardware constraints of the ±5 V
analog adapter.
Participants completed two 3-5 s maximal voluntary isometric contractions
(MVIC), with 1 min of rest between each contraction to prevent fatigue. If these first 2
trials differed by more than 10%, additional contractions were performed until the peak
torque during 2 subsequent trials were within 10% of each other. The root mean square
electromyography (RMS EMG) signal was sampled at baseline and over a 0.25 s period
encompassing the peak isometric torque during the 3-5 s MVIC trials. The maximum
RMS EMG signal and offset (i.e., baseline RMS EMG signal) was used to scale visual
feedback during the 30 s ramped isometric trials, displayed on a 27 inch LED monitor
positioned in front of the participant at eye-level. Next, the vastus lateralis of the
dominant thigh was visualized using an ultrasound system (Affiniti 70, Philips
Healthcare, Bothell, WA). Specifically, B-mode ultrasound was used with a linear array
transducer (Philips model: L12-5) and an insonation angle of 60° (191). The transducer
was placed over the midpoint of the vastus lateralis, as previously identified and marked
with indelible ink. The probe was adjusted as necessary to obtain the best visualization
of the muscle fascicles, and superficial and deep aponeuroses. Next, participants
performed 5 ramped MVICs (i.e., contractions which increased from 0-100% MVIC over
30 s) while an ultrasound video of the participant’s vastus lateralis was recorded.
Familiarization
Participants were seated on the dynamometer with hip and knee angles of 135°
and 110°, respectively. These joint angles were selected to mimic the position used for
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the contraction protocols in the MR scanner at visits 2 and 3. The dynamometer was
adjusted to ensure the axis of rotation of the lever arm was aligned with the axis of
rotation of the participant’s knee joint. The length of the lever arm was adjusted to each
participant’s tibia length and secured with inelastic straps ~2 cm proximal to the malleoli.
Additional inelastic straps were fastened across the participant’s torso and hips to prevent
unwanted movement. Participants were instructed not to hold onto any part of the
dynamometer during the testing to ensure the torque and velocity measurements were
generated predominantly by the knee extensor muscles. Once positioned on the
dynamometer correctly, each participant completed 2-3 MVICs (3-5 s each) to determine
their maximal voluntary torque. After each participant’s MVIC was determined,
measures of muscle-tendon unit (MTU) stiffness were obtained (see below).
Following the ultrasound measures, participants completed two 40 s trials of
dynamic contractions with their dominant leg to familiarize them with the contraction
protocols to be performed at visits 2 and 3. Specifically, participants performed 40 s of
maximal voluntary dynamic contractions (MVDCs) at 120°.s-1 and 240°.s-1, with 1
contraction completed every 2 s and 2 min of rest between the practice trials at the 2
velocities. Each contraction was cued by an auditory signal and all contractions were
performed over a 30° range of motion (110-140°). Participants were instructed to ‘kick
their leg out as hard and fast as possible’ for all contractions. The investigators provided
strong verbal encouragement throughout the familiarization protocols. Visual torquefeedback was provided via computer monitor positioned at the participant’s eye level.
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Magnetic Resonance Imaging
Upon arriving for Visit 2, participants completed an MR safety questionnaire
(Appendix C), removed all metal objects, and walked through an upright metal detector
to ensure their safety. Subsequently, participants were positioned supine inside a Skyra 3
Tesla, 70 cm bore MR scanner (Siemens Medical Systems, Erlangen, Germany). To
avoid movement while inside the scanner, inelastic straps were fastened over the
participant’s lower leg and hips. A multi-echo (6-point), 2D gradient-echo Dixon
sequence was applied with the following parameters: TR=35 ms, FOV=230, TE=2.46
and 6.15 ms, 3.69 and 7.38 ms, and 4.92 and 8.61 ms, matrix=192 x 144, GRAPPA
factor=2, flip angle=15°, 1 average. These images were acquired using an 18-channel
flex coil and a 32-channel spine coil. Slices (6 mm thick) were obtained from the greater
trochanter to the lateral epicondyle of the femur, and slices in which all four quadriceps
muscles were visible were analyzed for muscle and fat content. Water and fat images
were reconstructed offline using the MatLab Fatty Riot algorithm (53). A region of
interest (ROI) was drawn around the quadriceps muscle group in each slice. Fat fraction
was calculated on a pixel-by-pixel basis from the ratio of separate water-only (W) and
fat-only (F) images, using the equation (F/(W+F)) (51). Fat-free muscle cross-sectional
area (CSA, cm2) of the knee extensors was quantified using a custom-written MatLab
program (MathWorks, Natick, MA; (145)). Muscle volume was estimated as the sum of
CSAs multiplied by the slice thickness. To eliminate the possibility of inter-investigator
error, the same investigator analyzed all MR images.
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Muscle Oxidative Capacity
Participants were randomly assigned to complete this measure at either visit 2 or
3, prior to the fatigue protocol. Each participant was positioned inside the MR scanner
with a dual-tuned 31P/1H surface coil (8 x 10.5 cm) fastened over the vastus lateralis of
their dominant leg using a bandage and velcro straps. The knee and ankle of the
dominant leg were strapped to an MR-compatible ergometer using velcro straps. An
additional strap was fastened over the participant’s hips to prevent unwanted movement.
Our custom-made ergometer is capable of imposing and recording isometric, isokinetic,
and isotonic contractions of the knee extensor muscles (96). Gradient scout images were
obtained to ensure correct placement of the surface coil and positioning within the
isocenter of the MR scanner. Subsequently, the homogeneity of the magnetic field was
optimized by shimming on the proton signal.
After optimization of the magnet for metabolic measures, participants completed
three 5 s MVICs, and 3 sets of 6 MVDCs at either 120°.s-1 (MVDC120) or 20% MVIC
(MVDC20%), separated by 2 min rest. Because of the physical constraints of the MR
scanner’s bore, the range of motion for all dynamic contractions was limited to 30° with a
starting knee angle of ~110° (180° = full extension). Participants then completed 24 s of
MVDCs (1 every 2 s). The number of contractions and duty cycle for this contraction
protocol were selected based on pilot work showing that PCr was depleted by ~50% with
minimal change in pH; conditions which are optimal for quantifying muscle oxidative
capacity in vivo (6,162). Following 15 dummy pulses, 31P spectra were acquired for 60 s
before, during, and 10 min following the 12 contractions, using a 0.1 ms hard pulse,
nominal 60° flip angle, 4,000 Hz bandwidth, 2,048 complex points, 2 s repetition time
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and 0.15 ms echo time. Representative spectra at rest and the end of both fatigue tasks
from 1 young and 1 older man are shown in Figure 4.1.
MVDC20% Fatigue Protocol
While positioned inside the MR scanner, participants completed a unilateral
fatigue protocol consisting of 1 isotonic MVDC against a load equivalent to 20% MVIC
every 2 s for 4 min. Contractions were performed over a 30° range of motion (110-140°).
The slower time to target velocity in older muscle (132) and limited range of motion
possible within the MR-environment precluded the performance of high velocity
isokinetic contractions from use in this study. As a result of these limitations, we opted
for isotonic fatiguing contractions to permit the older adults to achieve higher peak
contraction velocities. Participants received the same verbal instructions and
encouragement, visual torque-feedback, and auditory cues for each contraction as
described for the oxidative capacity measurement. Representative torque and velocity
traces for a contraction during the MVDC20% protocol from one young male are shown in
Figure 4.2A.
MVDC120 Fatigue Protocol
While positioned inside the MR scanner, participants completed a unilateral
fatigue protocol consisting of 1 isokinetic MVDC at 120°.s-1 every 2 s for 4 min with the
same range of motion as the MVDC20% fatigue protocol. The same instructions, verbal
encouragement, and visual feedback were given to participants during this trial as was
provided for the MVDC20% protocol. Representative torque and velocity traces for a
contraction during the MVDC120 protocol from one young male are shown in Figure
4.2B.
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Measurements and Data Analyses
Muscle-tendon unit stiffness
After the deep and superficial aponeuroses were visualized on the ultrasound
screen, a 5 V pulse was sent from the ultrasound system to EMGWorks via a trigger
(Delsys Inc., Natick, MA), which initiated the 30 s ramped isometric contraction. Realtime feedback was provided based on the RMS EMG signal, which was scaled to the
maximal RMS EMG from the 3-5 s MVICs. Ultrasound videos and torque signals were
saved for offline analysis.
The sampling frequency of the ultrasound videos varied, depending on the depth
of the acquired images (range: 26.3 to 41.8 Hz). Because the sampling frequency was not
identical to that of the torque signal, the torque data were downsampled to match the
sampling frequency of the corresponding ultrasound data using a piecewise cubic hermite
interpolating polynomial function in MatLab (MathWorks, Natick, MA). The
EMGWorks software, which recorded the torque signals, was triggered to begin
recording on the negative edge of the 5 V synchronization pulse. Using an A/D board,
we discovered that the time delay between the recording of the ultrasound and torque
signals was 1 s. To account for this, the ultrasound and torque signals were synchronized
by removing the first 1 s of data from the ultrasound signal.
To quantify muscle-tendon unit stiffness, the torque-extension relationship must
be determined (84). To quantify extension of the aponeurosis, multiple points on the
ultrasound images were identified: one set of 8 superficial reference points evenly spaced
near the skin, and a cluster of 8 points along the deep aponeurosis of the vastus lateralis
(Figure 4.3). The movement of all points was automatically tracked using a two-
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dimensional cross-correlation tracking algorithm, as described elsewhere (84). As
illustrated in Figure 4.3, there was movement of the superficial reference points and
clustering of the tracking points on the deep aponeurosis which resulted in the extension
of the aponeurosis not following the expected trajectory, preventing accurate
quantification of aponeurosis extension. Because of this, calculations of muscle-tendon
unit stiffness were not possible.
Muscle Torque, Velocity, and Power
Position, torque, and velocity were sampled at 500 Hz using a custom-written
MatLab user interface. A separate MatLab post-processing program calculated the
average torque, velocity and power, as well as the range of motion, and power-time
integral, and the duration of each contraction. Only the concentric phase of each
contraction was analyzed, as shown in Figure 4.2. Because the range of motion
decreased in some participants during the fatiguing contractions, and there were some
issues with the ergometer’s torque and velocity controllers (e.g., overshoot of torque and
velocity) during the isotonic and isokinetic contraction modes, respectively, several
indices of fatigue were visually inspected, including: average torque, velocity, and power.
Because the power-time integral captures the fatigue-induced decline in torque, velocity,
and range of motion, fatigue during the both contraction protocols was calculated using
the power-time integral (PTI) as:

average PTI over final 5 contractions
peak PTI during first 10 contractions
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100

[Eq. 4.1]

31

P spectral analysis
All free induction decays were analyzed using jMRUI v6.0beta. Spectra were

zero-filled (2,048 points), filtered using a 1 Hz Lorentzian function, Fourier-transformed,
and phased. Once the PCr peak was set to 0 ppm, the spectra were line-fit using the
AMARES algorithm and the areas under the peaks corresponding to phosphomonoesters,
Pi, phosphodiesters, PCr, and gamma ATP were determined. Concentrations of Pi and
PCr were calculated assuming that [Pi] + [PCr] = 42.5 mM in resting muscle (161), and
ATP was quantified assuming [ATP] = 8.2 mM in resting muscle (82). Intracellular pH
was calculated based on the chemical shift of Pi relative to PCr (168).
Muscle oxidative capacity
Spectra were averaged to achieve 90 s temporal resolution at rest and 4 s
resolution throughout the 24 s contraction period. For the recovery period, spectra were
averaged to achieved the following temporal resolutions: 4 s for the first 20 s, 8 s for the
next 280 s, and 30 s for the remaining 5 min. Once [PCr], [Pi], [ATP], and pH were
determined, the repletion of PCr during the 10 min recovery period was fit with a monoexponential function and the rate constant (kPCr) determined, as shown in equation 4.2:

PCr t

∆PCr 1

e

PCr

[Eq. 4.2]

where ΔPCr = (PCrrest – PCrex), and PCrex is [PCr] at the end of the contraction. The rate
constant of PCr recovery, kPCr, reflects the capacity for oxidative phosphorylation under
these conditions (117). This measure is highly reliable and well correlated with in vitro
respirometry measures of maximally-stimulated respiration (i.e., state 3) (129) and
oxidative enzyme activities (134,156).
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P-MRS Acquisition during Fatigue Protocols
Spectra were averaged to achieve 60 s and 10 s resolution at rest and during the

fatigue protocol, respectively. For the recovery period, spectra were averaged to achieve
the same temporal resolution as for the oxidative capacity measurement. Following
determination of [PCr], [Pi], [ATP], and pH, ATP production rates by the creatine kinase
reaction (ATPCK) and non-oxidative glycolysis (ATPGLY) were calculated.
ATP Flux
Under conditions where there is no net change in [ATP], ATP production can be
reasonably assumed to equal ATP consumption (20,226). We calculated rates of ATPCK,
ATPGLY, and ATPOX during both fatigue protocols. The rate of PCr breakdown by the
creatine kinase (CK) reaction was calculated as the rate of decline in PCr at each 10 s
time point, as follows:

∆PCr
∆t

ATP

[Eq. 4.3]

Intracellular pH was calculated based on the chemical shift (σ) of Pi relative to PCr, in
parts per million, as follows (168):

pH

6.75

log

σ 3.27
5.69 σ

[Eq. 4.4]

Broadening and splitting of the Pi peak can occur due to distinct intracellular pH pools
during contractions (180). When Pi splitting was visibly evident, 2 Pi peaks were fit, the
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pH corresponding to each Pi pool was calculated separately (based on the chemical shift
of each Pi pool relative to PCr), and the weighted average determined (128):

pH

pH

area Pi
total Pi area

area Pi
total Pi area

pH

[Eq. 4.5]

The concentration of H2PO4- was calculated as (127):

H PO

Pi
10

1

[Eq. 4.6]

.

Glycolytic ATP synthesis was calculated using linear regression to determine the rate of
change in pH and PCr over each 10 s period for each fatigue protocol. Proton
consumption by the CK reaction, intracellular buffering, and oxidative proton production
were also taken into account, as follows:

ATP

1.5

β

∆pH
∆t

θ

∆PCr
∆t

V

[Eq. 4.7]

where β represents the total buffering capacity; calculated as the sum of inherent
buffering, and buffering from bicarbonate and Pi (108). The pH dependent rate of H+
efflux (VEff) was measured in mM.s-1 at the end of each fatigue task. The proton
stoichiometry of the CK reaction coupled with ATP hydrolysis, θ, was calculated as:

θ

1
1

10
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[Eq. 4.8]

Oxidative ATP synthesis was calculated from the initial velocity of PCr resynthesis
(Vi[PCr]), which reflects the rate of oxidative ATP production at the end of a bout of
contractions (26,107). Vi[PCr] was calculated as the change in [PCr] measured over the
first 4 s of the PCr recovery kinetics.
Statistical Analyses
All data were checked for normality and homogeneity of variance prior to any
statistical comparisons using the Kolmogorov-Smirnov test and Levene’s statistic,
respectively. Differences in group descriptive characteristics, muscle morphology,
maximal torque and power, muscle oxidative capacity, and fatigue (%initial power-time
integral) were analyzed using independent t-tests. Age-related differences in the average
torque, velocity, power, range of motion, power-time integral, and duration of
contractions throughout each fatigue trial were evaluated using a 2-way ANOVA
(group×time). Similarly, age-related differences in metabolites (PCr, Pi, pH, H2PO4-,
PME, and ATP) throughout each fatigue trial were evaluated using a 2-way ANOVA
(group×time). Group differences in ATP flux (creatine kinase, non-oxidative glycolysis,
and Vi[PCr]) were evaluated using a 2-way ANOVA (group×time). All statistical analyses
were performed using the SPSS statistical software package (v24.0, IBM, Chicago, IL)
with an alpha level of 0.05. Data are reported as mean±SD, with exact p-values and 95%
confidence intervals for differences in group means.
Results
Baseline Characteristics
Group characteristics are reported in Table 4.1. There were no group differences
in height, body mass or BMI. Additionally, groups were well matched for total daily
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physical activity and minutes of moderate-to-vigorous physical activity. We observed no
difference between groups for measures of physical function, chair rise time, TUG, and
SPPB-A. The rate constant of PCr recovery (kPCr) was not different between young and
older adults.
Contractile volume was lower in older compared with young adults (p=0.025;
Figure 4.4A, Table 4.2), despite no differences in the percentage of the femur analyzed
(p=0.651), indicating that similar portions of the knee extensor muscles were sampled for
the estimation of muscle volume in both groups. Fat fraction was not different between
groups (p=0.340; Figure 4.4C). At baseline, maximal isometric torque and power during
the MVDC120 and MVDC20% contractions were lower in older compared with young
adults (p≤0.05; Figure 4.4D-F). Specific isometric torque was not different between
groups (p>0.05; Figure 4.4G). In contrast, specific power during the MVDC120 (p=0.037;
Figure 4.4H) and MVDC20% contractions (p=0.004; Figure 4.4I) was ~25% and ~30%
lower in older compared with young adults, respectively.
MVDC20% Fatigue Trial
Ergometer Measurements
There was no group difference in fatigue (% initial PTI) in response to 4 min of
isotonic contractions (p=0.546). Changes in the average torque, velocity and power,
range of motion, power-time integral, and duration of contractions throughout the
MVDC20% are shown in Figure 4.5. There was no group×time interaction (p≥0.998) for
changes in ergometer measurements. There was an effect of group (p=0.001), but not
time (p=0.100), on the average torque throughout the MVDC20%, indicating that our
ergometer was able to control torque near the set-point of 20% MVIC. However, post88

hoc analyses revealed the average torque was higher in young than older adults between
20 and 60 s (p≤0.043). We observed main effects of group (p=0.001) and time (p=0.001)
for changes in average velocity and power, range of motion, power-time integral, and the
duration of contractions. Post-hoc analyses revealed the average velocity was higher in
young than older muscle from 90 s onwards (p≤0.018), and declined from the initial
value after 100 s in young (p≤0.04) and 80 s in older (p≤0.018) adults. However, the
average power was not different between groups at any timepoint (p≥0.187), but declined
from the initial value after 90 s in young (p≤0.019) and 80 s in older (≤0.016) muscle,
reflecting a similar rate of fatigue development in both groups in this condition. The
range of motion was lower in older than young muscle from 60 s onwards (p≤0.025), and
declined from the initial value after 160 s in young (p≤0.029) and 100 s in older
(p≤0.022) adults. The power-time integral was not different between groups at any
timepoint (p≥0.097), but had fallen from the initial value after 130 s in young (p≤0.034)
and 100 s in older muscle (p≤0.021). Lastly, the duration of contractions was longer in
older than young adults at every timepoint (p≤0.026), did not increase with fatigue in
young (p≥0.071), but increased from the initial duration after 170 s in older adults
(p≤0.033).
Metabolites
Changes in [PCr], [Pi], pH, [H2PO4-], [PME], and [ATP] throughout the 4 min of
contractions are illustrated in Figure 4.6. There were no group×time interactions for
changes in any metabolite during the trial (p≥0.695). However, we observed main effects
of group and time for changes in each metabolite (p≤0.016). Post-hoc analyses revealed
no group differences in [PCr] or [Pi] throughout the trial (p≥0.193), but pH was lower in
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young than older muscle from 210-240 s (p≤0.05; Figure 4.6C). We observed a greater
[H2PO4-] in young than older muscle at 210 s (p=0.037), but not at any other point during
the contractions. The concentration of phosphomonesters was greater in young than older
muscle at 180 and 190 s, but not at any other point during the fatigue trial. Intracellular
[ATP] declined from resting concentrations in young and older muscle by 150 and 220 s,
respectively (p≤0.032).
ATP flux
ATP flux through the creatine kinase reaction and non-oxidative glycolysis are
reported in Table 4.3. We did not observe a group×time interaction (p=0.773) or a main
effect of group (p=0.813) on minute-by-minute changes in ATP flux through the creatine
kinase reaction. However, there was a main effect of time (p=0.001) such that ATPCK
declined over the first 3 min (p≤0.028) but was not different between minutes 3 and 4 in
either group (p≤0.977). There was no group×time interaction (p=0.280) for ATP flux
through non-oxidative glycolysis, but we did observe main effects of group (p=0.032)
and time (p=0.001). Post-hoc analyses revealed ATPGLY was higher in young than older
muscle, but only during the second minute (p=0.009). There was no difference in
ATPGLY between minutes 1 and 2 (p≤0.225), or 3 and 4 (p≤0.473), but ATPGLY declined
between minutes 2 and 3 (p≤0.001) in both groups.
Under conditions where there is no net change in [ATP], ATP production can be
reasonably assumed to equal ATP consumption (20,226). Because [ATP] declined
throughout the 4 min of isotonic contractions, in young and older adults (Figure 4.6F), we
were unable to evaluate the oxidative contribution to ATP flux in the traditional manner.
To circumvent this problem, we report changes in Vi[PCr] (Table 4.3) from baseline to the
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end of the fatiguing contractions. There was no group×time interaction (p=0.124) and no
main effect of group (p=0.209), but we did observe a significant effect of time (p=0.025).
Post-hoc analyses revealed Vi[PCr] increased from baseline to post fatigue in older
(p=0.01), with no difference observed in young muscle (p=0.577).
MVDC120 Fatigue Trial
Ergometer Measurements
Fatigue (% initial PTI) in response to 4 min of isokinetic contractions was greater
in young than older adults (p=0.007). Changes in the average torque, velocity and power,
range of motion, power-time integral, and duration of contractions throughout the
MVDC120 are shown in Figure 4.7. We observed a group×time interaction (p=0.001) for
changes in the average torque during the MVDC120. Post-hoc analyses revealed the
average torque was lower in young compared with older adults from 110 s onward
(p≤0.05).
There was no group×time interaction for changes in the average velocity during
the MVDC120 (p=0.999), but we did observe main effects of group (p=0.001) and time
(p=0.001). Post-hoc analyses revealed no clear trends for group differences in the
average velocity, and where any differences were small and presumably due to a slower
rate of torque development in older compared with young muscle because all contractions
were isokinetic and performed at 120°.s-1. Compared with that achieved in the first 10 s,
the average velocity was not different at any timepoint in older adults (p≥0.0134), but
was slower from 180 s onward in young adults (p≤0.028). The latter finding is
presumably due to a fatigue-induced slowing in the rate of torque development in young
adults. We also observed a group×time interaction for changes in the average power
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(p=0.001), such that it was lower in young than older adults from 150 s onwards
(p≤0.012). Similarly, there was a group×time interaction (p=0.001) for changes in the
power-time integral, such that it was lower in young than older adults from 150 s
onwards (p≤0.004). We did not observe a group×time interaction for changes in the
range of motion (p≥0.556), but there were main effects of group (p=0.001) and time
(p=0.001). Post-hoc analyses revealed no group differences in the range of motion at any
timepoint (p≥0.072), nor changes at any timepoint compared with the first 10 s
(p≥0.154). There was no group×time interaction for the duration of contractions
(p=0.999), but there were main effects of group (p=0.001) and time (p=0.007). Although
post-hoc testing showed no group differences at any timepoint (p≥0.056), the range of
motion was lower at 240 s and 220 s in young and older adults, respectively, compared
with that achieved over the first 10 s (p≤0.045).
Metabolites
Changes in [PCr], [Pi], pH, [H2PO4-], [PME], and [ATP] throughout the
MVDC120 are shown in Figure 4.8. There were no group×time interactions for changes in
any metabolite during the moderate-velocity fatigue trial (p≥0.064). However, we
observed main effects of group and time for changes in [PCr], [Pi], pH, [H2PO4-], and
[PME] (p≤0.001 for all). Post-hoc analyses revealed PCr was lower, and Pi higher, in
young compared with older muscle after 40 s (p≤0.017), and both PCr and Pi fell from
their initial concentrations by 10 s (p≤0.001). Intracellular pH was lower in young than
older muscle from 80 s until the end of the contractions (p≤0.033), and was lower
compared with rest by 60 and 70 s in young and older muscle, respectively (p≤0.001).
The [H2PO4-] was higher at 60 s, and remained elevated for the rest of the contractions, in
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young compared with older muscle (p≤0.028). By 30 s, [H2PO4-] was higher than at rest
in both groups (p≤0.001). Post-hoc analyses revealed no group differences in [PME] at
any timepoint, but [PME] was greater compared with rest by 50 s in young and 60 s in
older muscle (p≤0.014). There was a main effect of time (p=0.001), but not group
(p=0.065), for changes in [ATP] during the MVDC120. Post-hoc analyses revealed [ATP]
declined from resting values by 130 s in young and 150 s in older muscle (p≤0.026).
ATP flux
ATP flux through the creatine kinase reaction and non-oxidative glycolysis are
reported in Table 4.4. We observed a group×time interaction for changes in ATP flux
through the creatine kinase reaction (p=0.006). Post-hoc analyses revealed ATPCK was
greater in young than older muscle during the first minute of contractions (p=0.001), but
not throughout the rest of the fatigue protocol (p≥0.296). Further, ATPCK declined over
the first 3 minutes in both groups (p≤0.001), but was not different between minutes 3 and
4 (p=0.503). There was no group×time interaction (p≥0.256) for changes in ATPGLY
during the fatigue protocol, but main effects of age (p=0.001) and time (p=0.001) were
observed. Post-hoc analyses revealed glycolytic ATP flux was greater in young than
older muscle during the first (p≤0.015), but not final (p≥0.192), 2 min of the protocol.
Further, ATPGLY did not decline until minute 3 (p=0.001) in either group.
Throughout the 4 min of isokinetic contractions, [ATP] decline in both groups
(Figure 4.8F). Because of this, we report changes in Vi[PCr] (Table 4.4) from baseline to
the end of the fatiguing contractions. There was no group×time interaction (p=0.243) and
no main effect of group (p=0.422), but we did observe a significant effect of time
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(p=0.041). Post-hoc analyses revealed Vi[PCr] increased from baseline to post fatigue in
older (p=0.025), with no difference observed in young muscle (p=0.512).
Discussion
This study was designed to evaluate whether age-related differences in muscle
oxidative capacity might result in a greater accumulation of Pi and H2PO4-, and a lower
pH, in older than young muscle and therefore be potential mechanisms for the expected
age-related differences in fatigue in response to high-velocity contractions
(24,48,49,222,223). Additionally, we tested the hypothesis that the expected absence of
age-related differences in fatigue in response to moderate-velocity contractions
(23,24,49) would be explained by a similar accumulation of Pi and H2PO4-, and pH, in
young and older muscle. Lastly, we hypothesized that the proportion of ATP derived
from oxidative phosphorylation would be lower in older than young muscle during the
MVDC20%, but not different between groups during the MVDC120, fatigue protocol.
In contrast with our first hypothesis, muscle oxidative capacity was not different
between young and older adults in this study (Table 4.1). Fatigue (% initial PTI) in
response to the MVDC20% was also not different between groups (Figure 4.5). No agerelated differences in [Pi] were observed during the MVDC20%, and [H2PO4-] was only
different at one timepoint. However, pH was lower in young than older muscle for the
final 30 s of the MVDC20% (Figure 4.6). ATP flux through non-oxidative glycolysis was
greater in young than older muscle, but only during the second minute of the MVDC20%
(Table 4.3). No change in Vi[PCr] from baseline to post-fatigue was observed in young,
but it did increase in older muscle (Table 4.3). Fatigue (% initial PTI) in response to the
MVDC120 was greater in young than older muscle (Figure 4.7). We observed greater [Pi]
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and [H2PO4-], and lower pH, in young than older muscle during the MVDC120 (Figure
4.8). ATP flux through the creatine kinase reaction was greater in young than older
muscle during the first minute of the MVDC120, but not at any other timepoints (Table
4.4). Similarly, we observed a greater ATP flux through non-oxidative glycolysis in
young than older muscle during the first, but not final, 2 min of the MVDC120 protocol.
We observed no change in Vi[PCr] from baseline to post-fatigue in young muscle, but it
increased in older adults (Table 4.4). Overall, these results provide a bioenergetic basis
for the task-dependent conditions under which age-related differences in muscle fatigue
are observed.
Baseline
Contractile volume of the knee extensors was lower in older than young adults
(Figure 4.4, Table 4.2), which is consistent with previous work in this area (90).
However, we observed no group differences in fat fraction, evaluated by Dixon MR
imaging, indicating fat deposition in the knee extensors is similar in young and older
adults. This observation is in contrast with previous reports that used either T1-weighted
(24) or Dixon MR imaging (90). Thus, the lack of group differences in fat fraction do not
appear to be related to the imaging sequence used. A noteworthy point, however, is that
the fat fraction values obtained in this study are considerably higher than those reported
by Hogrel et al. (90). Specifically, those authors reported fat fractions of ~2.7 and 4.6%
in young and older quadriceps, respectively. In contrast, the mean fat fraction was 8.4
and 9.2% for young and older quadriceps in this study. The cause of this discrepancy is
not clear.
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Although maximal isometric torque was higher in young than older adults, we
observed no difference in specific torque between groups (Figure 4.4, Table 4.2).
However, peak power at 120°.s-1 and against a load equivalent to 20% MVIC were higher
in young than older adults both in absolute terms and when normalized to muscle
volume. These observations are consistent with previous reports (3,24,113) and indicate
that the age-related loss of maximal isometric torque is primarily due to the loss of
muscle mass with age while the loss of peak power in the aged cannot be explained by
muscle atrophy alone. Other factors that may contribute to a lower peak power in older
adults include a more compliant muscle-tendon unit (52,198) and a lower maximal motor
unit discharge rate (104,119). Muscle-tendon unit stiffness affects the torque-velocity
and force-length relationships of muscle such that a less stiff, or more compliant, muscletendon unit reduces the torque produced at a given velocity (106); an observation
commonly seen in older compared with young adults (24,132). The motor unit discharge
rate during the maximal rate of torque development of an isometric contraction is
markedly lower in older than young adults (119). Moreover, the age-related decline in
the maximal rate of torque development was greater during rapid isometric torque
development than during electrically-evoked twitch contractions, suggesting maximal
motor unit discharge frequency limits the torque produced during fast voluntary
contractions in older adults (119). The extent to which a lower maximal motor unit
discharge rate affected torque production at different velocities in the current study is not
known, but is worthy of further investigation.
Our observation of similar muscle oxidative capacity in the knee extensors of
young and older adults is in contrast with a systematic review and meta-analysis (73), but
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in agreement with a recent study (223). The lack of difference in muscle oxidative
capacity observed here is likely not due to the age (i.e., old vs. very old) or physical
activity of the older adults because Larsen et al. (2012) observed lower oxidative capacity
in the knee extensors of older compared with young adults when matched for physical
activity (133). Moreover, the age of the groups in the current study are similar to those in
previous studies that have observed an age-related reduction in oxidative capacity of the
knee extensors (133,136), suggesting the lack of difference observed in this study was not
because the older group were too young. A noteworthy point is that our values of kPCr for
older adults were similar to those reported previously (133). However, the kPCr values
observed in this study are only ~70% of those reported by Larsen et al. (133). Potential
reasons for the slower kPCr in young groups the current study and previous work are not
clear. Because mitochondrial energetics are closely associated with maximal aerobic
capacity and walking speed in older adults (38), future studies should try to elucidate the
participant characteristics that are associated with a reduced muscle oxidative capacity
with age.
MVDC20% Fatigue Trial
Previous work has consistently shown greater fatigue in older than young adults
in response to high-velocity contractions (i.e., ≥ 240°.s-1) of the knee extensors
(24,48,49,222,223) and other muscles groups (50,234). Further, a systematic review and
meta-analysis of the available literature observed greater muscle fatigue in older than
young adults in studies where dynamic contractions were performed or muscular power
was used as the index of fatigue (33). In contrast with these reports, we observed no agerelated differences in muscle fatigue (% initial PTI) in response to the MVDC20%
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protocol, as illustrated by the almost identical reductions in the power-time integral
between young and older adults in response to this task (Figure 4.5E). During the
MVDC20% the torque imposed by the ergometer was set to 20% of each individuals
MVIC. With the exception of a higher average torque in young compared with older
adults over the first 20-60 s of the 4 min MVDC20% protocol, our MR-compatible
ergometer was able to control torque near the 20% MVIC target. Due to the limited
range of motion within an MR-environment (30° in this study), the average contraction
velocity over the first 10 s of the MVDC20% protocol was ~180 and 120°.s-1 in the young
and older adults, respectively. Although we observed a greater slowing of contraction
velocity with fatigue in older relative to young adults, the absolute velocities achieved at
the beginning of the MVDC20% protocol were likely too slow to elicit age-related
differences in muscle fatigue. Indeed, previous work has shown similar fatigue in young
and older women when contractions were performed at the velocity associated with 50%
MVIC, which was 250±18 and 200±12°.s-1 in young and older women, respectively (24).
The slower contractile velocity of older adults in the MVDC20% protocol resulted in a
longer contraction duration throughout this protocol compared with young muscle
(Figure 4.5F). Additionally, both groups lost their full range of motion during the
MVDC20% protocol (Figure 4.5D), but the decline in range of motion was greater in older
adults.
We observed no difference in [PCr] or [Pi] between groups throughout the
MVDC20% protocol (Figure 4.6). Conversely, [H2PO4-] was higher in young than older
muscle, although this was only significant at 210 s and not at any other point during the
protocol. However, pH was lower in young than older muscle during the final 30 s of the
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protocol. Notably, [ATP] was lower than at rest from 150 s and 220 s onward in young
and older muscle; the decline was ~25% decline by the end of the protocol in both
groups.
These observations appear to be in contrast with a recent report evaluating agerelated differences in muscle fatigue and bioenergetics in response to 4 min of maximal
voluntary contractions against a load equivalent to 20% MVIC (223). Specifically, those
authors observed similar PCr depletion, but greater [Pi] and [H2PO4-], and a lower pH in
older than young muscle. Notably, in that study no change in [ATP] was observed
throughout the fatiguing contractions. The source of the discrepancies between studies is
not entirely clear. However, Sundberg et al. reported similar [PCr] and [Pi] in young and
older muscle at rest, and similar depletion of PCr between groups despite a ~10 mM
greater [Pi] in older than young muscle at the end of the fatiguing contractions. The
source of the additional ~10 mM of phosphate in the older muscle in their study is
unclear; the intracellular phosphate pool should remain relatively constant.
Part of the discrepancy between studies may also be due to the position of the
participants inside the MR-scanner and the recruitment patterns of the knee extensors in
those positions. Participants in our study were supine and performed contractions over a
30° range of motion (110-140°, 180° = full extension). Although Sundberg et al. reported
an angular displacement of ~25-30° in their study, the starting angle of the contractions
was not reported. Thus, participant’s muscles may have been performing over different
portions of the force-length relationship which could explain the lower absolute velocity
of contractions in our study because the force-length relationship affects the torquevelocity relationship (22,132).
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One of the notable findings in the present study is the ~25% decline in [ATP] in
both young and older muscle during the MVDC20% protocol (Figure 4.6E). Cytosolic
[ATP] is generally very well maintained during muscular contractions, until extreme
levels of fatigue are observed (226). A previous study observed [ATP] was reduced in
some, but not all, participants in response to maximal intermittent fatiguing contractions
of the forearm musculature (226). Those authors reported a greater decline in PCr
(17±5% of resting value) and lower pH (6.12±0.04) in the participants where [ATP]
declined compared with those participants in which [ATP] was unchanged (26±5% for
PCr and 6.37±0.09 for pH). In the present study, [ATP] declined in all participants
during the MVDC20% protocol, so such comparisons are not possible. Phosphocreatine
declined to 8.5±0.8% and 12.6±2.2% of the resting value in young and older muscle,
respectively. During the MVDC20% protocol we also observed significant increases in the
concentration of phosphomonoesters (PME) in both groups; PME generally increases
during intense contractions due to an accumulation of sugar phosphates (e.g., glucose-6phosphate, inosine monophosphate) (12). However, the decline in [ATP] likely to
contributed to the increase in [PME] during the contractions in Study 1 because adenine
nucleotide breakdown results in the formation of inosine monophosphate (163), which
contributes to the PME pool in the 31P spectrum.
Our observations of similar [Pi] but lower pH in young compared with older
muscle, despite no age-related differences in muscle fatigue, suggests that the contractile
machinery may be more sensitive to changes in pH with age. At the molecular level,
elevated cytosolic [H+] depresses muscular force production due to prolonged attachment
of myosin to actin as a result of slowed ADP release (57,58,123,239). Therefore, we
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would have expected to observe greater fatigue in the young than older group. Although
a recent study observed similar depressive effects of high [Pi] and [H+] on skeletal
muscle fiber force, velocity, and power production in young and older men (221), those
experiments were conducted at saturating [Ca2+]. However, the force-pCa2+ relationship
shifts leftward in type I, IIa, and IIx fibers with aging and the difference is greatest at
submaximal [Ca2+] (220). Therefore, whether the contractile machinery of older muscle
is more sensitive to changes in pH under submaximal [Ca2+] is not clear and is worthy of
further investigation.
We observed no age-related differences in ATP flux through the creatine kinase
reaction during the MVDC20% protocol (Table 4.2). However, glycolytic ATP flux was
greater in young compared with older muscle during the second minute of this protocol,
consistent with previous observations during maximal isometric contractions of the
dorsiflexors (128). The lower glycolytic ATP flux in older compared with young muscle
does not appear to be due to an impairment in the glycolytic pathway with age (130).
Although Vi[PCr] was not different between groups at baseline, we observed a trend for it
to be higher in older than young muscle at the end of the MVDC20% (p=0.051). In sum,
the proportion of ATP derived via oxidative phosphorylation may have been greater in
older compared with young muscle.
MVDC120 Fatigue Trial
Previous work has shown fatigue is similar between young and older adults in
response to 4 min of isokinetic contractions at 120°.s-1 (23). In contrast with these
studies, we observed greater fatigue (% initial PTI) in young than older muscle during the
MVDC120 protocol, as illustrated in Figure 4.7E. During the MVDC120 the velocity was

101

constrained to 120°.s-1, as shown in Figure 4.2. The average concentric contraction
velocity was similar in young and older adults (Figure 4.7), and declined by 180 s in
young, but not older, adults. The cause of the slower average velocity was likely due to
less time spent at the target velocity as visual inspection of the data confirmed the target
velocity was achieved during each contraction. The average concentric torque and power
declined to a greater extent in young than older muscle, and all participants were able to
maintain the full range of motion during the MVDC120 protocol.
In agreement with our observation of greater fatigue in young than older muscle
in response to moderate-velocity contractions, some authors have reported greater fatigue
in young than older adults at moderate contraction velocities (131); although others have
observed no difference in fatigue with age under these conditions (23,24,49). Previous
work suggests that age-related differences in fatigue might be explained by the intrinsic
characteristics of the torque-velocity relationship, which shifts leftward with age
(24,132). The torque-velocity relationship was likely shifted leftward in our study due to
the lower range of motion possible within an MR environment (30° in this study)
compared with that possible using conventional dynamometry (e.g., 70° in a study by
Callahan & Kent-Braun; (24)). This leftward shift in the torque-velocity relationship
likely occurs because the time spent at the target velocity is shorter and thus the time
available for torque development is lower. Consistent with this speculation, Callahan and
Kent-Braun reported the torque produced during isokinetic contractions at 120°.s-1 to be
~70 and 60% MVIC in young and older women, respectively. Conversely, in our study
the young and older adults performed the MVDC120 contractions at ~50 and 35% MVIC
at the beginning of the fatigue protocol (data not shown). Thus, young adults produced
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relatively greater torque during the MVDC120 compared with older adults, which may
explain the greater fatigue in this group.
As might be expected with greater fatigue, we observed higher [Pi] and [H2PO4-],
and a lower pH in young than older muscle throughout the MVDC120 protocol (Figure
4.8). These observations are consistent with previous studies of age-related differences in
fatigue in response to maximal isometric contractions (114,128). In further agreement
with these results, Callahan et al. developed a computational model to understand the
mechanisms of age-related differences in fatigue during isometric contractions, and
reported the greater fatigue in young than older adults is largely due to a higher glycolytic
ATP flux in young muscle (25). We observed a greater glycolytic ATP flux in young
than older muscle during the first, but not final, 2 min of the MVDC120 protocol (Table
4.3). A higher glycolytic ATP flux in young than older muscle has been reported during
isometric contractions (128,130). The reason for the lower glycolytic ATP flux in older
muscle is not clear but is not due to an impairment in the glycolytic pathway because
when blood flood is impeded with cuff-induced ischemia, the peak glycolytic rate is
similar in young and older dorsiflexors (130).
The Vi[PCr] did not change from baseline to post-fatigue in the young group, but it
increased in older muscle, reflecting an increase in oxidative phosphorylation in older
muscle by the end MVDC120 protocol. Although only one timepoint, this observation is
consistent with previous work showing a greater contribution from oxidative ATP
production in older than young muscle (128,130). In sum, the fatigue resistance of older
compared with young muscle during the MVDC120 was likely due to a greater proportion
of ATP being derived from oxidative sources.
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Similar to the MVDC20% protocol, during the MVDC120 we observed a ~25%
decline in [ATP] in both groups (Figure 4.8E). In concert with this observation, PCr
declined to 7.7±0.6% and 14.0±2.3% of the resting value in young and older muscle,
respectively. Further, [PME] increased relative to resting concentrations by 50 and 60 s
in young and older muscle during the MVDC120. As discussed above, the decline in
[ATP] likely contributed to the increase in [PME] because nucleotide breakdown results
in the formation of inosine monophosphate (163), which contributes to the PME pool in
the 31P spectrum. The observation of declining [ATP] during both protocols suggests that
the energetic cost of the contractions was greater than could be sustained by ATP
production in vivo.
A notable observation in both fatigue protocols is the lower pH in young than
older muscle at the end of the fatiguing contractions. This observation is consistent with
several reports (114,128,136). One potential explanation for this is the fiber composition
of young and older muscles. Repeated cycles of denervation-reinnervation with age
resulting in the grouping of fiber types (87), which becomes more pronounced at
advanced ages (≥80 years). A long-held belief is that type II muscle fibers are
preferentially impacted by the aging process. In contrast with this view, atrophy of type I
muscle fibers with age may be concealed by co-expression of the myosin heavy chain
(192,200), a preferential atrophy of fast muscle fibers with old age is not always observed
(27), and some authors have reported a shift towards a greater proportion of type II muscl
fibers with age (75). Therefore, the greater acidosis observed in young compared with
older muscle may not due to shifts in myosin heavy chain expression with age.
Alternatively, a decline in lactate dehydrogenase activity with age has been observed
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(102,135,182). In addition, lactate dehydrogenase may shift away from a muscle-specific
isoenzyme with age (135,211), which would result in greater accumulation of cytosolic
pyruvate. Pyruvate is the precursor to the Krebs cycle and therefore, a greater
accumulation of cytosolic pyruvate may explain the relatively lower glycolytic ATP flux
in older muscle observed in this study and others (128,130); the lactate dehydrogenase
isoenzyme in older muscle may favor formation of pyruvate, and thus oxidative energy
production. However, whether age-related changes in lactate dehydrogenase isoenzyme
and activity can fully explain the lower pH in young than older muscle remains to be
determined.
Limitations
There were several technical limitations with this study. One of these technical
issues was our inability quantify muscle-tendon unit stiffness. This may have been
partially due to participant’s receiving real-time feedback based on their RMS EMG
signal rather than joint torque. Although the RMS EMG signal is loosely associated joint
torque, the signal is likely not linear due to the confounding effects of motor unit
recruitment and discharge rate. Further to this, the real-time feedback was based on the
RMS EMG signal of the rectus femoris muscle and the ultrasound video, to visualize
aponeurosis extension, was recorded from the vastus lateralis. This approach was
necessary because the software did not allow for real-time torque feedback and the
placement of the ultrasound probe precluded using surface EMG on the vastus lateralis.
Perhaps a bigger problem, however, was the offline tracking of aponeurosis extension.
The MatLab program used a two-dimensional cross-correlation tracking algorithm to
track points of interest of the deep aponeurosis and just beneath the skin. However, this

105

program was developed to track displacement of the aponeuroses in the ankle
dorsiflexors and plantar flexors captured with a different ultrasound system (84). The
image resolution of the ultrasound system used previously (720 x 480) is lower than that
achieved with the system in the current study (800 x 600). Thus, the sensitivity of the
tracking algorithm may need to be optimized for tracking aponeurosis displacement with
modern ultrasound systems.
Another limitation of this study is that the absolute contraction velocity in the
MVDC20% was likely lower than necessary to observe age-related differences in muscle
fatigue. Although previous studies have observed greater fatigue in older than young
muscle using both isotonic (48,49,222,223) and isokinetic contractions (24), the range of
motion was greater in those studies due to the contractions being performed on a fullsized dynamometer and thus not limited by the MR environment. A recent study,
conducted within an MR environment, observed greater fatigue in older compared with
young adults using a similar contraction protocol and range of motion (25-30°) to the
MVDC20% one reported here. The reasons for the discrepancy between studies were
discussed above (see MVDC20%). During the MVDC20% protocol, the range of motion
declined in both groups, but was greater in older than young adults (Figure 4.6).
Although this does not explain the unexpected observation of similar fatigue between
groups (a smaller range of motion would negatively affect power production), the main
effect of age on the range of motion does complicate the interpretation of the results
because the two groups were not performing the same contractions.
Lastly, the exclusion of 1 older male’s data from the MVDC20% protocol resulted
in reduced statistical power. This participant’s data were excluded because their power-
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time integral was higher at the end compared with the beginning of the MVDC20%
protocol, suggesting they did not exert maximal effort throughout the duration of the task
but were pacing themselves. Although the exclusion of this participant’s data reduced
our statistical power, significant age-related differences in muscle fatigue and
bioenergetics were observed in a recent study with only 7 participants in their young and
older groups (223).
Conclusions
We observed similar fatigue in young and older adults in response to maximal
dynamic contractions at a low relative load (MVDC20%). Coincident with this
observation, pH was lower in young than older muscle during the MVDC20% protocol
suggesting the contractile machinery may become more sensitive to changes in pH with
age. We also observed greater fatigue in young than older adults in response to maximal
dynamic contractions performed at 120°.s-1. During that protocol, pH was lower and
H2PO4- higher in young than older muscle. These metabolites are putative agents of
fatigue at the molecular level. During the first half of both fatigue protocols, we
observed a greater glycolytic ATP flux in young compared with older muscle, which
provides a bioenergetic basis for the age-related differences in muscle fatigue observed in
this study. Future investigations should try to elucidate the mechanisms for the lower pH
in young than older muscles to deepen our understanding of age-related differences in
bioenergetics.
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Table 4.1. Group characteristics
Young (n=10)
Older (n=10)
95% CI
P
Age (yrs)
27.5 ± 3.9
71.2 ± 5.0
Height (m)
1.69 ± 0.1
1.64 ± 0.11
-0.46, 0.15
0.286
Body mass (kg)
75.3 ± 14.0
67.8 ± 12.4
-4.91, 19.87
0.221
. -2
26.0 ± 2.7
24.9 ± 2.2
-1.27, 3.45
0.344
BMI (kg m )
PA (counts.d-1000)
238.7 ± 102.0
238.6 ± 99.5
-94.65, 94.73
0.999
. -1
MVPA (min d )
38.3 ± 17.8
27.2 ± 23.3
-8.39, 30.55
0.247
4m gait speed (m.s-1)
1.13 ± 0.14
1.16 ± 0.15
-0.16, 0.11
0.657
Chair rise time (s)
16.1 ± 4.0
19.7 ± 5.2
-7.85, 0.81
0.105
TUG (s)
9.0 ± 1.5
9.5 ± 0.8
-1.70, 0.53
0.280
SPPB-A
2.82 ± 0.28
2.57 ± 0.28
-0.02, 0.12
0.067
kPCr (s-1)
0.021 ± 0.004
0.022 ± 0.004
-0.004, 0.003
0.632
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group
means; BMI, body mass index; PA, physical activity; MVPA, moderate- to vigorous-intensity
physical activity; TUG, timed up-and-go; SPPB-A, advanced short physical performance
battery; kPCr, rate constant of PCr recovery.
Table 4.2. Age-related differences in muscle size, maximal torque, and power
Young (n=10)
Older (n=10)
95% CI
P
Contractile volume (cm3)
1125.6 ± 347.5
803.5 ± 228.7 45.7, 598.4
0.025
Femur length analyzed (%)
46.1 ± 4.9
45.0 ± 5.7
-3.9, 6.1
0.651
Fat fraction (%)
8.4 ± 1.1
9.2 ± 2.1
-2.2, 0.81
0.340
Isometric torque (Nm)
252.0 ± 64.6
187.9 ± 62.9
4.2, 124.0
0.037
Isokinetic power (W)
238.5 ± 96.5
133.5 ± 62.1
28.7, 181.3
0.010
Isotonic power (W)
367.7 ± 135.4
178.1 ± 84.5
29.4, 96.8
0.002
Specific MVIC (Nm.cm-3)
0.232 ± 0.051
0.232 ± 0.034
-0.1, 0.1
0.826
Specific MVDC120 (W.cm-3)
0.218 ± 0.070
0.161 ± 0.040
0.1, 0.1
0.037
Specific MVDC20% (W.cm-3)
0.328 ± 0.075
0.219 ± 0.072
0.1, 0.2
0.004
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group
means. MVIC, maximal voluntary isometric contraction; MVDC120, maximal voluntary
dynamic contraction at 120°.s-1; MVDC20%, maximal voluntary dynamic contraction against a
load equivalent to 20% MVIC.
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Table 4.3. Changes in ATP flux throughout the MVDC20% fatigue protocol
Young (n=10)

Older (n=10)

95% CI

P

Creatine kinase*
Minute 1
2.82 ± 0.45
2.85 ± 0.32
-0.23, 0.16
0.736
Minute 2
0.58 ± 0.23
0.52 ± 0.13
-0.12. 0.27
0.439
Minute 3
0.18 ± 0.11
0.21 ± 0.12
-0.23, 0.17
0.752
Minute 4
0.11 ± 0.06
0.17 ± 0.05
-0.26, 0.14
0.553
Non-oxidative glycolysis*#
Minute 1
1.70 ± 0.55
1.67 ± 0.44
-0.27, 0.40
0.707
Minute 2
1.74 ± 0.48
1.31 ± 0.40
0.11, 0.78
0.009
Minute 3
0.80 ± 0.24
0.64 ± 0.26
-0.14, 0.54
0.237
Minute 4
0.52 ± 0.19
0.54 ± 0.32
-0.31, 0.36
0.893
Oxidative ATP production*
Baseline Vi[PCr]
0.44 ± 0.11
0.43 ± 0.11
-0.11, 0.13
0.835
End fatigue Vi[PCr]
0.47 ± 0.09
0.59 ± 0.18
-0.24, 0.01
0.051
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group
means; Vi[PCr], initial velocity of PCr recovery. *Main effect of time (p≤0.001), #main effect of
age (p=0.032).
Table 4.4. Changes in ATP flux throughout the MVDC120 fatigue protocol
Young (n=10)

Older (n=10)

95% CI

P

Creatine kinase*
Minute 1
3.08 ± 0.21
2.81 ± 0.26
0.13, 0.40
0.001
Minute 2
0.47 ± 0.16
0.47 ± 0.14
-0.14, 0.13
0.933
Minute 3
0.12 ± 0.06
0.20 ± 0.11
-0.21, 0.07
0.296
Minute 4
0.12 ± 0.06
0.08 ± 0.11
-0.11, 0.17
0.635
Non-oxidative glycolysis*#
Minute 1
2.15 ± 0.47
1.71 ± 0.49
0.14, 0.75
0.005
Minute 2
1.79 ± 0.29
1.40 ± 0.48
0.08, 0.69
0.015
Minute 3
0.66 ± 0.25
0.46 ± 0.18
-0.10, 0.51
0.192
Minute 4
0.37 ± 0.17
0.33 ± 0.21
-0.26, 0.35
0.764
Oxidative ATP production*
Baseline Vi[PCr]
0.44 ± 0.11
0.43 ± 0.10
-0.08, 0.10
0.793
End fatigue Vi[PCr]
0.47 ± 0.10
0.53 ± 0.08
-0.16, 0.03
0.166
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group
means; Vi[PCr], initial velocity of PCr recovery. *Main effect of time (p≤0.001), #main effect of
age (p=0.032).
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Figure 4.1. Representative 31P spectra at rest and the end of each fatigue protocol.
Representative 31P spectra at rest and the end of the MVDC20% in a young (A) and older (B) male.
Representative spectra at rest and the end of the MVDC120 in a young (C) and older (D) male are
also shown.
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Figure 4.2. Representative torque and velocity traces. Traces are shown from the MVDC20% (A)
and MVDC120 (B) protocols. The shaded area illustrates the concentric period. Data are from 1
young male.
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Figure 4.3. Ultrasound tracking of aponeurosis displacement during a ramped maximal isometric
contraction. Ultrasound stills from the start (A) and end (B) of a maximal voluntary contraction
of the knee extensors. The multi-coloured dots are points of interest, including a set of reference
points near the skin and a set of points along the deep aponeurosis of the vastus lateralis. We
attempted to track the motion of points throughout 30 s ramped isometric contractions using an
automated cross-correlation algorithm. Comparisons of the location of the multi-coloured points
in A and B, shows the reference points near the skin have moved and the points on the deep
aponeurosis have bunched together, resulting in minimal net extension and precluding analysis of
the torque-extension relationship necessary to quantify muscle-tendon unit stiffness.
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Figure 4.4. Age-related differences in muscle size, maximal torque and power. *p<0.05; ns,
non-significant (p>0.05). Symbols representing men (♂) and women (♀) are shown.
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Figure 4.5. Age-related differences in fatigue during the MVDC20% fatigue protocol. No group
difference in fatigue (% initial PTI) was observed in response to the MVDC20% protocol
(p=0.546).
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Figure 4.6. Metabolite concentrations in young and older muscle throughout the MVDC20%
fatigue protocol.
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Figure 4.7. Age-related differences in fatigue during the MVDC120 fatigue protocol. Fatigue (%
initial PTI) was greater in young than older adults in response to the MVDC120 protocol
(p=0.007).
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Figure 4.8. Metabolite concentrations in young and older muscle throughout the MVDC120
protocol.
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CHAPTER 5
EFFECTS OF OLD AGE AND CONTRACTION VELOCITY ON KNEE
EXTENSOR MUSCLE METABOLIC ECONOMY IN VIVO
Abstract
Dynamic contractions are more energetically costly than isometric contractions.
Metabolic economy (ME; mass-normalized torque or power produced per unit ATP
consumed) is similar between young and older adults during isometric contractions, but
less is known about age-related differences in ME during dynamic contractions. The
purpose of this study was to examine age-related differences in ME during maximal
effort isometric, isokinetic, and isotonic contractions of the knee extensor muscles. We
hypothesized that age-related differences in ME would be present only during dynamic
contractions. Ten young (Y; 27.5±1.2 yr, 6 men) and 10 older (O; 71.2±1.6, 5 men)
healthy adults performed three 24-s bouts of maximal knee extensor contractions: 1)
sustained isometric contraction (MVIC), 2) isokinetic contractions (120°ꞏs-1 (MVDC120;
0.5 Hz), and 3) isotonic contractions with a load of 20% MVIC (MVDC20%; 0.5Hz).
Phosphorus magnetic resonance spectroscopy of the vastus lateralis was used to calculate
ATP flux through the creatine kinase reaction, non-oxidative glycolysis, and oxidative
phosphorylation. Quadriceps muscle contractile volume was measured using serial fatwater magnetic resonance images. All spectroscopy and imaging data were acquired
using a whole-body 3T magnetic resonance system. The torque-time integral (TTI)
during the MVIC, and power-time integral (PTI) during MVDC120 and MVDC20%, were
calculated. Total ATP flux was used to determine the ATP cost of each 24-s bout, and
ME was calculated as specific TTI or PTI, divided by ATP cost. Differences between

118

groups were evaluated using independent samples t-tests. ME was not different between
young (0.12±0.01 Nm.s.cm-3.mM ATP-1) and older (0.11±0.01 Nm.s.cm-3.mM ATP-1;
p=0.765) muscle during the MVIC. However, during both MVDC120 and MVDC20%, ME
was greater in young than older muscle (MVDC120: 0.011±0.001 vs. 0.007±0.001
W.s.cm-3.mM ATP-1; p=0.002, respectively; and MVDC20%: 0.011±0.001 vs.
0.009±0.001 W.s.cm-3.mM ATP-1; p=0.031, respectively). These results show an agerelated deficit in ME that is evident only during dynamic contractions, potentially due to
the higher energy demand of these contractions.
Key words: bioenergetics, metabolism, mitochondria, creatine kinase, glycolysis,
oxidative phosphorylation, efficiency
Introduction
Old age is accompanied by multiple changes within the neuromuscular system
including slower maximal motor unit discharge rates and contractile properties
(24,42,103,114,119), declines in maximal torque and power production (24,49), slowed
crossbridge kinetics (164), atrophy of muscle fibers and fiber-type grouping (141-143).
The greater maximal torque and power produced by young compared with older adults
(24,49) is likely due to a loss of muscle mass (24,90) and slower maximal contraction
velocities (132,232) with age. Structural changes with age, such as increased compliance
of the muscle-tendon unit (125,150,219), may also affect maximal torque and power
production. Although some of these age-related changes within the neuromuscular
system may improve muscle metabolic economy (ME; mass-normalized torque or power
produced per unit ATP consumption), others may negatively affect ME. Studies in rat
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muscle have shown age-related differences in ME (55,88), yet relatively scant data are
available in human muscle in vivo (31).
Developing an understanding of the conditions where age-related differences in
ME are present, and the mechanisms responsible for those differences, is necessary for
identifying the cause of the increased energetic cost of daily activities, such as walking,
in older adults (76). Moreover, developing such an understanding may help explain why
older adults experience less, similar, or greater muscle fatigue compared with young
adults (23,24,49).
In vivo, ME of muscle contraction is likely influenced by metabolic and neural
factors, as well as mechanical properties. For example, type I fibers are more economical
than type II fibers (43,77,80,85). The cause of this greater efficiency in type I compared
with type II fibers stems from slower crossbridge kinetics and a lower cost of calcium
resequestration in type I fibers (85,224). There is some evidence that older adults have a
greater proportion of type I muscle fibers (141-143), which is thought to result from
recurring denervation-reinnervation cycles (214). Additionally, crossbridge kinetics are
slower in older than young muscle (164). These observations of age-related changes in
muscle morphology and function may result in lower ME in young than older muscle.
However, a 12-year longitudinal study observed an increase in the proportion of type II
fibers in older men (75). This discrepancy may, at least in part, be explained by the
muscle group being investigated, because shifts toward a faster and slower phenotype
have been observed in different muscles with age (166), and fiber co-expression (5,192).
Collectively these observations suggest that age-related differences in ME may be
muscle-dependent.
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To determine ME in vivo, phosphorus magnetic resonance spectroscopy (31PMRS) can be used to non-invasively quantify ATP production rates during muscle
contractions (20). Because [ATP] is maintained until extreme levels of fatigue (226), the
rate of ATP production can reasonably be assumed to equal its rate of consumption
(128,226). Using this approach, the ATP cost of dynamic contractions has been shown to
be greater than isometric contractions (205). This observation is consistent with in vitro
studies in rat diaphragm muscle, where the actomyosin ATPase rate was ~3x greater
when myofibers were contracting at 33% maximal shortening velocity compared with an
isometric contraction (209). The increased ATP cost of dynamic compared with
isometric contractions is likely due to the greater energetic cost of producing, rather than
maintaining, force (202).
Only one study has examined age-related differences in ME in vivo (31), while
more studies have examined age-related differences in the ATP cost of contraction (i.e.,
torque or power per unit ATP) (136-139). Some authors have reported lower (130) or
similar (31) ME in young compared with older muscle during maximal isometric
contractions. Christie et al. reported no differences in ME of the dorsiflexors during a
sustained 12-s MVIC between young and older adults (31). Similarly, no age-related
difference in the ATP cost of contraction was observed during a sustained 24-s MVIC of
the knee extensors (136). However, during intermittent MVICs of the knee extensors,
where metabolic demand is greater than during a sustained MVIC, the torque produced
per unit ATP was greater in young compared with older adults (136), suggesting there is
an age-related increase in the cost of developing, but not maintaining force. Age-related
differences in the ATP cost of dynamic contractions have also been observed (137-139).
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The ATP consumed per Watt is significantly lower in young compared with older muscle
during submaximal (138,139) and supramaximal contractions of the plantar flexors (137).
However, the question of whether ME is changed with old age remains uncertain.
Specifically, we are not aware of any studies that have examined age-related differences
in the ME of dynamic contractions in the knee extensors.
Although energy demand is higher during dynamic than isometric contractions
(205), and the ATP cost of producing force is greater than maintaining it (202), whether
age-related differences in ME are more pronounced as the metabolic demand increases is
unclear. To address this knowledge gap, we examined age-related differences in muscle
ME during isometric, isokinetic, and isotonic contractions of the knee extensor muscles.
Consistent with faster crossbridge kinetics in the vastus lateralis (164), and greater
fatigue in response to isometric contractions (28,35,60,114,130), of young compared with
older adults we hypothesized that ME would be lower in young compared with older
adults during a 24-s MVIC. We also hypothesized, based on observations of similar
fatigue in young and older adults in response to moderate-velocity isokinetic contractions
(23,24,49,147), that ME would be similar in young and older muscle during 24s of
isokinetic contractions at 120°.s-1. Lastly, we hypothesized, based on the observation of
less fatigue in young compared with older adults in response to high-velocity contractions
(24,48,49,159,222,223), that ME would be higher in young than older muscle during 24s
of isotonic contractions against a load equivalent to 20% MVIC.
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Methods
Participants
Ten young (24-35 yrs; n=6 men) and 10 older (66-80 yrs; n=5 men) adults were
studied. Prior to enrollment, each participant gave their written, informed consent, as
approved by the University of Massachusetts Amherst, and in accordance with the
Declaration of Helsinki. Physician’s consent to participate was obtained for all older
participants. Participants were sedentary by self-report, defined as completing less than
two 30-min sessions of structured exercise per week. They also reported being healthy,
as evaluated by a health-history questionnaire, and were not taking any medications
known to affect physical function or muscle fatigue (e.g., beta-blockers, calcium channel
blockers, sedatives, etc.). Participants with significant arthritis in their lower extremities,
symptoms upon exertion, metal implants, or claustrophobia were excluded from the study
prior to enrollment. Participants answered ‘no’ to all questions on the Physical Activity
Readiness Questionnaire (229), and were thus suitable for performing the contraction
protocols.
Experimental Design
Participants reported to the University of Massachusetts Amherst for 3 visits. At
visit 1, physical function was measured and participants were familiarized with the
contraction protocols to be completed at visits 2 and 3. At the beginning of visit 2,
magnetic resonance images of the entire thigh were obtained and participants completed
2 of the 3 contraction protocols (see below), with at least 10 min of rest between each.
The third contraction protocol was completed at visit 3, which was at least 3 days after
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visit 2. The order of the contraction protocols (see Muscle oxidative capacity and
Contraction protocols) was randomized.
Physical Function and Activity
Measures of mobility and physical activity were obtained in order to characterize
the study groups. Mobility was measured using the Timed-Up-and-Go (TUG; (188)) and
an advanced version of the short physical performance battery (SPPB-A; (210)). For the
TUG test, participants were asked to stand up from a seated position, walk 3m, return to
the chair and sit down (188). Participants completed this test twice at their usual walking
speed, with 1 min of rest between each trial. The fastest of the 2 trials was used for
analysis. Participants next completed the SPPB-A, which combines chair rise time,
balance time with 3 different foot positions, and gait speed over a 4 m path (210). For the
chair rise task, participants were instructed to fold their arms across their chest and
completely stand up and sit back down again 10 times, as fast as possible, using a
standardized chair (seat height = 45cm). For the balance tasks, participants stood with
their feet in semi-tandem and tandem positions, and on one leg, for as long as possible,
up to a maximum of 30 s. To measure gait speed, the time taken to walk along a straight,
4 m path was recorded. Participants completed this walking task twice at their preferred
speed, with 1 min of rest between trials. The walking test was then repeated, with the
participant instructed to stay within a 20cm path. The time taken to complete each
mobility test was recorded with a stopwatch.
At the end of visit 1, participants were asked to wear a uniaxial accelerometer
(Actigraph, Pensacola, FL) for 7 days. Accelerometers were worn over the right hip, and
data were recorded with a 60-s epoch. Participants wore the accelerometer for a
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minimum of 10 hours per day, and at least 4 days (3 weekdays and 1 weekend day).
These criteria have been shown to provide good reliability (>80%) for quantifying
overall, light, and moderate-to-vigorous physical activity (153,154). Average daily
activity counts and minutes spent in moderate-to-vigorous physical activity were
determined using ActiLife v6.13 software (ActiGraph, Pensacola, FL) with established
cutpoint thresholds for uniaxial ActiGraph accelerometers (74).
Familiarization
Participants were seated on a dynamometer (Biodex system 4, Biodex Medical
Systems, Shirley, NY), with hip and knee angles of 135° and 110°, respectively. These
joint angles were selected to mimic the position used for the contraction protocols in the
MR scanner at visits 2 and 3. The dynamometer was adjusted to ensure the axis of
rotation of the dynamometer’s lever arm was aligned with the axis of rotation of the
participant’s knee joint. The length of the lever arm was adjusted to each participant’s
tibia length and secured with inelastic straps ~2cm proximal to the malleoli. Additional
inelastic straps were fastened across the participant’s torso and hips to prevent unwanted
movement. Participants were instructed not to hold onto any part of the dynamometer
during the testing to ensure the torque and velocity measurements were generated
predominantly by the knee extensor muscles. Once correctly positioned on the
dynamometer, participant’s completed 2-3 maximal voluntary isometric contractions
(MVIC) followed by two 40-s trials of maximal voluntary dynamic contractions
(MVDCs) at 120°.s-1 and 240°.s-1, with 1 contraction completed every 2s. Each
contraction was cued by a metronome, and all contractions were performed over a 30°
range of motion (110-140°). Participants were instructed to ‘kick their leg out as hard
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and fast as possible’ for all contractions. The investigators provided strong verbal
encouragement throughout the familiarization protocols. Visual torque-feedback was
provided via a computer monitor, positioned at the participants eye-level. All
contractions were performed with the dominant leg (preferred kicking leg) to familiarize
participants with the contraction protocols to be performed at visits 2 and 3.
Contractile Volume Measurement
Upon arriving for Visit 2, participants completed an MRI safety questionnaire
(Appendix C) and walked through an upright metal detector to ensure their safety.
Subsequently, participants were positioned supine inside a Skyra 3T MR scanner
(Siemens Medical Systems, Erlangen, Germany). To avoid movement while inside the
MR scanner, inelastic straps were fastened over the participant’s lower leg and hips. A
multi-echo (6-point), 2D gradient-echo Dixon sequence was applied with the following
parameters: TR=35 ms, FOV=230, TE=2.46 and 6.15ms, 3.69 and 7.38ms, and 4.92 and
8.61 ms, matrix=192 x 144, GRAPPA factor=2, flip angle=15°, 1 average. These images
were acquired using an 18-channel flex coil and a 32-channel spine coil. Axial slices
(6mm) were obtained from the greater trochanter to the lateral epicondyle of the femur,
and slices in which all four quadriceps muscles were visible were analyzed for muscle
and fat content. Water and fat images were reconstructed offline using the MatLab Fatty
Riot algorithm (53). A region of interest (ROI) was drawn around the quadriceps muscle
group on each slice. Fat fraction was calculated on a pixel-by-pixel basis from the ratio
of separate water-only and fat-only images, using the equation (F/(W+F)) and expressed
as mean±SD of multiple measurements. Fat-free muscle cross-sectional area (CSA, cm2)
of the knee extensors was quantified using a custom-written MatLab program
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(MathWorks, Natick, MA). Contractile volume was calculated as the sum of CSAs,
multiplied by the slice thickness. To eliminate the possibility of inter-investigator error,
the same investigator analyzed all MR images.
Muscle Oxidative Capacity
Participants were randomly assigned to complete the muscle oxidative capacity
protocol at either visit 2 or 3. Participants were positioned inside the MR scanner with a
dual-tuned 31P/1H surface coil (8x10.5 cm) fastened over the vastus lateralis of their
dominant leg using a bandage and velcro straps. The knee and ankle of the dominant leg
were strapped to an MR-compatible ergometer. An additional strap was fastened over the
participants hips to prevent unwanted movement. Gradient scout images were obtained
to ensure correct placement of the surface coil and positioning within the isocenter of the
MR scanner. Subsequently, the homogeneity of the magnetic field was optimized by
localized shimming on the proton signal.
After optimization of the magnet for metabolic measures, participants completed
three 5-s MVICs, and 3 sets of 6 maximal isokinetic contractions at 120°.s-1 (MVDCIsoK),
and 3 sets of 6 maximal isotonic contractions at 20% MVIC (MVDCIsoT), separated by 2
min of rest. These contractions were performed to obtain baseline measures of knee
extensor torque and power and to ‘warm-up’ participants muscles.
Participants then completed 24s of MVDCIsoK’s (1 every 2s). The number of
contractions and duty cycle for this contraction protocol were selected based on pilot
work demonstrating that PCr was depleted by ~50% with minimal change in pH;
conditions which are optimal for quantifying muscle oxidative capacity in vivo (6,162).
Phosphorus spectra were acquired for 60s before (plus 15 dummy pulses), during, and
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10-min following the 12 contractions with a 0.1 ms hard pulse, 60° flip angle, 4,000 Hz
bandwidth, 2,048 complex points, 2s repetition time and 0.15 ms echo time. Figure 5.2
illustrates a representative 31P spectrum at rest, spectra throughout the muscle oxidative
capacity measurement, and the PCr recovery kinetics from 1 older male.
Contraction Protocols
Following the 10-min recovery period from the oxidative capacity measurement,
participants completed one of 2 contraction protocols. The order of these 2 contraction
protocols was randomly assigned between visits 2 and 3 such that participants either
completed a total of 2 contraction protocols at visit 2 or 3 (MVDCIsoK (muscle oxidative
capacity) and MVIC or MVDCIsoT).
For one of the contraction protocols, participants completed a 24-s maximal
voluntary isometric contraction (MVIC). For the other contraction protocol, participants
completed 24s of maximal isotonic contractions against a load equivalent to 20% of their
MVIC (MVDCIsoT). Phosphorus spectra were collected for 90-s prior and throughout
each 24-s protocol. Torque and velocity traces from each of the 3 contraction protocols
(MVIC, MVDCIsoK, and MVDCIsoT) are shown for 1 representative young male in Figure
5.1.
Measurements and Data Analyses
Mechanical Torque and Power
Position, torque, and velocity were sampled at 500Hz using a custom MatLab user
interface, and these data were post-processed offline using MatLab. Power was
calculated as the product of the instantaneous torque and velocity signals. The postprocessing program calculated the torque-time and power-time integrals for the 3
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contraction protocols. The power-time integral for both dynamic contraction protocols
(MVDCIsoK and MVDCIsoT) was calculated using only the concentric phase of each
contraction, as illustrated in Figure 5.1. Torque and power were integrated using the
Riemann sum.
31

P Spectral Analysis
All free induction decays were analyzed using jMRUI v6.0beta. Spectra were

zero-filled (2,048 points) and Fourier-transformed. A 1Hz Lorentzian filter was applied
and spectra were phased manually. Once the PCr peak was set to 0 ppm, spectra were
line-fit using the AMARES algorithm and the area under the peaks corresponding to
phosphomonoesters, Pi, phosphodiesters, PCr, alpha and gamma ATP quantified.
Concentrations of Pi and PCr were calculated assuming that [Pi] + [PCr] = 42.5mM in
resting muscle (161). Intracellular pH was calculated based on the chemical shift (σ) of
Pi relative to PCr (168).
PCr Recovery
For the recovery period, spectra were averaged to achieve the following temporal
resolution: 4s for the first 20s, 8s for the next 280s, and 30s for the remaining 5-min.
Once [PCr], [Pi], [ATP], and pH were determined, the repletion of PCr during the 10-min
recovery period was fit with a mono-exponential function and the rate constant (kPCr)
determined, as shown in equation [5.1]:

PCr t

∆PCr 1
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[Eq. 5.1]

where ΔPCr = (PCrrest – PCrex), and PCrex is [PCr] at the end of the contraction. The rate
constant of PCr recovery, kPCr, reflects the capacity for oxidative phosphorylation under
these conditions (117). This measure is highly reliable and well correlated with
respirometry measures of maximally stimulated in vitro (i.e., state 3) respiration (129)
and oxidative enzyme activities (134,156).
ATP Flux
Under conditions where there is no net change in [ATP], ATP production can be
reasonably assumed to equal ATP consumption (20,226). We calculated rates of ATP
production through the creatine kinase reaction (ATPCK), non-oxidative glycolysis
(ATPGLY), and oxidative phosphorylation (ATPOX) during the MVIC, MVDCIsoK, and
MVDCIsoT contraction protocols. The first 15 resting spectra (30s) were discarded as
dummy pulses. Spectra were averaged to achieve 60s and 4s resolution at rest and during
the contraction protocols, respectively.
The rate of PCr breakdown by the CK reaction was calculated as the rate of decline in
PCr at each 4s time point, as follows:

∆PCr
∆t

ATP

[Eq. 5.2]

Oxidative ATP synthesis was quantified under the assumptions that the resting
concentration of ATP is equal to 8.2mM (82), and the phosphorylation potential
([Pi][ADP]/[ATP]) is regulated with a Km of 0.11 (235), as follows:
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[Eq. 5.3]

where Vmax (mM ATP/s), the theoretical maximal muscle oxidative capacity, was
calculated as the product of the rate constant of PCr recovery following the MVDCIsoK
trial (kPCr) and [PCr] at rest (161). [ADP] was calulcated assuming that free creatine and
Pi are equal (235), as follows:

ATP Pi
K PCr

ADP

[Eq. 5.4]

where KCK is the equilibrium constant of the CK reaction, which was corrected for pH
assuming [Mg2+] equals 1mM (78):

K

1.66

10

.

[Eq. 5.5]

Intracellular pH was calculated based on the chemical shift (σ) of Pi relative to
PCr, in parts per million, as follows (168):

pH

6.75

log

σ 3.27
5.69 σ

[Eq. 5.6]

Broadening and splitting of the Pi peak can occur due to distinct pH pools during
contractions (180). When Pi splitting was visibly evident, the pH corresponding to each
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Pi pool was calculated separately (based on the chemical shift of each Pi pool relative to
PCr), and the weighted average determined (128):

pH

pH

area Pi
total Pi area

pH

area Pi
total Pi area

[Eq. 5.7]

Glycolytic ATP synthesis was calculated based on changes in pH and PCr during
each 24s contraction protocol, using linear regression for the rate of change. Proton
consumption by the CK reaction, buffering, and oxidative proton production were also
taken into account:

ATP

1.5

β

∆pH
∆t

θ

∆PCr
∆t

V

[Eq. 5.8]

where β represents the total buffering capacity; calculated as the sum of inherent
buffering, and buffering from bicarbonate and Pi (108). The pH dependent rate of H+
efflux (VEff) was measured in mM.s-1 at the end of each fatigue task. The proton
stoichiometry of the CK reaction coupled with ATP hydrolysis, θ, was calculated, as
follows:

θ

1
1

10

.

[Eq. 5.9]

The total rate of ATP production (mM.s-1) was calculated as the sum of ATP flux
through the CK reaction, non-oxidative glycolysis, and oxidative phosphorylation (31).
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Absolute quantities of ATP production (mM) were determined by multiplying the total
rate of ATP production (mM.s-1) by the duration of the contraction (i.e., 24s).
Metabolic Economy
Because our study design required the use of 3 different contraction modes
(isometric, isokinetic, and isotonic), ME was determined using the torque-time integral
(TTI) for the MVIC protocol, and the power-time integral (PTI) for the MVDCIsoK and
MVDCIsoT contraction protocols. To determine the ME for the MVIC protocol, the TTI
was normalized to contractile volume and ATP production (Nm.s.cm-3.mM ATP-1), as
previously reported by our lab (31). For both the MVDCIsoK and MVDCIsoT protocols,
ME was calculated as the PTI normalized to contractile volume and ATP production
(W.s.cm-3.mM ATP-1)
Statistical Analyses
All data were checked for normality and homogeneity of variance prior to any
statistical comparisons using the Kolmogorov-Smirnov test and Levene’s statistic,
respectively. If the assumptions of normality or homogeneity of variance were violated,
non-parametric statistical comparisons were performed. Differences in group descriptive
characteristics, muscle contractile volume, maximal torque and power, and oxidative
capacity were analyzed using independent t-tests or Mann-Whitney U tests. Age-related
differences in muscle metabolic variables and ATP flux across each 24-s contraction
protocol were evaluated using repeated measures ANOVA (age × time). Where
significant effects were found, post-hoc pairwise comparisons were performed. Group
differences in TTI or PTI, total ATP flux, ATP cost of contraction, and ME were
evaluated for each contraction protocol using independent t-tests. All statistical analyses
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were performed using the SPSS statistical software package (v25.0, IBM, Chicago, IL)
with an alpha level of 0.05. Data are reported as mean±SE, with exact p-values and 95%
confidence intervals for differences in group means in the Tables and text.
Results
Baseline Characteristics
Group characteristics are reported in Table 5.1. There were no differences in
height, body mass, or BMI between groups. Additionally, habitual physical activity and
average daily moderate-to-vigorous physical activity were similar between young and
older groups. We observed no difference between groups for measures of physical
function, including chair rise time, TUG, and SPPB-A.
Peak contractile CSA and contractile volume were larger in young compared with
older muscle (p≤0.025; Table 5.2), whereas fat fraction was similar between groups
(p=0.340). At baseline, maximal isometric torque (MVIC) and power during the
MVDC120 and MVDC20% trials were greater in young compared with older adults (Table
5.2). Specific isometric torque was similar between young and older adults (Table 5.2).
However, maximal specific power during the MVDC120 and MVDC20% trials was ~25%
and ~30% greater in young compared with older adults, respectively (Table 5.2). The
rate constant of PCr recovery (kPCr) was not different between young and older groups
(Table 5.2).
The torque- and power-time integrals during the MVIC, isokinetic, and isotonic
contractions are shown in Figure 5.3. We observed no age-related differences in the TTI
during the MVIC, regardless of whether data were expressed in absolute terms (p=0.096)
or normalized to muscle volume (p=0.739). However, PTI was greater in young
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compared with older adults during the isokinetic contractions both in absolute terms
(p=0.003) and when normalized to muscle volume (p=0.0022). During the isotonic
contractions, the PTI was greater in young than older adults in absolute terms (p=0.003),
but no difference was observed between groups when the PTI was normalized to muscle
volume (p=0.128).
Changes in PCr, pH, and ATP throughout the MVIC, isokinetic, and isotonic
contractions are illustrated in Figures 5.4, 5.5, and 5.6, respectively. There were no
effects of age and no age×time interactions for changes in PCr during any of the 3
contraction protocols (p≥0.123), although there was a main effect of time for each
protocol (p<0.001). We observed no age×time interactions for changes in pH during any
of the protocols (p≥0.268). However, there was a main effect of age on changes in pH
during the MVIC and isokinetic contractions (p≤0.002), but not the isotonic contractions
(p=0.093). Post-hoc analyses revealed group differences in pH at 20 and 24s during the
MVIC protocol and only at 16s during the isokinetic contractions. There was a main
effect of time on changes in pH for each of the 3 contraction protocols (p≤0.001). We
observed no age×time interaction or main effect of time for changes in [ATP] during the
MVIC, isokinetic, or isotonic contractions (p≥0.068), indicating the assumption of
unchanging [ATP] necessary for ATP flux calculations was appropriate in this study
(20,226). However, there was a main effect of age on [ATP] during the MVIC (p=0.002)
and isotonic contractions (p=0.018), but not isokinetic contractions (p=0.144), such that
[ATP] was higher in older than young muscle. Nonetheless, these differences were small
(~0.5mM) and [ATP] appeared relatively constant in both groups, suggesting our
calculations of ATP flux are valid.
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ATP Flux during the MVIC
There was a main effect of time (p≤0.001) for changes in ATP flux the creatine
kinase reaction and oxidative phosphorylation (p≤0.001; Figure 5.4), but no age×time
interaction and no main effect of age (p≥0.647). Post-hoc analyses revealed ATP from
PCr breakdown decreased over the first 12s (p≤0.023), while oxidative ATP flux
increased over the first 8s (p≤0.026). There was a main effect of age (p=0.017), but no
main effect of time and no age×time interaction for the glycolytic ATP flux (p≥0.513).
Post-hoc analyses revealed greater glycolytic ATP flux in young compared with older
adults at 20s (p=0.036), but no other time points (p≥0.164).
When expressed as a percentage of total ATP flux, we observed no age×time
interaction (p≥0.413) for the contributions from each bioenergetic pathway (Figure 5.7).
However, we did observe main effects of time (p≤0.032) for the contribution from each
bioenergetic pathway. Post-hoc analyses revealed the contribution from the creatine
kinase reaction decreased over the first 12 and 16s in older and young adults, respectively
(p≤0.048). The ATP contributed by oxidative phosphorylation increased over the first
12s in young and older adults (p≤0.046). There was no effect of age (p≥0.103) on the
contribution to total ATP flux by the creatine kinase reaction nor oxidative
phosphorylation. However, a main effect of age was observed for the contribution to
total ATP flux by non-oxidative glycolysis (p=0.005), and post-hoc analyses revealed a
greater relative ATP contribution from glycolysis at 20s (p=0.005).
ATP Flux during the Isokinetic Contractions
There was a group×time interaction (p=0.021) for changes in ATP flux through
the creatine kinase reaction (Figure 5.5). Post-hoc analyses revealed PCr breakdown was
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lower in young than older adults during the first 4s (p=0.004), but not different between
groups at any other time points (p≥0.155). After increasing over the initial 4s in young
(p=0.001), but not older adults (p=0.152), ATP flux through the creatine kinase reaction
decreased from 8-16s in both groups (p≤0.016). There was no main effect of age
(p=0.892) or time (p=0.062), and no age×time interaction (p=0.150) for changes in
glycolytic ATP flux. Lastly, there was a main effect of time (p=0.001), but no main
effect of age (p=0.579) and no age×time interaction (p=0.994) for changes in oxidative
ATP flux. Post-hoc analyses revealed oxidative ATP flux increased over the initial 12s
in young and older (p≤0.014).
When expressed as a percentage of total ATP flux, we observed no age×time
interaction (p≥0.186) for the contributions from each bioenergetic pathway (Figure 5.7).
However, there was a main effect of age on the contributions from the creatine kinase
reaction and oxidative phosphorylation (p≤0.017), but not non-oxidative glycolysis
(p=0.868). Post-hoc analyses revealed the contribution to total ATP flux by creatine
kinase was greater in young compared with older muscle at 16 and 24s (p≤0.01), and the
contribution from oxidative phosphorylation was lower in young compared with older
muscle at 24s (p=0.019). Main effects of time were observed for the contributions from
each bioenergetic pathway (p≤0.001). Post-hoc analyses revealed ATP flux through the
creatine kinase reaction decreased between 8 and 16s (p≤0.002), and 20 and 24s
(p≤0.012) in both groups. The ATP contribution from glycolysis fluctuated between ~15
and 20% in young and older muscle throughout the 24s contraction period. Oxidative
contributions to total ATP flux gradually increased over the first 16s in both young and
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older muscle (p≤0.015), but were not different between successive time points after 16s
in either group (p≥0.059).
ATP Flux during the Isotonic Contractions
There was no age×time interaction (p≥0.792) and no main effect of age (p≥0.641)
for changes in ATP flux through the creatine kinase reaction, non-oxidative glycolysis, or
oxidative phosphorylation (Figure 5.6). However, main effects of time were observed for
the contributions from each bioenergetic pathway (p≤0.001). Post-hoc analyses revealed
PCr breakdown decreased over the first 8 and 12s in older and young adults, respectively
(p≤0.012). Glycolytic ATP flux decreased over the first 8s in young and older muscle
(p≤0.013), while oxidative ATP flux increased over the first 12s in young and older
muscle (p≤0.041).
When expressed as a percentage of total ATP flux, we observed no age×time
interaction (p≥0.842) nor main effect of age (p≥0.590), but main effects of time
(p≤0.006) for the contributions from each bioenergetic pathway (Figure 5.7). Post-hoc
analyses revealed the contribution to total ATP flux through the creatine kinase reaction
increase over the first 16s in both groups (p≤0.049). The contribution of non-oxidative
glycolysis to total ATP flux fluctuated between ~15 and 20% throughout the 24s
contraction period in both groups. Oxidative ATP flux gradually increased over the first
16s in both groups (p≤0.049).
Metabolic Economy
The total ATP flux, ATP cost of contraction, and ME for the MVIC, isokinetic,
and isotonic contractions are shown in Figure 5.8. Total ATP flux, ATP cost of
contraction, and ME were not different between groups during the MVIC (p≥0.095).
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Although the total ATP flux was not different between groups during the isokinetic or
isotonic contractions (p≥0.827), the ATP cost of contraction, and ME were greater in
young compared with older muscle during both dynamic contraction protocols (p≤0.031).
Discussion
This study was designed to evaluate age-related differences in muscle ME during
24s of maximal isometric, isokinetic, and isotonic contractions. We hypothesized that
ME would be: 1) lower in young compared with older adults during a 24-s MVIC, 2)
similar between age groups during 24s of isokinetic contractions at 120°.s-1, and 3)
greater in young compared with older adults during 24s of isotonic contractions against a
load equivalent to 20% MVIC. These hypotheses were based on previous observations of
greater, similar, and less fatigue in young compared with older muscle in response to
isometric (28,35,60,114,130), moderate-velocity (23,24,49,147), and high-velocity
contractions (24,48,49,159,222,223), respectively. Our data do not support our first
hypothesis as we observed no age-related differences in muscle ME during the 24-s
MVIC. Similarly, our data do not support our second hypothesis; we observed greater
muscle ME in young compared with older muscle during the isokinetic contractions.
However, our data support our third hypothesis; muscle ME was greater in young
compared with older adults during the isotonic contractions. These results extend
previous working examining age-related differences in muscle ME in the dorsiflexors
(31), and ATP cost of contraction in the plantar flexors and knee extensors (136-139).
Our results suggest that the source of age-related differences in muscle ME may arise
from the increased energy demand, as a result of the intermittent nature of force
production, during dynamic contractions.
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Baseline
Peak contractile CSA and volume were greater in young compared with older
muscle (Table 5.2), consistent with the majority of the literature in this area (24,90,231).
However, we observed no age-related differences in fat fraction, which is in disagreement
with some studies which demonstrate an increase in intramuscular lipid with age (24,90).
The cause of this discrepancy is not clear at this time, but might be due to the amount of
moderate-to-vigorous physical activity of the older adults in the present study (Table 5.1).
At baseline, maximal isometric torque was ~30% greater in young compared with
older adults (Table 5.2), which is consistent with previous work (3,23,24). No agerelated differences in specific torque (i.e., maximal isometric torque normalized to
contractile volume) were observed, consistent with previous work (24,113). Peak power
during the isokinetic and isotonic contractions were ~55 and ~70% greater in young
compared with older adults (Table 5.2). The magnitude of these age-related decrements
in peak power are considerably larger than has been reported elsewhere in the knee
extensors (23,24). The cause of the discrepancy between previous studies and our current
results is likely due to the larger range of motion possible with a full-sized dynamometer
compared with that inside the MR environment (70 vs. 30° range of motion) and the
leftward shift in the torque-velocity relationship with aging (24). Indeed, the time to
target velocity is longer in older than young adults during isokinetic contractions (132); a
smaller range of motion would reduce the time available to reach target velocity and
likely exacerbate age-related differences in the torque produced at a given velocity.
Therefore, one would expect the torque produced at a given velocity to be lower in older
than young adults, and for this to be exacerbated with a smaller range of motion. Age-
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related differences in peak power during the isokinetic and isotonic contractions were still
observed after normalizing to contractile volume. The latter observation indicates that
the decline in muscular power with age is not exclusively due to the age-related loss of
muscle mass.
A systematic review and meta-analysis of the available literature in 2016 revealed
oxidative capacity is higher in the knee extensor muscles of young compared with older
adults (73). In contrast, we observed no difference in the rate constant (kPCr) of PCr
recovery between groups (Table 5.2). This observation is consistent with some more
recent reports of age-related differences in knee extensor oxidative capacity (83,223).
The reasons for the lack of differences observed in muscle oxidative capacity here are not
currently clear, but are likely not due to the age of the older adults or group differences in
physical activity. Larsen et al. observed higher oxidative capacity of the knee extensors
in young compared with older adults matched for physical activity (133). Moreover, the
age of the participants in Larsen et al. closely matches the age of the groups in the current
study and participants in the present study were well matched for physical activity (Table
5.1). Understanding the participant characteristics that lead to reduced muscle oxidative
capacity with age requires further study.
ATP Flux
Resting [PCr] and pH were not different between groups for the 3 conditions
(Figures 5.4, 5.5, and 5.6), indicating a similar intracellular milieu was present in young
and older muscle prior to each contraction protocol, as has been reported previously
(133,136,223). [PCr] at the end of each 24s contraction protocol was also similar
between young and older muscle. However, pH at the end of the 24-s MVIC was lower

141

in young compared with older adults (Figure 5.3). This observation is consistent with
previous work where young muscle acidified to a greater extent than older muscle during
a sustained isometric contraction (114,136). Despite this, no age-related differences were
observed in pH at the end of either dynamic protocol, which may be, at least in part, due
to the relatively brief nature of the contraction protocols in the present study because
young muscle has been shown to acidify less than older muscle during high-velocity
dynamic contractions to fatigue (223).
With the exception of the first 4s during the isokinetic contractions, we observed
no age-related differences in the absolute or normalized contribution to ATP flux from
the creatine kinase reaction (Figures 5.4, 5.5, 5.6, and 5.7). This observation is consistent
with previous reports during isometric contractions in the tibialis anterior (31,128,130),
plantar flexors (137), and knee extensors (136). These results indicate that PCr
breakdown is able to meet the immediate energy demands in young and older muscle
and, given that resting [PCr] was similar between groups for all conditions, suggests that
creatine kinase activity is unchanged with age.
Some studies have demonstrated a decline in the activities of lactate
dehydrogenase (102,135,182) and hexokinase (182) with age. These observations would
suggest there is an age-related decline in the capacity for non-oxidative glycolysis.
However, these observations may be muscle-specific, as enzyme activity of lactate
dehydrogenase and hexokinase were greater in the rectus abdominus but not the vastus
lateralis or gluteus maximus muscles of young compared with older adults (182). To
determine if there is an age-related impairment in non-oxidative glycolysis in vivo, Lanza
et al. used 31P-MRS to determine the rate of non-oxidative glycolysis in young and older
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men during a 60-s MVIC of the ankle dorsiflexors (128). The authors observed a faster
rate of non-oxidative glycolysis in the young compared with older men, consistent with a
difference in the use of this bioenergetic pathway with age. To determine if the lower
rate of non-oxidative glycolysis in older muscle was due to an impairment in this
pathway, Lanza et al. performed a similar experiment with and without blood flow to the
ankle dorsiflexors (130). The results confirmed the previous finding of faster rates of
non-oxidative glycolysis in young compared with older muscle when blood flow was
intact. However, during ischemia the rate of non-oxidative glycolysis increased in older
muscle, such that it was similar in young and older muscle. Together, these studies
suggest that there is no age-related impairment in non-oxidative glycolysis, although
whether these findings in the ankle dorsiflexors can be generalized to other muscle
groups is not clear. In the present study, we only observed a greater glycolytic ATP flux
in young compared with older muscle after 20s of the MVIC protocol, but no differences
during either dynamic protocol (Figures 5.4, 5.5, 5.6, and 5.7). These findings suggest
there is no age-related impairment in non-oxidative glycolysis with age.
Activity of citrate synthase, a classic marker of mitochondrial bioenergetic
capacity, has been observed to be greater in young compared with older muscle
(69,92,182), suggesting the capacity for ATP production via oxidative phosphorylation
declines with age. Measures of state III respiration (i.e., maximally stimulated
respiration) and ATP production in isolated mitochondria (64,186) have supported this
notion. However, caution is urged when interpreting some of these findings as agerelated differences in state III respiration have been shown to be exacerbated when
isolated mitochondria rather than muscle bundles are examined (186,187). In order to
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study the intact system, 31P-MRS has been used to measure the PCr recovery kinetics and
infer the oxidative capacity (6,161,162). Our systematic review and meta-analysis
revealed muscle-specific age-related changes in muscle oxidative capacity, such that it is
higher in the knee extensors, unchanged in the plantar flexors and elbow flexors, and
lower in the dorsiflexors of young compared with older adults (73). However, the present
data did not support this observation as oxidative capacity was not different between
young and older adults (Table 5.2). Further, we observed no age-related differences in
the rate of oxidative phosphorylation during the MVIC or isotonic contractions, and the
oxidative ATP contribution was only different between groups at 24s during the
isokinetic contractions. These observations suggest there is no age-related impairment in
oxidative ATP production during isometric nor dynamic contractions of the knee
extensors.
Metabolic Economy
In contrast to our hypothesis, TTI, total ATP flux, ATP cost of contraction, and
ME during the MVIC were not different between young and older adults (p>0.05;
Figures 5.3 and 5.8). Although we hypothesized ME would be similar between groups
during the isokinetic contractions, PTI, ATP cost of contraction, and ME were higher in
young compared with older muscle (p≤0.003; Figures 5.3 and 5.8), despite no difference
in total ATP flux between groups (p=0.827; Figure 5.8). Consistent with our hypothesis,
PTI, ATP cost of contraction, and ME during the isotonic contractions were higher in
young compared with older muscle (p≤0.031; Figures 5.3 and 5.8). Notably, the total
ATP flux during the isotonic contractions was not different between groups (p=0.861;
Figure 5.8).
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Previous work has shown the energetic cost of dynamic contractions is greater
than isometric contractions (205), an observation due at least in part to the ATP cost of
generating force being higher than maintaining force (202). In a preparation of canine
gastrocnemius muscle, Hogan et al. reported greater estimates of ATP utilization rate in
contractions of short (0.25s) compared with long (1s) duration (89). Using an in vivo
approach, some authors have reported lower (130) or similar (31) ME in young compared
with older muscle during sustained MVICs of the ankle dorsiflexors. Layec et al.
observed no age-related differences in the ATP cost of contraction of the knee extensors
during a sustained 24-s MVIC (136). However, during intermittent MVICs of the knee
extensors, the ATP consumed per unit power was lower in young compared with older
adults (136), suggesting there is an age-related increase in the cost of developing, but not
maintaining force. Our observation of similar ME between young and older adults during
the MVIC, but not during either bout of dynamic contractions, is consistent with these
previous observations.
Only a few studies have examined age-related differences in the ATP cost of
dynamic contractions (31,136-139). Layec et al. reported the ATP consumed per unit
power during contractions of the plantar flexors at 40% of each participant’s maximal
work rate to be lower in young compared with older muscle (139). Similarly, during
plantar flexion at 120% of maximal aerobic power the ATP consumed per unit power was
lower in young compared with older muscle (137). Further, in rat diaphragm muscle
ATP consumption by myosin ATPase has been shown to be ~3x greater when myofibers
are contracting at 33% maximal shortening velocity compared with an isometric
contraction (209). Collectively these observations suggest ME during dynamic
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contractions might decline with age. Our results support this suggestion as ME was
greater in young compared with older adults during both the isokinetic and isotonic
contraction protocols.
An age-related shift in fiber-type is unlikely to account for our results. Although
type I muscle fibers are more economical than type II fibers (80,85), if there was a shift
toward a slower muscle phenotype with age then older muscle would presumably be
more economical than young muscle under various conditions. Further, whether muscle
fiber composition changes with age is not currently clear; shifts toward a slower
phenotype (141-143), faster phenotype (75), and no change in fiber type with age (164)
have been reported. Part of this discrepancy may be due to the method used to determine
muscle fiber composition (see (193) for review). Another possible explanation for this
discrepancy is the age and physical activity levels of the older adults studied. For
example, there is growing evidence that recurrent cycles of denervation and reinnervation
result in myofiber co-expression (200), and the capacity to reinnervate those myofibers is
greater in octogenarian master athletes than in pre-frail/frail older women (214).
Considering our observations of age-related differences in the ATP cost of
contraction and ME across 3 different contraction modes, and those of prior
investigations (31,136-139), there may be an age-related increase in the energetic cost of
generating, but not maintaining, force. This idea has been suggested before (136), but
that study did not match the total TTI between sustained and intermittent isometric
contractions. Therefore, this hypothesis has not yet been directly tested. Nonetheless, an
age-related increase in the energetic cost of generating, but not maintaining, force could
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explain why ME is often observed to be greater in young compared with older adults
during intermittent isometric and dynamic, but not sustained isometric contractions.
The cause of an age-related increase in the cost of generating force is not clear at
this time. Notably, where age-related differences in ME were observed in the present
study the total ATP flux was not different between groups (Figure 5.8) but the work
done, as measured by the PTI, was greater in young than older adults (Figure 5.3). A
similar observation has been made in rat muscle, where maximal force production was
greater in young than older animals despite no differences in myosin ATPase activity
with age (148). Further, those authors noted the apparent rate constant for stronglybound myosin’s dissociation from actin was ~30% lower in young compared with older
muscle, consistent with a greater flux of myosin from the strong- to weakly-bound state
during an isometric contraction. Conversely, work in single human muscle fibers has
shown slower crossbridge kinetics, characterized by a longer myosin-actin attachment
time, in older compared with young muscle (164). Thus, whether a faster dissociation
from a strong- to weakly-bound state in older muscle is exacerbated during dynamic
contractions is unclear at this time, but might explain the current results.
Another potential explanation for the greater ME of young compared with older
muscle during dynamic, but not isometric, contractions is a decline in the series elasticity
of the muscle-tendon unit with age. With a more compliant muscle-tendon unit, poweror torque-amplification is lower (198). During short, rapid contractions such as the
dynamic contractions performed in the present study, power-amplification would likely
be exacerbated by a less stiff muscle-tendon unit. However, during a sustained isometric
contraction, the elasticity of the muscle-tendon unit is largely irrelevant to the
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maintenance of torque as the muscle is operating on the steep part of the force-extension
relationship. Although the evidence for greater muscle-tendon unit stiffness in young
compared with older adults is equivocal (84,125,150,217,219), computer simulations
using physiologically-relevant modeling parameters from young and older rat muscle
demonstrated a compromised ability of older muscle-tendon units to store elastic energy
and produce positive work (52). Therefore, evaluating the effects of old age on the
relationship between in vivo muscle ME and muscle-tendon unit stiffness is worthy of
further investigation.
Another avenue worthy of further investigation is determining the relative
contributions from each site of ATP consumption during different contraction modes.
Approximately 30-50% of the total ATP cost of contraction is associated with the Na2+K+ and Ca2+ ATPases; the majority of which is attributed to SERCA pump activity (8).
The remaining 50-70% is consumed by myosin ATPase in the crossbridge cycle (8).
However, these percentages may change during different contraction modes; a premise
that has been used to examine age-related differences in ATP cost from ion pumping and
crossbridge cycling (136), but is not yet clear.
Conclusion
This study adds important new information regarding the conditions under which
age-related differences in ME are present. We have shown that ME is similar in young
and older muscle during a sustained MVIC, but greater in young than older muscle
during isokinetic and isotonic contractions at 2 distinct velocities. Our observations,
along with those of previous investigations (136), suggest there is an age-related increase
in the energetic cost of developing, but not maintaining, force. Because activities of daily
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living largely require dynamic contractions, these results may be important for
understanding the increase in mobility-disability with advanced age.

Table 5.1. Group characteristics
Young (n=10)
Older (n=10)
95% CI
P
Age (yrs)
27.5 ± 1.2
71.2 ± 1.6
Height (m)
1.69 ± 0.03
1.64 ± 0.03
-0.46, 0.15
0.286
Body mass (kg)
75.3 ± 4.4
67.8 ± 3.9
-4.91, 19.87
0.221
BMI (kg.m-2)
26.0 ± 0.9
24.9 ± 0.7
-1.27, 3.45
0.344
PA (counts.d-1000)
238.7 ± 32.3
238.6 ± 31.5
-94.65, 94.73
0.999
. -1
MVPA (min d )
38.3 ± 5.6
27.2 ± 7.4
-8.39, 30.55
0.247
Chair rise time (s)
16.1 ± 1.3
19.7 ± 1.6
-7.85, 0.81
0.105
TUG (s)
9.0 ± 0.5
9.5 ± 0.3
-1.70, 0.53
0.280
SPPB-A
2.82 ± 0.09
2.57 ± 0.09
-0.02, 0.12
0.067
Values are mean±SE. 95% CI, 95 % confidence intervals for the difference between group
means; BMI, body mass index; PA, physical activity; MVPA, moderate- to vigorous-intensity
physical activity; TUG, timed up-and-go; SPPB-A, advanced short physical performance
battery.
Table 5.2. Muscle characteristics
Young (n=10)

Older (n=10)

95% CI

P

Muscle morphology
Peak contractile CSA (cm2)
68.7 ± 5.7
51.2 ± 4.1
2.6, 32.2
0.023
Contractile volume (cm3)
1125.6 ± 109.9
803.5 ± 72.3
45.7, 598.4
0.025
Fat Fraction (%)
8.4 ± 0.3
8.8 ± 1.1
-2.2, 0.8
0.340
Femur length analyzed (%)
46.1 ± 1.5
45.0 ± 1.8
-3.9, 6.1
0.651
Peak torque and power
MVIC (Nm)
252.0 ± 20.4
187.9 ± 19.9
4.2, 124.1
0.037
MVDCIsoK (Nm)
113.3 ± 14.2
66.0 ± 9.7
11.4, 83.4
0.013
MVDCIsoK (W)
238.5 ± 30.5
133.5 ± 19.6
28.7, 181.3
0.010
MVDCIsoT (W)
367.7 ± 42.8
178.1 ± 26.7
29.4, 96.8
0.002
MVDCIsoT (deg/s)
266.2 ± 6.0
203.1 ± 14.3
82.1, 297.6
0.002
Specific torque and power
MVIC (Nm/cm3)
0.232 ± 0.02
0.232 ± 0.01
-0.04, 0.4
0.826
MVDCIsoK (W/cm3)
0.218 ± 0.02
0.161 ± 0.01
0.004, 0.1
0.037
MVDCIsoT (W/cm3)
0.328 ± 0.02
0.219 ± 0.02
0.04, 0.2
0.004
Muscle oxidative capacity
kPCr (s-1)
0.021 ± 0.001
0.022 ± 0.001
-0.01, 0.01
0.632
Values are mean±SE. 95% CI, 95 % confidence intervals for the difference between group
means; MVIC, maximal voluntary isometric contraction; MVDCIsoK, maximal voluntary
isokinetic contraction at 120°.s-1; MVDCIsoT, maximal voluntary isotonic contraction at 20%
MVIC; kPCr, rate constant of PCr recovery.
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Figure 5.1. Representative torque and velocity traces from each protocols. Torque for the 24-s
MVIC (A), and torque and velocity traces for the isokinetic (B) and isotonic contractions (C).
One 24-s MVIC was performed with a target torque of 100% MVIC (dotted line). A total of 12
isokinetic contractions were performed at 120°.s-1 over a 24-s period (IsoK; note that target
velocity, shown by the dotted line, was attained in each contraction). A total of 12 isotonic
contractions were performed at a load equivalent to 20% MVIC over a 24-s period (MVDC20%;
target torque is shown by the dotted line). Representative data are from 1 young man. The shaded
area reflects the concentric phase of each contraction.
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Figure 5.2. Quantitation of in vivo muscle mitochondrial capacity using 31-phosphorus magnetic
resonance spectroscopy. Spectrum at rest illustrates metabolites of interest in human quadriceps
muscle (A); stack plot shows changes in PCr and Pi during 24-s of isokinetic contractions at
120°.s-1 followed by 10-min recovery (B); mono-exponential fit of PCr recovery which yields the
rate constant for PCr recovery (kPCr) reflecting the oxidative capacity of the muscle (C).
Representative data from 1 older man are shown.
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Figure 5.3. Torque- and power-time integrals during the 24-s isometric, isokinetic, and isotonic
contractions. TTI, torque-time integral; PTI, power-time integral; MVIC, maximal voluntary
isometric contraction; IsoK, maximal voluntary isokinetic contractions; IsoT, maximal voluntary
isotonic contractions. Symbols representing men (♂) and women (♀) are shown.
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Figure 5.4. Changes in metabolites and rates of ATP flux during the 24-s MVIC. ATPCK, ATP
flux through creatine kinase; ATPGLY, ATP flux through non-oxidative glycolysis; ATPOX, ATP
flux through oxidative phosphorylation.

153

Figure 5.5. Changes in metabolites and rates of ATP flux during the isokinetic contractions.
ATPCK, ATP flux through creatine kinase; ATPGLY, ATP flux through non-oxidative glycolysis;
ATPOX, ATP flux through oxidative phosphorylation.
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Figure 5.6. Changes in metabolites and rates of ATP flux during the isotonic contractions.
ATPCK, ATP flux through creatine kinase; ATPGLY, ATP flux through non-oxidative glycolysis;
ATPOX, ATP flux through oxidative phosphorylation.
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Figure 5.7. Relative contributions from each bioenergetic pathway to total ATP flux throughout
the isometric, isokinetic, and isotonic contractions. MVIC, maximal voluntary isometric
contraction; IsoK, maximal voluntary isokinetic contractions; IsoT, maximal voluntary isotonic
contractions. ATPCK, ATP flux through creatine kinase; ATPGLY, ATP flux through non-oxidative
glycolysis; ATPOX, ATP flux through oxidative phosphorylation.
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Figure 5.8. Total ATP flux, ATP cost of contraction, and metabolic economy during the 24-s
MVIC, isokinetic, and isotonic contractions. ME, metabolic economy; MVIC, maximal voluntary
isometric contraction; IsoK, maximal voluntary isokinetic contractions; IsoT, maximal voluntary
isotonic contractions.

157

CHAPTER 6
DISSERTATION SUMMARY
The goals of this dissertation were to elucidate if there is a bioenergetic basis for
the age-related differences in muscle fatigue that might be, at least in part, explained by a
lower metabolic economy in older than young adults during high-velocity contractions.
Previous work has shown that fatigue is: a) greater in young than older adults in response
to maximal isometric contractions (28,35,60,114,130), b) similar between age groups in
response to contractions at intermediate velocities (23,24,49,147), and c) lesser in young
than older adults in response to maximal contractions at high velocities
(24,48,49,159,222,223). Although the cause of age-related differences in muscle fatigue
in response to maximal isometric contractions appears to be related to a greater [Pi] and
[H2PO4-], and lower pH in young compared with older muscle (114,128), the mechanisms
for the lesser muscle fatigue in young compared with older muscle in response to highvelocity contractions are not clear. Additionally, the physiological basis for the similar
fatigue in young and older muscle in response to moderate-velocity contractions is not
yet established. Nonetheless, because activities of daily living, such as climbing stairs or
walking, require repeated dynamic contractions (184), the ability to resist muscle fatigue
may be especially important for older adults in order to maintain their quality of life
(227). Therefore, there is a desire to understand the cause of age-related differences in
muscle fatigue and develop strategies to resist it and maintain independence into old age.
Together, the studies presented in this dissertation provide novel insight into the impact
of old age on muscle fatigue, metabolic economy, and bioenergetics in vivo.
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Study 1 (Chapter 4) examined the potential bioenergetic mechanisms for agerelated differences in muscle fatigue during dynamic contractions of the knee extensors.
A summary of the age-related differences at baseline and in response to each bout of
fatiguing contractions observed in Study 1 are shown in Table 6.1. We observed lower
muscular power production during isotonic contractions against a load equivalent to 20%
MVIC (MVDC20%) and isokinetic contractions at 120°.s-1 (MVDC120) in older compared
with young adults at baseline. In contrast with our hypothesis (H 1a), in vivo oxidative
capacity was similar in young and older knee extensor muscles, demonstrating the
capacity for oxidative ATP production was similar between groups in this dissertation.
Although this finding is in disagreement with the majority of studies that have evaluated
the effects of old age on oxidative capacity of the knee extensors (73), a recent study
observed the same result (223). We expected to observe less fatigue in young compared
with older adults in response to the MVDC20% protocol, which we hypothesized would be
accompanied by lower [Pi], [H+], and [H2PO4-] in the young than older muscle (H 1b). In
contrast with this, we observed an almost identical decline in the power-time integral (%
initial) and similar [Pi] between groups in response to the MVDC20%. However, [H2PO4-]
was higher, and pH lower, in young compared with older muscle towards the end of this
protocol. In concert with this, glycolytic ATP flux was higher in young than older
muscle during the first 2 min of the MVDC20% protocol, and Vi[PCr] (a measure of
oxidative ATP production) did not change with fatigue in young but increased in older
muscle. Collectively, this indicates glycolytic and oxidative ATP production is lower and
higher, respectively, in older than young muscle. The accumulation of protons, and Pi,
during fatiguing contractions is well known to inhibit force production at the crossbridges
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(57-59,123,225,239). The observation of similar fatigue and [Pi], but lower pH, in young
compared with older muscle suggests that the contractile machinery may be more
sensitive to changes in pH in older compared with young muscle in vivo. Although this
suggestion is in contrast with a recent report that observed no effect of old age on single
fiber sensitivity to [Pi] and [H+] (221), that experiment was performed under maximally
activated conditions (i.e., saturating [Ca2+]). Whether there are age-related differences in
single fiber sensitivity to the inhibitory effects of high [Pi] and [H+] at submaximal [Ca2+]
is yet to be established, but is worthy of further investigation.
We expected to observe no age-related differences in fatigue and similar [Pi],
[H+], and [H2PO4-] between groups in response to the MVDC120 protocol (H 1c). Our
results did not support this hypothesis; fatigue (% initial PTI) was greater in young than
older muscle. The greater fatigue in young muscle was accompanied by higher [Pi] and
[H2PO4-], as well as a lower pH compared with older muscle. Although others have
observed no age-related differences in muscle fatigue of the knee extensors in response to
isokinetic contractions at 120°.s-1 (23), the range of motion in those studies was 70°
whereas it was 30° in this study. We observed that torque production, relative to MVIC,
was markedly lower in older than young adults over 30° compared with what might be
expected over a 70° range of motion. This suggests that the torque-velocity relationship
shifts further left in older than young when contractions are performed over a 30 vs. 70°
range of motion. However, this requires further investigation. Nonetheless, given the
well-established effects of high [Pi] and [H+] on force production at the molecular level
(57-59,123,225,239), the age-related difference in fatigue observed in response to the
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MVDC120 protocol can likely be attributed to the greater metabolic perturbation observed
in the young muscle.
We expected oxidative ATP production to be lower in older than young muscle
during the MVDC20%, but similar between groups during the MVDC120 protocol. In
contrast with this hypothesis, we observed no group differences in Vi[PCr] at baseline nor
the end of the fatigue protocols. However, we did find no change in oxidative ATP
production from baseline to post-fatigue in the young, but an increase in Vi[PCr] in the
older group. The latter observation suggests fatigue did not impair Vi[PCr] in older muscle
and supports previous reports of a preponderance for oxidative ATP production in older
compared with young muscle (128,130).
We were also unable to test our exploratory hypotheses, where we expected
muscle-tendon unit stiffness to be greater in young than older adults (EH 1a) and
positively associated with fatigue during the MVDC20% (EH 1b). Although these data
were collected, we were unable to analyze them due, at least in part, to issues with the
tracking algorithm used to quantify extension of the force-Δlength relationship.
Collectively, in Study 1, we observed similar fatigue between groups in response
to the MVDC20%, and greater fatigue in young than older adults in response to the
MVDC120 protocol. During the MVDC20% protocol, [Pi] was similar in young and older
muscle, but [H2PO4-] was greater and pH lower in young than older muscle. These data
suggest that the contractile machinery may be more sensitive to changes in pH in older
compared with young muscle. During the MVDC120 protocol, [Pi] and [H2PO4-] were
higher and pH lower in young compared with older muscle. These data provide a
bioenergetic basis for the greater fatigue we observed under this condition. Thus, the
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results reported in this dissertation may be explained by age-related changes in myofiber
sensitivity to metabolites known to inhibit force production by the crossbridges (i.e., [Pi],
[H2PO4-], and [H+]).
Study 2 (Chapter 5) evaluated age-related differences in muscle metabolic
economy during isometric, isokinetic, and isotonic contractions of the knee extensors. To
date, I am aware of only one study that has examined in vivo muscle metabolic economy
(31). Thus, whether age-related differences in metabolic economy depend upon the
metabolic demand was unclear. A summary of the age-related differences in the torqueand power-time integral, contribution from each bioenergetic pathway, ATP cost, and
muscle metabolic economy from the three contraction modes in Study 2 are shown in
Table 6.2.
The first hypothesis for Study 2 (H 2a) was not supported; metabolic economy
during a 24-s maximal isometric contraction was similar in young and older adults. In
contrast with our second hypothesis (H 2b), but in support of our third hypothesis (H 2c),
metabolic economy was higher in young than older muscle during both dynamic
contraction modes in Study 2. Integrating these results with previous literature on in vivo
muscle metabolic economy (31) and ATP cost of contraction (136), we postulate that
age-related differences in metabolic economy are not due to contraction mode per se, but
are likely due to an increased cost of force production, but not maintenance, with age.
This postulation is supported by prior work showing a higher ATP cost of contraction in
older than young knee extensor muscles during brief intermittent versus a sustained
isometric contraction (136). Thus, there may be an age-related increase the cost of
generating, but not maintaining, force. Although the cause of an age-related increase in
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the cost of generating force is not clear at this time, where age-related differences in
metabolic economy were observed in Study 2 the total ATP turnover was not different
between groups but the work done, as measured by the PTI, was greater in young than
older adults. A similar observation has been made in rat muscle, where maximal force
production was greater in young than older animals despite no differences in myosin
ATPase activity with age (148). Further, those authors noted the apparent rate constant
for strongly-bound myosin’s dissociation from actin was ~30% lower in young compared
with older muscle, consistent with a greater flux of myosin from the strong- to weaklybound state during an isometric contraction. Conversely, work in single human muscle
fibers has shown slower crossbridge kinetics, characterized by a longer myosin-actin
attachment time, in older compared with young muscle (164). Therefore, the interplay
between crossbridge kinetics, force production, and metabolic economy with age requires
further investigation to try and elucidate the molecular mechanism for an age-related
decline in in vivo muscle metabolic economy during dynamic, but not isometric,
contractions.
Significance
This dissertation addressed the potential bioenergetic mechanisms for the agerelated differences in fatigue, and the effect of old age on in vivo muscle metabolic
economy during 3 distinct bouts of knee extensor contractions. Although a systematic
review and meta-analysis of the available literature in 2016 demonstrated the capacity for
oxidative ATP production is impaired in the knee extensors of older compared with
young adults (73), we observed similar oxidative capacity in young and older muscle in
this dissertation. This is an important observation because mitochondrial energetics are
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closely associated (r2=0.647) with preferred walking speed, a measure of mobility, in
older adults (38), suggesting the mitochondria play an important role in gait speed.
Another novel finding of this dissertation was the lack of age-related differences in
fatigue of the knee extensors in response to the MVDC20% protocol. Notably, we
observed a greater [H2PO4-] and lower pH in young compared with older muscle during
that fatiguing task. These observations suggest that the contractile machinery may be
more sensitive to changes in pH in older compared with young muscle in vivo. This
extends previous research and, if true, may offer a translatable explanation for age-related
differences in muscle fatigue during other contraction protocols. Another new finding
from Study 1 is the ~25% decline in [ATP] in young and older muscle during dynamic
contractions to fatigue, which suggests that the energetic demand outweighs its supply
during these contractions. Notably, [ATP] did not fully recover after 10 min. During
both bouts of fatiguing contractions, we also observed significant increases in the
concentration of phosphomonoesters (PME in both groups; PME generally increases
during intense contractions due to an accumulation of sugar phosphates (e.g., glucose-6phosphate, inosine monophosphate) (12). However, the decline in [ATP] likely
contributed to the increase in [PME] during these contractions because adenine
nucleotide breakdown results in the formation of inosine monophosphate (163), which
contributes to the PME pool in the 31P spectrum.
Study 2 of this dissertation confirmed previous observations where no age-related
differences in the in vivo muscle metabolic economy were observed during a maximal
isometric contraction (31). A novel finding of this dissertation was that in vivo muscle
metabolic economy was higher in young compared with older muscle during dynamic
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contractions, regardless of the power output. Together, these observations suggest that
the cost of generating, but not maintaining force, is lower in young than older muscle.
Older adults should be aware of this lower metabolic economy during dynamic
contractions as it could affect their ability to sustain activities of daily living that require
repeated dynamic contractions. However, all of the contractions performed in this study
were maximal. Activities of daily living are likely performed at submaximal intensities,
so future research should attempt to address this gap by evaluating age-related differences
in muscle metabolic economy of large locomotor muscles, such as the knee extensors,
during submaximal dynamic contractions to provide a more generalizable context for the
observations in this dissertation. Such experiments may provide a bioenergetic basis for
the greater energy cost of walking in older compared with young adults (76).
Future Directions
This dissertation provides novel information about the bioenergetic mechanisms
for age-related differences in muscle fatigue during two bouts of contractions with
different loads, and the effects of old age on in vivo muscle metabolic economy. A recent
study observed similar myofiber sensitivity to high [Pi] and [H+] in young and older men
(221), which is inconsistent with our findings in Study 1. One possible reason for this
discrepancy is that the previous study was performed at saturating [Ca2+]; conditions
which are likely not present during fatigue in vivo (140,236). Therefore, the effects of
high [Pi] and [H+] on single-fiber force and power production should be evaluated in
young and older muscle at submaximal [Ca2+]. This would help elucidate the effects of
high concentrations of these metabolites on single-fiber force and power production in
conditions that are more physiologically relevant during fatigue.
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Additionally, our results in Study 1 are in contrast with a recent report that used a
similar fatiguing protocol, within the MR environment, to ours (223). Because the cause
of this discrepancy is not clear, further work is needed to help clarify the mechanisms
responsible for age-related differences in muscle fatigue. The absolute velocity of
contractions during the MVDC20% were markedly lower in older adults than reports
where age-related differences in muscle fatigue have been observed (24,48,49,222), and
this likely explains a large portion of the discrepancy between studies. To help interpret
the results of future studies, researchers should evaluate whether the lower range of
motion affects the torque-velocity and power-load relationships to a lesser extent in
young than older adults. Indeed, evaluating the role of bioenergetics on age-related
differences in muscle fatigue while controlling for the effects of old age on the torquevelocity and power-load relationships may prove fruitful in interpreting these results and
extend our results to explain why older adults are resistant to fatigue during isometric
contractions (28,35,60,114,130), experience similar fatigue to young adults during
moderate-velocity contractions (23,24,49,147), and fatigue more than young adults
during high-velocity contractions (24,48,49,159,222,223). Although aging is associated
with mitochondrial dysfunction and reduced in vivo muscle oxidative capacity
(73,185,186), we observed relatively greater oxidative ATP production at the end of both
bouts of fatiguing contractions in older than young muscle. The mechanism responsible
for this is unclear and warrants further investigation.
In Study 2, we confirmed previous observations of a greater glycolytic ATP flux
in young compared with older muscle during a sustained isometric contraction (128,130).
However, we also observed similar glycolytic ATP flux in young and older muscle
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during 24 s of isokinetic and isotonic contractions. The mechanism for the greater
glycolytic ATP flux in young compared with older muscle during isometric contractions
does not appear to be due to blood flow (130), and is worthy of further investigation.
In Studies 1 and 2 we evaluated age-related differences in muscle fatigue and
metabolic economy in vivo by comparing young and older adults matched for physical
activity. However, relatively little is known about these variables in middle-aged adults.
Because we found marked differences in in vivo muscle metabolic economy, and the
trajectory of these changes with age are unknown, future studies should quantify
metabolic economy across the lifespan so that researchers can begin to understand how
these variables change with age. Such studies would help elucidate when in the lifespan
metabolic economy begins to decline. Additionally, including participants who are
physically active and sedentary would help clarify if an active lifestyle can prevent or
slow the decline in metabolic economy with age.
All of the participants in these studies were relatively healthy, with no mobility
impairments. To date, only one study has evaluated muscle metabolic economy in vivo in
older adults with mobility impairments (31). In that study, metabolic economy was lower
in older, mobility-impaired compared with older and young adults during submaximal,
but not maximal isometric contractions. In Study 2, we also observed no age-related
differences in metabolic economy of the knee extensor muscles during a 24 s maximal
isometric contraction. Whether muscle metabolic economy is lower in older, mobilityimpaired compared with older adults during dynamic contractions is not clear at this time
and warrants investigation. Indeed, this may help elucidate a mechanism to explain why
older adults with mobility impairments have a slower gait speed than healthy older adults.
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The goal of this dissertation was to evaluate the potential bioenergetic mechanisms of
age-related differences in muscle fatigue. Our data indicate that maximal dynamic
contractions are more energetically costly for older adults even when the muscular power
is normalized to the muscle volume. Older adults should be cognisant of this if they are
performing maximal effort work and, when necessary, consider taking more breaks than
their younger counterparts. The greater energetic cost of dynamic contractions may
result in impaired force and power production if the activity is long enough. This could
ultimately lead to an increased risk of falls in older adults. Identifying the molecular
mechanisms responsible for the age-related differences in metabolic economy during
maximal dynamic contractions in vivo may help elucidate potential targets to counteract
this decline in old age. Such experiments might lead to the development of training
protocols to reduce the lower metabolic economy of dynamic contractions with age,
which may help minimize the risk of falls in older adults. A combination of behavioural
modifications (e.g., taking breaks when necessary) and training, or pharmaceutical,
interventions may lead to an improved healthspan and quality of life in older adults,
prevent some of the detrimental health outcomes that occur as a result of falls, and
decrease the financial burden of these negative health outcomes on society.
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Table 6.1. Summary of the results from Study 1
Baseline
Y vs. O

MVDC20%
Y vs. O

MVDC120
Y vs. O

Ergometer measurements
PTI (% initial)
↔
↑O
Metabolic variables
PCr (rest)
↔
↔
Pi (rest)
↔
↔
pH (rest)
↔
↔
H2PO4- (rest)
↔
↔
PCr (end contractions)
↔
↑O
Pi (end contractions)
↔
↓O
pH (end contractions)
↑O
↑O
H2PO4 (end contractions)
↓O
↓O
ATPCK (minute 1)
↔
↓O
ATPCK (minute 2)
↔
↔
ATPCK (minute 3)
↔
↔
ATPCK (minute 4)
↔
↔
ATPGLY (minute 1)
↔
↓O
ATPGLY (minute 2)
↓O
↓O
ATPGLY (minute 3)
↔
↔
ATPGLY (minute 4)
↔
↔
Vi[PCr]
↔
↑O*
↔
kPCr
↔
Arrows represent where differences (p≤0.05) were lower (↓), higher (↑), or similar (↔) in
young and older adults at baseline, and during the high-velocity (MVDC20%) or moderatevelocity fatigue protocols (MVDC120). The * symbol represents p=0.051. Shaded boxes
indicate data not collected. PTI, power-time integral; PCr, phosphocreatine; Pi, inorganic
phosphate; H2PO4-, diprotonated phosphate; Vi[PCr], initial velocity of PCr resynthesis; kPCr,
rate constant of PCr recovery reflecting in vivo oxidative capacity.
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Table 6.2. Summary of the results from Study 2
MVIC
Y vs. O

MVDCIsoK
Y vs. O

MVDCIsoT
Y vs. O

Ergometer measurements
Specific TTI
↔
Specific PTI
↓O
↓O
Metabolic variables
ATPCK
↔
↔
↔
ATPGLY
↓O
↔
↔
ATPOX
↔
↔
↔
ATP cost
↔
↓O
↓O
Metabolic economy
↔
↓O
↓O
Arrows represent where differences (p≤0.05) were lower (↓), higher (↑), or similar (↔) in
young and older adults for the isometric (MVIC), isokinetic (MVDCIsoK), and isotonic
(MVDCIsoT) contractions. Shaded boxes indicate data not collected. TTI, torque-time
integral; PTI, power-time integral; ATPCK, ATP flux through the creatine kinase reaction;
ATPGLY, glycolytic ATP flux; ATPOX, oxidative ATP flux.
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APPENDIX A
INFORMED CONSENT DOCUMENT
Informed Consent Document
University of Massachusetts
Amherst, MA 01003
Project Title: Muscle Fatigue and Aging
Principal Investigator: Jane A. Kent, Ph.D
Co-Investigators: Liam F. Fitzgerald, Miles F. Bartlett, Joseph A. Gordon, Julia D. Miehm, and
Rajakumar Nagarajan, PhD
Your written informed consent is required before you can participate in this project. Please read
this document carefully and then sign your name on the last page if you agree to participate. This
document is in accordance with regulations for the Protection of Human Research Subjects (45
CFR 46). You are encouraged to ask questions at any time before, during, or after participating.
Purpose: Older adults experience greater muscle fatigue than young adults during fast
contractions that produce movement. However, when performing slower contractions, muscle
fatigue is similar between young and older adults. Although there are several causes of muscle
fatigue, chemical factors such as muscle acidity and the build-up of metabolic by-products are
two leading contributors to fatigue. However, at this time, we do not know if these chemical
factors contribute to the greater muscle fatigue that older adults experience during fast
contractions. Therefore, the purpose of this study is to investigate the potential impact of muscle
structure and biochemistry on fatigue in young and older adults during medium and high speed
contractions.
Eligibility: To participate in this study you must be healthy, age 25-40 or 65-80 years of age, and
complete ≤ two 30 minute bouts of exercise per week. You may not have any: neurological or
neuromuscular disease; a history of stroke, peripheral vascular disease, cardiac or pulmonary
disease; be a smoker, significant arthritis of the lower limbs; or a history of any metabolic
diseases/disorders. You may not be pregnant. You may not have any metal implants or anything
that would prevent you from undergoing a magnetic resonance imaging (MRI) exam.
Procedures: Prior to your first visit, you will be screened by telephone interview for general
health, medical history, current medications, usual physical activity habits, and eligibility for the
study. If you qualify and agree to participate, you will be invited to the Human Testing Center
(HTC) at the University of Massachusetts Amherst for your first visit. At this visit you will
complete the consent process and we will measure your muscle’s stiffness and be familiarized
with the procedures for the second and third visits, which will take place at the human Magnetic
Resonance Center (hMRC).
Visit 1 (~1 hour): Paperwork, Physical Function Measures, Muscle-Tendon Unit Stiffness and
Familiarization (HTC)
Upon arriving at the HTC, you will be asked to read this Informed Consent document. At
this time, we will also answer any questions you may have about any of the study procedures.
Following completion of this consenting procedure, you will be asked to complete a Physician’s
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Clearance Form (older adults only), Medical History Form, Physical Activity Readiness
Questionnaire, and Magnetic Resonance Safety Form. Next, we will measure your blood
pressure while you are seated, and then obtain your height and weight. We will then measure
your walking speed and you will complete two mobility tests; the Timed-Up-and-Go (TUG) test
and the Advanced Short Physical Performance Battery (SPPB-A). For the TUG, you will stand up
from a seated position, walk approximately 10 feet out to a standardized marker (a cone), and
then return to the chair and sit down. You will complete this mobility test twice with
approximately 1 minute rest between each trial. The SPPB-A test involves 3 parts:
1) Completing 10 chair raises without using the hands, as quickly as possible
2) Walking a straight, 6-meter path at their usual speed, repeated 4 times
3) Standing with 4 different foot positions, each for up to 30 seconds. The 4 foot positions
are: feet parallel to each other (side-by-side), the heel of one foot beside the ball of the
other foot (semi-tandem), one foot in front of the other (tandem), and on one foot.
You will be asked to sit on a machine that we will use to measure your leg strength. Your
foot, hips, and torso will be strapped securely to this machine, to prevent unwanted movement.
You will be asked to fold your arms across your chest and then straighten your leg as hard and
fast as possible while the machine measures your strength. Your leg will not move during this
measurement. We will repeat this exercise several times to allow you to learn the required
technique. Next we will ask you to repeat the static strength measure, but this time you will take
~30 seconds to reach your maximum. During this contraction your target effort will be shown to
you on a computer screen so that you can gradually increase the strength of your contraction.
Throughout the contraction, an ultrasound transducer will be applied to your thigh muscles, and
we will capture a video of your muscle while you contract it.
Next, you will be shown the exercise apparatus, and you will practice the fatigue protocol
that you will perform during your second and third visits. This apparatus is similar to some
weight machines used at fitness gyms and will be used to measure your knee extension strength.
We will also show you the magnet (located at hMRC) that you will lay in for the fatigue studies,
which will be completed at your second and third visits. Lastly, we will give you a uniaxial
accelerometer, which is a small activity monitor that will record the amount and intensity of
physical activity you perform over the next 7 days. You will be instructed on how and when to
use it and how to keep a simple physical activity log book. The accelerometer and log will be
returned to the lab at Visit 2.
Visit 2 (~1.5 hours): Imaging and Fatigue Protocol #1 (hMRC)
Before entering the magnet room, we will review your Magnetic Resonance Safety Form,
and have you remove all jewelry and change into paper scrub pants. We will then scan you for
metal using a hand-held metal detector. Next, you will be escorted to the Magnet Room, where
you will be positioned in the MR scanner on your back, with your arms resting comfortably at
your side. We will lay a flexible mat on the thigh of your dominant leg, and use this mat to
obtain images of your thigh muscles. This will take about 15 minutes. We will then remove that
mat and position you with your leg on top of our leg exercise apparatus. Your lower leg will be
strapped to the apparatus just above your ankle and at your knee using Velcro straps. Inelastic
straps will also be secured over your hips to prevent unwanted movement during the muscle
contractions that you will perform. A specially designed copper coil encased in a plastic box will
be secured over your thigh muscles using Velcro straps. This coil will be used to measure
changes in your muscle biochemistry during the contractions. Headphones will be provided to
you to limit the amount of noise from the MR scanner, and to enable clear and constant
communication between you and the investigators. We will talk with you and explain each set of
measures as we go along. These measures are described next.
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We will position your thigh muscle in the center of the MR scanner, and then “tune” the
magnet to your muscle. This will require you to lay quietly for about 15 minutes. We will then
prepare for the fatigue protocol by first determining your strength during 2-3 maximal static
contractions, each lasting 3-4 seconds. For these, you will attempt to straighten your leg as
quickly and forcefully as possible. The strap across your leg will prevent it from moving, but we
will be able to measure your strength during each contraction. You will be given 1-2 minutes of
rest between each of these contractions.
We will then ask you to perform 2 sets of 3 rapid, maximal dynamic contractions (i.e.,
“with movement”), during which your leg will move as you straighten your leg at the knee.
These contractions will be used to determine your maximal dynamic strength. You will be given
1-2 minutes of rest between each of these 2 sets. You will then perform one of 2 fatigue
protocols (fast or medium speed), which will consist of 4 minutes of maximal dynamic
contractions, one every 2 seconds. We will encourage you to give your best effort throughout this
protocol, which is designed to tire your leg. At the end of this 4 minutes, you will again rest
quietly in the magnet for 10 minutes while we continue to monitor your muscle’s biochemistry.
Immediately after this 10 minute recovery period, you will perform a final maximal static
contraction and set of 3 maximal dynamic contractions, to evaluate your muscle’s recovery from
fatigue. In total, we expect Visit 2 to last approximately 90 minutes.
Visit 3 (~1.5 hours): Aerobic Capacity and Fatigue Protocol #2 (hMRC)
All procedures for Visit 3 are identical to those of Visit 2, with two exceptions. First, we
will measure your aerobic capacity instead of obtaining images of your thigh muscles. Once you
are positioned inside the MR scanner with your leg on the exercise apparatus, we will ask you to
complete 2-3 maximal isometric (i.e., ‘static’) contractions to determine your maximal strength.
We will allow you 1-2 minutes of rest between each of these contractions. Next, we will ask you
to repeat this effort, but this time you will maintain the maximal static contraction for 24 seconds.
After this, we will ask you to lay quietly inside the MR scanner, without moving, for 10 minutes.
This procedure allows us to measure the thigh muscle’s “aerobic” capacity.
Second, you will be asked to perform the fatigue protocol you did not complete at Visit 2
(i.e., fast or medium speed). This fatigue protocol will consist of 4 minutes of maximal dynamic
contractions, one every 2 seconds. Again, we will encourage you to give your best effort
throughout this protocol, which is designed to tire your leg. At the end of this 4 minutes, you will
be asked to rest quietly, without moving, in the MR scanner for 10 minutes while we continue to
monitor your muscle’s biochemistry. Immediately after this 10 minute recovery period, you will
perform a final maximal static contraction and set of 3 maximal dynamic contractions, to evaluate
your muscle’s recovery from fatigue. In total, we expect Visit 3 to last approximately 90
minutes.
Subject Enrollment/Length of Study: We expect to enroll 60 participants in this study. Your
participation will include 3 visits. The first visit will last about 1 hour and the second and third
visits about 1.5, for a total of approximately 4 hours.
Possible Risks and Discomforts: There are minimal risks associated with the procedures used in
this research study. You may experience soreness in your muscles in the days following the
testing, but this would be a normal response and should be temporary. Injury is possible if you
have any metal in or on you during the magnetic resonance testing, but we will check you
beforehand to detect any such metal.
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Magnetic Resonance Spectroscopy (MRS) and Imaging (MRI) – The United States Food and
Drug Administration (FDA) has established guidelines for magnet strength and exposure to radio
waves, and we carefully observe those guidelines. No ill effects have been reported for the radio
wave exposure associated with this protocol. Some people may feel uncomfortable or anxious
while in the MR scanner, which is a large magnet. If this happens to you, you may ask to stop the
study at any time and we will take you out of the MR scanner. On rare occasions, some people
might feel dizzy, get an upset stomach, have a metallic taste, feel tingling sensations, or
experience muscle twitches. These sensations usually go away quickly but please tell the
research staff if you have them.
MRI and MRS pose some risks for certain people. If you have a pacemaker or certain types of
metal objects inside your body, you may not be in this study because the strong magnet used for
these MR studies might harm you. Another risk is a metallic object flying through the air toward
the magnet and hitting you. To reduce this risk we require that all people involved with the study
remove all metal from their person and all metal objects from their pockets. Nothing metal can
be brought into the magnet room at any time. Also, once you are in the magnet, the door to the
room will be closed so that no one accidentally bring a metal object near the magnet while you
are in it.
Please read the Magnetic Resonance Safety Form and complete it very carefully. Those
questions are for your safety. Take a moment now to be sure that you have read this Form and be
sure to ask any questions and tell us any information you think might be important. Even if you
think that it is probably okay, we would rather have you ask us to make sure.
If you experience significant claustrophobia during the MR testing, you will be removed
immediately. You will be positioned feet-first in the magnet and your head will remain near the
opening in order to minimize claustrophobia.
What if there is an unexpected finding on my MRI scan? The investigators for this research
project are not licensed or trained diagnosticians or clinicians. The testing performed in this
project is not intended to find abnormalities, and the images or data collected do not constitute a
diagnostic or clinical study. The investigators and the University of Massachusetts Amherst are
not responsible for failing to find abnormalities. However, on occasion the investigators may
perceive an abnormality. When this occurs, the UMass Amherst researchers will consult with a
specialist. If the specialist determines that additional inquiry is warranted, the researcher will
contact you. In such a case, you are advised to consult with a licensed physician to determine
whether further examination or treatment would be prudent. The investigators, radiologist, and
the University of Massachusetts Amherst are not responsible for any decision you make with
regard to examination or treatment. Although the data collected for this research project do not
constitute a diagnostic or clinical study, the images can be made available to you for clinical
follow-up.
Confidentiality: Steps are taken to protect the identities of participants and the data collected in
this study. The Informed Consent, Physical Activity Readiness Questionnaire, and MR Safety
Form (all of which will have your name on them) will be stored and locked in a filing cabinet
within a locked office. All other data collection sheets will be coded with your participant
number and the study name instead of your name, so that no potential identifiers can be linked
back to you. Data collection sheets and lists of participant codes and names are kept separate
from all other study materials. Paper documents with names or codes will be stored in separate
locked filing cabinets located in a locked office. All electronic data will be kept on a password-
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protected computer in a locked office. Any data that are published or used in a presentation will
not include any names or identifiers that could link back to you.
In Case of Injury: In the unlikely event of an injury resulting directly from participation in this
study, we will do everything we can to assist you in seeking medical treatment. The University
of Massachusetts does not have a program for compensating subjects for injury or complications
related to human subject research.
Benefits: You will receive no direct benefit from participating in this study.
Costs and Reimbursement: There is no cost to participate in this study. You will be given a $30
gift card if you complete all visits of this study. There is no compensation if you do not complete
all visits.
Withdrawal from Participation: Participation in this research is voluntary. You have the right
to refuse to continue or withdraw from the study at any point, without prejudice.
Alternative Procedures: The procedures described above are non-invasive techniques that are
commonly used in muscle research. There are no other non-invasive techniques that can be used
to obtain the information necessary in this study.
Request for Additional Information: You are encouraged to ask questions about the study.
The investigators will attempt to answer all of your questions to the best of their knowledge. The
investigators fully intend to conduct the study with your best interest, safety, and comfort in
mind. Please address any questions regarding the study to the Muscle Physiology Laboratory.
Our phone number is (413) 545-5305. We can also be reached by email at
umassmplab@umass.edu. You may also address questions to Prof. Kent by calling her at (413)
545-9477 or by emailing her at jkent@kin.umass.edu. If you would like to speak with someone
not directly involved in the research study, you may contact the Human Research Protection
Office at the University of Massachusetts via email at humansubjects@ora.umass.edu; telephone
(413) 545-3428; or mail at the Human Research Protection Office, Research Administration
Building, University of Massachusetts Amherst, 70 Butterfield Terrace, Amherst, MA 010039242.
Subject Statement of Voluntary Consent: By signing this form, I am agreeing to voluntarily
enter this study. I understand that, by signing this document, I do not waive any of my legal
rights. I have had a chance to read this consent form, and it was explained to me in a language
that I use and understand. I have had the opportunity to ask questions and have received
satisfactory answers. A copy of this signed Informed Consent Form will be given to me.
Participant’s name

Address

Signature

Phone Number

Date

STUDY REPRESENTATIVE STATEMENT:
The investigator has read and understands the federal regulations for the Protection of Human
Research Subjects (45 CFR 46) and agrees to comply with all of its clauses to the best of his
ability. The investigator also pledges to consider the best interests of the participant beyond the
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explicit statement contained in these regulations, and to exercise professional expertise to protect
the rights and welfare of the participant.
_________________________________
Signature of Person Obtaining Consent

____________
Date

_________________________________
(Please print name)
or
_________________________________
Jane A. Kent, Ph.D.
Principal Investigator, Department of Kinesiology
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____________
Date

APPENDIX B
TELEPHONE SCREENING FORM
Screened by:

Date:

Group:

Status:

1) Name________________________________
2) Phone # (Circle preferred contact):
a. Home
b. Work
c. Cell

Best time/day to contact:
Message?
Yes No
Message?
Yes No
Message?
Yes No

3) Email:
4) Age:
Height

Sex:
Weight:

BMI:

(calculate)

5) Current health status (general):
6) Do you have any physical limitations?
7) Do you smoke or have you ever smoked before?
For how long?
Quit?
8) Do you have any allergic reactions?
9) Do you have any significant past medical history? (e.g. hypertension, CAD, etc.)

10) Do you experience pain of any sort while exercising?

11) Do you have a history of muscle cramps or pain?
12) Is fatigue a problem for you?

Leg fatigue?

13) Have you been diagnosed with hypertension or hypercholesterolemia?
14) Do you have a pacemaker?
15) Have you had any surgeries?
16) Does your medical history include any of the following?
Stroke
Coronary

Diabetes
Neurological/Neuromuscular
Joint Problems
Pulmonary
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If yes, explain:
17) Current medications:
Drug Name

Classification Dose

Frequency

Duration

Prescribed for?

18) Current physical activity level (regular exercise, none, UMASS athlete, etc.)
19) Has your Doctor ever told you not to exercise?
20) What was the date of your last doctor’s visit?
21) When did you start your last menstrual cycle?
22) Have you ever taken or are you currently using hormone replacement therapies?
23) How did you find out about this study?
24) Are you currently participating in any other research studies?
If yes, describe:
25) Would you like to be contacted again for future studies (circle one)?
Comments:
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Yes

No

APPENDIX C
MAGNETIC RESONANCE SAFETY FORM
MR Safety Screening Questionnaire
Participant’s Name (print):
Study Name:
Year of birth:

Investigator:
Sex:

Height:

Today’s date:
Participant ID:
Weight:

Please read the following questions carefully. It is very important for us to know if you have any
metal devices or metal parts anywhere in your body. If you do not understand a question, please
ask us to explain!
1.
2.
3.
4.
5.

Yes
Yes
Yes
Yes
Yes

No
No
No
No
No

6. Yes

No

7. Yes
8. Yes
9. Yes

No
No
No

10. Yes
11. Yes
12. Yes

No
No
No

13.
14.
15.
16.

Yes
Yes
Yes
Yes

No
No
No
No

17. Yes

No

18. Yes
19. Yes

No
No

20. Yes
21. Yes
22. Yes

No
No
No

23. Yes
24. Yes

No
No

Do you get upset or anxious in small spaces (claustrophobia)?
Did you ever have an aneurysm clip implanted during brain surgery?
Do you have embolization coils (Gianturco) in your brain?
Do you have Carotid Artery Vascular clamp?
Do you have a “shunt” (a tube to drain fluid) in your brain, spine, or
heart?
Do you have a Vagus nerve stimulator to help you with convulsions or
with epilepsy?
Have you ever had metal removed from your eyes by a doctor?
Have you worked with metal? (For example, in a machine shop)?
Do you have implants in your eyes? Have you ever had cataract
surgery?
Do you wear colored contact lenses or permanent eye liner?
Do you have shrapnel or metal in your head, eyes, or skin?
Do you have implants in your ear (like cochlear implants) or a hearing
aid?
Do you wear braces on your teeth or have a permanent retainer?
Do you have a heart pacemaker or a heart defibrillator?
Do you have a filter for blood clots (Umbrella, Greenfield, bird’s nest)?
Do you have any stents (small metal tubes used to keep blood vessels
open)?
Did you ever have a device implanted in your body such as a nerve
stimulator?
Do you have an implanted pump to deliver medication?
Do you have metal joints, rods, plates, pins, screws, nails, or clips in any
part of your body?
Have you ever had a gunshot wound? Or a B-B gun injury?
Do you wear a patch to deliver medicines through the skin?
Do you have any devices to make bones grow (like bone growth or bone
fusion stimulators)?
Do you have an unremoved body-piercing or tattoo?
Have you ever had any surgery? Please list all:

FOR WOMEN
25. Yes

No

Do you use a diaphragm, IUD, or cervical pessary?
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26. Yes

No

Do you think there is any possibility that you might be pregnant?

IMPORTANT INSTRUCTIONS: Before entering the Magnet Room, you must remove all
metallic objects including hearing aids, dentures, partial plates, keys, beeper, cell phone,
eyeglasses, hair pins, barrettes, jewelry (including body piercing jewelry), watch, safety pins,
paperclips, money clip, credit cards, bank cards, magnetic strip cards, coins, pens, pocket knife,
nail clipper, tools, clothing with metal fasteners, and clothing with metallic threads in the
material.
I attest that the above information is correct to the best of my knowledge. I have read and
understand the entire contents of this form and have had the opportunity to ask questions
regarding the information on this form and regarding the MR procedure that I am about to
undergo.

Participant Signature:

Date:

MR Operator Signature:

Date:
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APPENDIX D
MEDICAL HISTORY FORM
Health History Questionnaire
Please fill out and sign in ink. This record is confidential.
Medical History
Do you take any prescribed or over-the-counter medications? Please include vitamins, herbs, or
other dietary supplements. If yes, please list the dose, frequency, and the duration of use.

Have you ever been told by a physician that you should not exercise?
Yes:

No:

If yes, please explain:

Do you have or have you EVER had any of the following problems? Check if YES and provide
details in the space provided below.
____ Heart disease/rheumatic fever
____ Thyroid disorder
____ Asthma
____ High blood pressure
____ Claustrophobia
____ Allergies
____ Elevated Cholesterol
____ Anemia
____ Stroke
____ Epilepsy or seizure disorder
____ Diabetes
____ Dizziness
____ Blurred or double vision
____ Orthopedic or joint problems (e.g., arthritis)
____ Shortness of breath or difficulty in breathing
____ Phlebitis, blood-clots, varicose veins, peripheral vascular disease
Lifestyle
Do you smoke cigarettes?
Yes ____
Do you drink alcohol?
Yes ____
Have you had surgery?
Yes ____
If yes:
What was the surgery for? _____________

No ____
No ____
No ____

When was your surgery? _____________
Is there any other information or concerns you have that you feel we should know about before
you participate in the study? If yes, please explain.
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APPENDIX E
PHYSICAL ACTIVITY READINESS QUESTIONNAIRE
PHYSICAL ACTIVITY READINESS QUESTIONNAIRE
1. Has a doctor ever said you have a heart condition and recommended only medically
supervised activity?
YES_______
NO_______
2. Do you have chest pain brought on by physical activity?
YES_______
NO_______
3. Have you developed chest pain in the last month?
YES_______
NO_______
4. Do you tend to lose consciousness or fall over as a result of dizziness?
YES_______
NO_______
5. Do you have a bone or joint that could be aggravated by the proposed physical activity?
YES_______
NO_______
6. Has a doctor ever recommended medication for your blood pressure or a heart condition?
YES_______
NO_______
7. Are you aware through your own experience, or a doctor’s advice, of any other physical
reason against your exercising without medical supervision?
YES_______
NO_______
Note: If you have a temporary illness, such as a common cold, or are not feeling well at this
time, you must postpone your participation in the study at this time.
Study ID:

Date:
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APPENDIX F
PHYSICAL ACTIVITY LOG
Date:

Participant ID:

DAY 1
Wake up time:

Bed time:

Monitor on time:

Monitor off time:

1) Please list any physical activities you completed (e.g., long walks, yard work, fitness club,
etc.), as well as any naps you took today:
Activity:

Approximate Time of Day:

Duration:

2) Did you wear the monitor during all waking hours, except for showering/bathing?
☐ Yes

☐ No, times not worn:

3) Was there anything out of the ordinary about your activity pattern today?
☐ Yes, explain below

☐ No
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APPENDIX G
EFFECTS OF OLD AGE ON KNEE EXTENSOR FATIGUE AND RECOVERY
FROM HIGH-VELOCITY MUSCLE CONTRACTIONS
Effects of Old Age on Knee Extensor Fatigue and Recovery From High-Velocity
Muscle Contractions
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Abstract
Although high-velocity contractions elicit greater muscle fatigue in older compared with
young adults, the mechanisms of this difference are not clear. We examined the potential
roles of resting muscle architecture and baseline contractile properties, as well as changes
in voluntary activation and low-frequency fatigue during fatigue (fall of peak power) due
to high-velocity knee extensor work. Vastus lateralis muscle thickness, pennation angle,
and fascicle length were determined in rested muscle by ultrasonography in 8 young
(23.4±1.8 yrs) and 8 older (69.6±1.1) women. Maximal voluntary dynamic (MVDC) and
isometric (MVIC), and stimulated (80Hz and 10Hz, 500ms) isometric contractions were
performed before and immediately after 120 MVDCs (240°.s-1, one every 2s).
Architecture variables did not differ between groups (p≥0.209), but the half-time of
torque relaxation (T1/2) was longer in older than young at baseline (151.9±6.0 vs.
118.8±4.4 ms, respectively, p=0.001). Older fatigued more than young (to 33.0±4.7% vs.
56.1±4.4% initial power, respectively; p=0.005), with no evidence of voluntary activation
failure (∆MVIC:80Hz torque) in either group (p≥0.317). Low-frequency fatigue
(∆10:80Hz torque) occurred in both groups (p=0.001), as did slowing of T1/2 (p=0.001),
with no differences by age in these changes. Baseline T1/2 was inversely associated with
fatigue in older (r2=0.591, p=0.043), but not young (r2=0.145, p=0.351). These results
indicate that muscle architecture, voluntary activation, and low-frequency fatigue do not
explain the greater fatigue of older compared with young during high-velocity
contractions. The inverse association between baseline T1/2 and fatigue in older women
suggests that slowing of muscle contractile properties may help protect against fatigue
during fast, repetitive contractions in aging.

185

Key Words: power, contractile properties, excitation-contraction coupling, muscle
architecture, low-frequency fatigue, neural activation

Introduction
Maximal torque and power production are lower in older compared with younger
adults (24,132,157,184,228,232), due to factors such as a loss of muscle mass
(24,90,115,141,231), slower maximal contraction velocities (50,132,232), and lower
maximal motor unit discharge rates (104). These changes have significant consequences
for older adults because deficits in muscular power are associated with an increased
likelihood of falling, which may place older adults at risk of injury, poor mobility and
subsequent loss of independence (11,155). In particular, power production by the knee
extensor muscles is important due to its association with physical function in aging (44),
as well as the concept that rapid contraction of the knee extensors appears to be crucial
for preventing falls following a balance perturbation (152).
The decline in maximal torque and power with old age might be explained, at
least in part, by changes in muscle architecture such as muscle thickness, pennation
angle, and fascicle length (146). Generally, muscles with a greater pennation angle have
more sarcomeres in parallel, whereas muscles with longer fascicles contain more
sarcomeres in series (19). Conceptually, a greater number of sarcomeres in parallel
allows for greater torque production, while more sarcomeres in series allows for greater
velocity of shortening (215).
In aging, the loss of muscle mass results in architectural remodeling (170);
fascicles can become shorter and less pennate (173). Previous work has shown fascicle
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length and pennation angle of the vastus lateralis to be ~12% shorter and ~25% smaller,
respectively, in older compared with young men (191). Given the apparent lack of sexrelated differences in the decline of quadriceps muscle volume with age (90), similar agerelated changes in muscle architecture may be expected in women. However, Kubo et al.
observed an age-related decrease in fascicle length in the vastus lateralis in men but not
women (124). Changes in fascicle length may account for ~20% of the age-related
difference in maximal shortening velocity of the medial gastrocnemius in men (228).
Thus, age-related differences in fascicle length could place older muscles at a
disadvantage for generating power during high-velocity contractions (24,48-50,234). To
date, the extent to which architectural remodeling affects age-related differences in
muscle fatigue is not known.
Muscle fatigue is defined as the reduced capacity to produce torque or power in
response to a period of contractile activity (112). Mechanisms of fatigue can include
transient impairments at any site along the pathway of force or power production, from
the brain to the myofilaments (112). The literature generally supports the observation of
less muscle fatigue in older (≥65 years) compared with young (≤40 years) adults in
response to isometric contractions (33). Conversely, during dynamic contractions at high
velocities, or when fatigue is expressed as a decline in power, older adults fatigue to a
greater extent than young adults (24,48-50,222,234). Despite consistent observations of
these age-related differences in muscle fatigue, the mechanisms for greater fatigue in
older compared with young adults in response to high-velocity contractions remain
poorly understood.
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Use of motor point stimulation offers a non-invasive approach for identifying
whether the cause of fatigue is proximal or distal to the stimulating electrodes (i.e.,
central or peripheral) (116). Small reductions (~5%) in voluntary activation, defined as
the neural drive to the contracting muscle, have been observed in both young and older
men following contractions of the knee extensors at slow- and moderate-velocities (49).
More recently, Sundberg et al. observed failure of voluntary activation in older, but not
young, women following 80 maximal-velocity contractions at a load of 20% maximal
isometric torque (222). However, the magnitude of the change in voluntary activation in
the older women was small (<2%), and no association was observed between fatigue (%
initial power) and changes in voluntary activation. Thus, age-related differences in
voluntary activation failure do not appear to contribute to age-related differences in
fatigue in response to high-velocity contractions.
The presence of low-frequency fatigue (LFF) can also be evaluated in vivo using
motor point stimulation by comparing fatigue-induced changes in torque in response to
low- vs. high-frequency stimuli (4,35,67,189). With LFF, the decline and slowed
recovery of torque produced by low-frequency stimuli are more pronounced than those
elicited at higher frequencies (67). Because LFF may stem, at least in part, from a failure
in excitation contraction coupling (ECC) the low:high frequency torque ratio has been
used as an indirect measure of ECC failure in vivo. In single muscle fibers, a greater loss
of force in response to low- vs. high-frequency stimuli is associated with impaired Ca2+
release (30,237). Thus, age-related impairments in Ca2+ handling could contribute to the
development of LFF (99). In response to fatiguing isometric contractions in humans,
there appear to be no age-related differences in LFF (4,35). However, the potential role
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of LFF in the greater fatigue and delayed recovery of power in older compared with
younger adults in response to high-velocity contractions is not known.
In unfatigued muscle, the half-time of torque relaxation (T1/2) is generally longer
in older than young adults (24,48,49,114,222). This difference could result from greater
type 1 fiber composition (143) or differences in cross-bridge kinetics (164) in older
muscle; the source of this slowing has not been definitively identified. In fatigue, T1/2
lengthens (114,131), presumably due to a slowing of Ca2+ release from troponin or its reuptake by the sarcoplasmic reticulum (1) in response to the accumulation of H+ (21).
During fatiguing isometric contractions, some authors report a similar slowing of T1/2 in
young and older muscle (48,114,131). In contrast, during dynamic contractions of the
knee extensor muscles, others reported a greater slowing of T1/2 in older compared with
young men following contractions at moderate and fast, but not slow, velocities (49).
More recently, intracellular pH was shown to be lower in older than young muscle in
response to dynamic contractions of the knee extensors to fatigue (223), which could
contribute to a greater slowing of T1/2 in older than young muscle.
Given the existing questions about the causes of muscle fatigue in aging, the
purpose of this study was to compare in young and older women several potential
mechanisms that may contribute to age-related differences in fatigue following highvelocity concentric contractions of the knee extensor muscles. Baseline muscle
architecture, as well as changes in voluntary activation and contractile properties, were
evaluated during fatigue and for 30 minutes of recovery. We hypothesized that fatigue
(fall of peak power relative to baseline) would be greater, and recovery of power slower,
in older compared with young muscle. We further hypothesized that vastus lateralis
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fascicle length and pennation angle would be shorter and smaller, respectively, in older
compared with young women, and that fascicle length would be positively associated
with peak power production at baseline, given the importance of the number of
sarcomeres in series for power generation (228). Based on the current literature, we did
not expect to observe any age-related differences in voluntary activation at the end of the
fatigue protocol (49,222). However, we did anticipate greater low-frequency fatigue and
slowing of T1/2 in older compared with young women.

Methods
Participants. Sample size estimates were calculated a priori to detect significant
differences in fatigue (% initial power) with 80% power, an alpha level of 0.05, and an
equal number of participants in young and older groups (GPower v3.1; (70)). For this
calculation, values from a study that used a similar fatigue protocol were used to
determine the effect size (24). These calculations revealed 8 participants were required
per group to detect significant age-related differences in muscle fatigue. Thus, 8 young
(21-36 years) and 8 older (66-76 years) women were studied. Prior to enrollment, each
participant gave their written, informed consent, as approved by the University of
Massachusetts Amherst, and in accordance with the Declaration of Helsinki. Physician’s
approval to participate was obtained for all of the older volunteers between Visits 1 and
2. To avoid any potential age-by-sex interactions, we restricted this study to women.
Participants reported being relatively sedentary in that they completed less than two 30min sessions of structured exercise per week. They also reported being healthy, as
evaluated by a health-history questionnaire, and were not taking any medications known
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to affect physical function or muscle fatigue (e.g., beta-blockers, calcium channel
blockers, etc.). All participants answered ‘no’ to all questions on the Physical Activity
Readiness Questionnaire (229). To minimize the effect of fluctuating hormone levels on
muscle function over the course of the menstrual cycle (207), all young women were
studied during days 1-5 of the menses. No participants had used any hormone
replacement therapies in the 6 months prior to enrolling in the study.

Procedures. Participants reported to the Muscle Physiology Laboratory for 2 Visits. At
Visit 1, mobility function was measured and familiarization with the fatigue protocol was
provided. During Visit 2, muscle architecture of the vastus lateralis was measured,
followed by the knee extensor fatigue protocol. Visits were separated by at least 2 days.

Mobility function and activity. Measures of mobility and physical activity were obtained
in order to characterize the study groups. Mobility was measured using the timed upand-go (TUG) (188) and advanced short physical performance battery (SPPB-A) (210).
The fastest time for the TUG was used for analysis. At the end of Visit 1, participants
were asked to wear a uniaxial accelerometer (GT3X, Actigraph, Pensacola, FL) at the hip
for 7 days in order to characterize habitual physical activity levels. Participants wore the
accelerometer for a minimum of 10 hours per day, and at least 4 days (3 weekdays and 1
weekend day). These criteria have been shown to provide good reliability (>80%) for
quantifying overall and moderate-to-vigorous physical activity (153,154). Average daily
activity counts and minutes spent in moderate-to-vigorous physical activity were
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calculated using ActiLife v6.13 software (ActiGraph, Pensacola, FL) with established
cutpoint thresholds (74).

Muscle architecture. Thigh, shank, and total leg length were measured using a tape
measure. The midpoint between the greater trochanter and lateral femoral condyle of the
femur was marked with indelible ink and thigh circumference was measured at this
position. Subsequently, the participant was seated on a Biodex System 3 dynamometer
(Biodex Medical Systems, Shirley, NY) with the same hip and knee angles used at Visit
1. After 10min of seated rest to account for fluid shifts in the thigh (171), ultrasound
images of the participant’s vastus lateralis were collected via a linear array probe (Philips
model L12-5, 12-5MHz), using a Philips HD11XE system (Philips Healthcare, Bothell,
WA). The probe was placed over the mark on the participant’s thigh, at approximately
50% of the length of the femur. Once the probe placement was optimized, determined as
the position that yielded the best visualization of the deep and superficial aponeuroses
and muscle fascicles, 5 images were collected. All images were obtained at a hip and
knee angle of 90° and 100°, respectively. To check whether peripheral edema occurred
during the imaging session, the widest circumference of the calf was measured before and
after images were obtained.
Ultrasound images were saved and transferred to a desktop computer for offline
analysis using ImageJ software (v1.50i, National Institutes of Health, USA). The
pennation angle was identified as the angle between the fascicle and the deep
aponeurosis. Muscle thickness was measured as the distance between the internal
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borders of the superficial and deep aponeuroses. Because visualization of entire fascicles
was not possible, fascicle length was estimated as follows:
Estimated fascicle length

Muscle thickness
Sin θ

[Eq. 1]

where ϴ represents the measured pennation angle. This approach, illustrated in Figure
F.1, is commonly used in studies of muscle architecture (195). To account for anatomical
differences between participants, we report estimated fascicle length in addition to
normalizing this measure to thigh length. Analysis of some images was not possible
because the superficial and deep aponeuroses were not parallel with each other. As a
result, muscle architecture was analyzed for 3 out of the 5 ultrasound images obtained
from each participant.

Muscle torque and power. Prior to the measurement of isometric torque and dynamic
power, participants completed 5 min of unloaded cycling at ~60-rpm to warm-up. The
dynamometer was used to test knee extensor torque and power during maximal voluntary
isometric (MVIC) and dynamic (MVDC) contractions of the dominant leg (preferred
kicking leg), respectively. Participants were seated upright with their hips at 90° and a
knee angle of 100° extension (180° = full extension). The dynamometer was adjusted to
ensure that the axis of rotation of the dynamometer’s lever arm was aligned with the axis
of rotation of the participant’s knee joint. The length of the lever arm was adjusted and
secured with inelastic straps proximal to the malleoli. Additional straps were fastened
across the participant’s torso and hips to prevent unwanted movement. Participants were
instructed not to hold onto any part of the dynamometer during the testing to ensure that
torque and velocity measurements were generated by the knee extensor muscles.
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Peak knee extensor torque was measured with the dynamometer in isometric and
isokinetic modes to determine MVIC and MVDC at 240°.s-1, respectively. To determine
the target torque for electrically-stimulated contractions (see Myoelectric stimulation
below), participants completed 2 brief MVICs at a knee angle of 100° with 1 min rest
between contractions. If those 2 MVICs differed by more than 10%, additional MVICs
were completed until the 2 strongest contractions were within 10% of each other. To
ensure participants were still familiar with the dynamic contractions performed at visit 1,
participants completed two sets of 2 MVDCs at a concentric velocity of 240°.s-1, with 1
min rest between sets to prevent muscle fatigue. Participant’s limbs were allowed to
return to the start position at a velocity of 500°.s-1 (i.e., against no load), and all MVDCs
were completed over a 70° range of motion. For all contractions, the participant sat with
her arms folded across her chest and were instructed to “kick your leg out as hard and fast
as possible.” Visual torque-feedback, scaled to each participant’s maximum torque, was
provided during each contraction.
Analog signals corresponding to torque, velocity, and position were acquired from
the dynamometer at a sampling rate of 2,500 Hz. Data were analyzed as reported
previously (23,24,131,132). Briefly, peak torque was taken during the target isovelocity
period. Power was calculated as the product of peak torque and the corresponding
velocity observed at that time.

Myoelectric stimulation. Motor point electrical stimulation was used to measure muscle
contractile properties during isometric contractions at baseline, immediately after the
fatigue protocol, and at 5, 10, 20, and 30 min of recovery. Two 7.6 × 12.7 cm self-
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adhesive stimulating electrodes were placed transversely across the thigh. One electrode
was positioned 3-5 cm distal to the inguinal crease and the other was placed 2-3 cm
proximal to the superior border of the patella. High- (80-Hz) and low-frequency (10-Hz)
stimulations were delivered (200-μs pulse duration, 500 ms) with a constant-current
stimulator (DS7AH; Digitimer, Hertfordshire, UK). The current that elicited an 80-Hz
contraction resulting in 50% of the participant’s MVIC was used for all subsequent
stimulations, as described previously (23,24). Immediately prior to the fatigue protocol,
participants completed a series of voluntary and electrically-stimulated contractions
consisting of 2 MVDCs (240°.s-1), 1 MVIC, one 80-Hz and one 10-Hz contraction. A
representative torque trace from the baseline series of contractions for 1 young woman is
shown in Figure F.2. This series of contractions was repeated at the end of the fatigue
protocol and throughout recovery.
Muscle contractile properties were quantified as peak torque during the 10 and
80-Hz contractions, as well as the maximal rate of torque development (RTD)), and T1/2
from the 80-Hz tetanus. The RTD was expressed as the percent of peak torque per
millisecond (%pk.ms-1), to account for the effects of peak torque achieved on this
measure. The T1/2 was measured as the time for torque to decline to 50% of that achieved
at the time of the last stimulus during the 80-Hz contraction. Changes in the ratio of peak
torques elicited during the 10-Hz and 80-Hz stimulations was used to determine the
presence of LFF (67). Additionally, the ratio of MVIC:80-Hz torque was calculated at
each time point. A decrease in this ratio reflects a greater fall in voluntary than
stimulated torque production, suggesting the presence of central fatigue (18).
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Fatigue protocol. Following the baseline test series of contractions, the participant
completed a unilateral knee extension fatigue protocol consisting of 1 MVDC at 240°.s-1
every 2 s for 4 min. Each contraction was cued by an auditory signal and strong verbal
encouragement was provided by the investigators throughout the protocol. Visual torque
feedback, scaled to each participant’s MVIC, was provided throughout the fatigue
protocol and recovery. Fatigue was calculated as (24):
average peak power of the final 5 contractions
average of peak power at baseline and during the fatigue trial

100

[Eq. 2]

To evaluate potential sites of fatigue and the recovery of power following fatigue,
the test series was repeated immediately after the final contraction of the fatigue trial, and
at 5, 10, 20, and 30 min of recovery. Because deficits in torque and central fatigue can
recover quickly, the final 2 contractions of the fatigue protocol were used as the first 2
contractions of the test series at the end of the fatigue protocol.

Statistical analyses. All data were checked for normality and homogeneity of variance
prior to any statistical comparisons, using the Kolmogorov-Smirnov test and Levene’s
statistic, respectively. If the assumptions of normality or homogeneity of variance were
violated, non-parametric statistical comparisons were performed. Differences in group
descriptive characteristics, muscle architecture, and fatigue were analyzed using
independent t-tests or Mann-Whitney U tests. Changes in peak power, MVIC:80-Hz
torque, 10:80-Hz torque, and contractile properties (RTD and T1/2) between baseline and
fatigue, and throughout recovery, were analyzed using repeated measures 2-way MIXED
procedure ANOVAs (group × time). Linear regression analyses were performed to
evaluate the relationships between muscle architecture and baseline isometric torque and
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power, as well as fatigue and measures of physical activity and function, muscle
architecture, and contractile properties. For regression analyses in which estimated
fascicle length was used, only the non-normalized values were included. All statistical
analyses were performed using the SPSS statistical software package (v25.0, IBM,
Chicago, IL) with an alpha level of 0.05. Data are reported as mean±SE, with exact pvalues, 95% confidence intervals for differences between group means, and effect sizes
also provided. Effect sizes were calculated as Cohen’s d (40).

Results
Baseline characteristics. Group characteristics are reported in Table F.1. The young and
older groups had similar height, body mass, and BMI. The young group had greater
habitual physical activity (daily counts and MVPA) compared with the older group. The
measures of mobility function indicated a difference only for the SPPB-A, which was
lower in the older group.
At baseline, older women were weaker and less powerful than young women
(Table F.2). There was no difference between groups in the maximum RTD, but T1/2 was
slower in older compared with young (Table F.2).
The within-subject coefficient of variation for the 3 images analyzed for
pennation angle, muscle thickness, and estimated fascicle length were 5.7±1.2 and
5.0±1.1, 3.9±1.3 and 3.8±0.9, and 5.7±1.5 and 5.2±1.3% for young and older women,
respectively, indicating that these were robust measurements in both groups. Calf
circumference did not change from pre- to post-imaging in young (38.8±1.6 vs. 38.8±1.5,
p=0.991) or older (36.4±1.4 vs. 36.5±1.4, p=0.950) women, suggesting that fluid shifts
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did not impact the architecture measures. There were no differences between groups in
pennation angle, muscle thickness, or fascicle length (Table F.2), nor was peak power at
baseline associated with fascicle length in young (r2=0.085, p=0.493) or older women
(r2=0.326, p=0.139). Neither baseline peak power nor maximal isometric torque were
associated with pennation angle or muscle thickness in young women (r2≤0.127,
p≥0.386). Likewise, neither peak power nor maximal isometric torque were associated
with pennation angle in older women (r2≤0.234, p≥0.225), although there was a trend
towards an association between muscle thickness and peak power in the older group
(r2=0.468, p=0.061). Lastly, muscle thickness was positively associated with maximal
isometric torque in older women (r2=0.613, p=0.022).

Muscle fatigue. Changes in peak power during the 4-min fatigue protocol are shown in
Figure F.3. With the exception of 1 older woman, who could not attain target velocity
after the first 25 contractions, all participants were able to complete the 4-min fatigue
protocol. Therefore, the fatigue data reported here represent the average for 7 older
women. Fatigue was greater in older compared with young women (33.0±4.7 vs.
56.1±4.4% initial power, respectively; p=0.005, 95% CI: 7.9-35.1, d=1.86). Analysis of
changes in the MVIC:80-Hz torque ratio (from 2.02±0.06 and 1.87±0.11 at baseline in
young and older groups, respectively, to 1.94±0.10 and 1.77±0.09 in young and older at
fatigue) revealed no age×time interaction (p=0.918) or main effects of group (p=0.097) or
time (p=0.317), indicating no failure of voluntary activation in either group in response to
fatiguing contractions.
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There was no group×time interaction (p=0.982) or main effect of group (p=0.399)
for changes in the 10:80-Hz ratio from pre- to post-fatigue, but we did observe a main
effect of time (p<0.001) for this measure (Figure F.4A), indicating the presence of LFF in
both groups. There was no group×time interaction (p=0.536), but we did observe main
effects of group (p=0.004) and time (p=0.001) on T1/2 such that relaxation slowed
similarly with fatigue in both groups (p=0.001, Figure F.4B). The RTD did not change
with fatigue in young (p=0.783) or older groups (p=0.99, data not shown).

Recovery from fatigue. The recovery of peak power showed a group×time interaction
(p=0.025) such that older women recovered more in the first 5 min following the protocol
than young women (p=0.005), Figure F.3. Peak power did not differ from baseline by 5
min of recovery in either group.
Maximal isometric torque recovered following the fatigue protocol (main effect of
time, p=0.001), with no effect of group (p=0.95) and no group×time interaction
(p=0.103); Table F.3. Full recovery of MVIC was observed 5 min post-fatigue in young
and older groups (p≤0.001).
The 10:80-Hz torque ratio revealed no group×time interaction (p=0.326), but we
did observe main effects of time (p<0.001) and group (p=0.037, Figure F.4A) during
recovery. The 10:80-Hz torque ratio increased to pre-fatigue levels within 5 min of
recovery in both groups (p≤0.01). There was no group×time interaction (p=0.359), but
we did observe main effects of time (p<0.001) and group (p<0.001) for changes in T1/2
during recovery such that torque relaxation recovered comparably in young and older
women (Figure F.4B). There was no group×time interaction (p=0.973) and no main
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effects of group (p=0.085) or time (p=0.867) for the RTD during recovery (data not
shown).

Factors associated with fatigue. Regression analyses revealed that fatigue was not
associated with any parameter of muscle architecture in the young or older women (r2 ≤
0.11, p ≥ 0.467). The ΔMVIC:80-Hz torque from baseline to post-fatigue was not
associated with fatigue in young (r2 = 0.17, p=0.306) or older women (r2= 0.001,
p=0.995), confirming that voluntary activation failure did not contribute to fatigue in this
study. The Δ10:80-Hz torque from baseline to post-fatigue was directly associated with
fatigue in young (r2 = 0.709, p=0.008) but not older women (r2=0.014, p=0.804). In
contrast, baseline T1/2 was inversely associated with fatigue in older (r2=0.591, p=0.043)
but not young women (r2=0.145, p=0.351), as illustrated in Figure F.5. Neither physical
activity counts nor MVPA were associated with fatigue in young (r2 ≤ 0.035, p ≥ 0.659)
or older (r2 ≤ 0.056, p ≥ 0.61) women. Fatigue was associated with SPPB-A score in
older (r2 = 0.564, p = 0.052), but not younger (r2 = 0.03, p = 0.667) women.

Discussion
This study was designed to evaluate whether age-related differences in muscle
architecture, voluntary activation, or contractile properties might be potential
mechanisms for the greater muscle fatigue observed in older adults in response to highvelocity muscle contractions. Peak power fell significantly more in healthy older women
than in healthy young women, demonstrating the expected age-related difference in knee
extensor muscle fatigue at high contraction velocities. The results indicate that baseline
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differences in contractile properties, and not acute changes in these properties in response
to fatigue, may contribute to high-velocity fatigue in aging: baseline T1/2 was slower in
older than young, and predictive of fatigue only in the older group. There were no agerelated differences in muscle architecture across our study groups, and we provide new
information that architecture did not contribute to the greater fatigue observed in the
older group. Comparisons of the fall in voluntary vs. stimulated tetanic contractions
during fatigue (i.e., MVIC:80Hz torque ratio) indicated no decrement in voluntary
activation in either group in response to this high-velocity contraction protocol, ruling out
activation failure as a source of the difference in muscle fatigue between age groups.
Comparable LFF was observed in both groups, indicating significant peripheral fatigue in
response to this protocol that was independent of age. Overall, these results support
previous reports of greater fatigue in older muscle during high-velocity work (24,49,222),
and suggest that this difference may be due in part to chronic changes in muscle
properties, but not architecture, in the aged.

Baseline. Notably, there were no age-related differences in baseline muscle architecture
of the vastus lateralis in these groups of healthy women (Table F.2). While some studies
have reported remodelling of muscle architecture in old age (170,173,191,228) such that
muscle thickness, pennation angle, and fascicle length are reduced with age, most of
those studies were conducted in men. In contrast to those results, our data are in
agreement with those of Kubo et al. who likewise observed no age-related differences in
vastus lateralis fascicle length, normalized to thigh length, in women (126). However,
our results differ from that study insofar as we observed no age-related differences in
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pennation angle and muscle thickness. The cause of this discrepancy is not clear at
present, but does not appear to be due to differences in the age of the participants, nor the
repeatability of the measurement given the low coefficient of variation found in our
study. Questions as to how factors such as habitual physical activity and sex may
influence architectural changes in old age, as well as the potential functional impacts of
these changes, remain to be answered.
At baseline, peak voluntary power and torque were ~40 and ~30% lower,
respectively, in older compared with young women (Table F.2), which is consistent with
previous reports (3,23,24). The maximal RTD during electrically-evoked contractions
was not different between young and older groups, similar to some (23,24) but not all
reports in the literature (222). The T1/2 was slower at baseline in older compared with
young muscle, a result that is in agreement with most studies (23,24,48,49), and
potentially due to slowed Ca2+ dissociation from troponin, slower crossbridge kinetics
(164), a greater relative proportion of type I fibers (141), or a decrease in muscle-tendon
unit stiffness with age (125). The slower relaxation in older muscle does not appear to be
caused by slowed Ca2+ re-uptake by the sarcoplasmic reticulum with age (94).

Fatigue. Consistent with previous reports (24,48,49,222), we observed greater knee
extensor muscle fatigue in older compared with young women during contractions at
240°.s-1. The question of whether older muscle fatigues more than young depends upon
the contraction velocity used to fatigue the muscle, with greater fatigue reported at higher
speeds, i.e., those to the right on the force-velocity curve (24). The fatigue resistance of
older muscle under isometric conditions is well reported (33), and the cause of this
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difference appears to be due to a lower reliance on glycolytic ATP production in older
compared with young muscle (25,128). Fatigue induced by slow- and moderate-velocity
dynamic contractions is similar between young and older adults (23,24,49), while fatigue
is generally greater in older than young muscle in response to high-velocity contractions
(24,48,49,222,223,234), as found here. The goal of this study was to evaluate several
candidate mechanisms for this difference in fatigue at high contraction velocities.
Although the young women in our study were more physically active than the
older women (Table F.1), the magnitude of fatigue in each group was nearly identical to
that reported by Callahan and Kent-Braun (24), who matched age groups for physical
activity and used a similar fatigue protocol to the one used here. Recently, Englund et al.
reported that 12 weeks of progressive resistance training in mobility-limited older men
and women improved total torque output (i.e., strength) during a moderate-velocity
fatigue protocol of the knee extensors, but had no effect on fatigue, expressed as the
relative fall in peak torque (68). The effects of an intervention designed specifically to
increase muscular endurance (i.e., fatigue resistance) remain to be determined, but the
results to date suggest that the greater fatigue in older compared with young adults during
high-velocity contractions may be independent of physical activity status. In further
support of this notion, we observed no relationship between physical activity counts or
MVPA and fatigue in either young or older women.
To evaluate the potential role of changes in the completeness of voluntary
activation on the age-related differences in muscle fatigue observed here, we compared
the changes in the MVIC:80-Hz torque from baseline to fatigue (18). There were no
changes in this measure from baseline to fatigue in either group, indicating no decrease in
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voluntary activation with fatigue due to high-velocity contractions, a result similar to that
reported previously in men (49). Recently, transcranial magnetic stimulation and femoral
nerve stimulation were used to examine potential neural mechanisms for greater fatigue
with age following high-velocity contractions of the knee extensors in men and women
(222). In that study, the authors observed a reduction in voluntary activation with fatigue
in older, but not young women, but these changes in voluntary activation were small and
not associated with fatigue. Rather, the authors found a positive association between
fatigue and the decrease in stimulated twitch torque, consistent with an age-related
difference in peripheral fatigue due to impairment within the muscle, potentially
including failure of ECC or crossbridge function. Indeed, subsequent work by this group
has shown a significant association between metabolic by-products (Pi, H+, H2PO4-) and
fatigue during a similar protocol, supporting the notion that age-related differences in
muscle fatigue occur to differences in the intracellular milieu (62).
Based upon measures of the m-wave (EMG response to a single electrical
stimulus), previous studies of knee extensor muscle fatigue indicate that impaired
excitability of the neuromuscular junction or along the sarcolemma are not responsible
for the age-related differences observed in fatigue during voluntary dynamic contractions
such as used here, including those at high velocities (49,222). Thus, these studies also
suggest that fatigue under these conditions originates within the muscle. To determine
whether greater fatigue in older compared with young muscle was due to failure of ECC,
i.e., from the t-tubules to the cross-bridges, we compared changes in the 10:80-Hz torque
ratio from baseline to fatigue (67). This ratio decreased similarly with fatigue in both
groups, indicating a comparable failure of excitation-contraction coupling in both young
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and older women. Thus, it appears that excitation-contraction coupling failure does not
explain the age-group difference in fatigue in this study.
Torque relaxation (T1/2) in response to the 80-Hz tetanic stimulus slowed to a
similar extent in young and older women during fatigue, which is consistent with some
literature (35,131). In contrast, a greater slowing of twitch T1/2 in older compared with
young muscle following moderate- and high-velocity, but not slow-velocity contractions
of the knee extensors has been reported (49), with no sex-based differences observed
(222). The slowing of T1/2 with fatigue is likely due to an accumulation of proton in the
cytosol during contractions (21), which has been shown to inhibit Ca2+-ATPase ~2-fold
with a change in pH from 7.1 to 6.6 (2). Indeed, the recent work of Sundberg et al (223)
indicated greater fatigue due to more accumulation of Pi and H+ in the knee extensor
muscles of older adults.
Notably, baseline T1/2 was predictive of fatigue in older, but not young women,
such that ~60% of the variation in fatigue during high-velocity contractions in the older
group was associated with the rate of torque relaxation in the unfatigued muscle.
Whether this relationship may reflect an underlying alteration to contractile function that
is protective against the greater fatigue in older muscles during high-velocity
contractions, is not known at present. The mechanisms for slowed T1/2 in old age are not
entirely clear, but do not appear to include impaired calcium resequestration by the
sarcoplasmic reticulum (94). Theoretically, the age-related slowing of T1/2 could be
caused by: 1) a relatively greater volume of type 1 muscle fibers, 2) slowed detachment
of myosin from actin, and 3) a less stiff muscle-tendon unit. These potential mechanisms
require further evaluation in the context of muscle fatigue in aging.
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Recovery from fatigue. Although peak power and maximal isometric torque were lower
in older compared with young women at fatigue, both groups returned to pre-fatigue
values by the fifth minute of recovery (Figure F.3). Because both groups returned to prefatigue values by the fifth minute of recovery, we could not determine whether recovery
was faster in young or older women. In contrast to our observation of maximal isometric
torque recovering within 5 min, Allman and Rice found incomplete recovery of maximal
isometric force of the elbow flexor muscles in young and older men following
intermittent, submaximal isometric contractions, which likewise was accompanied by
low-frequency fatigue in both groups (4). More recently, Kent-Braun et al. reported no
age-related differences in the recovery of torque following 4-min of contractions of the
knee extensors at 120°.s-1 (109). Those authors also observed maximal torque was almost
completely recovered within 5 min, consistent with our observations here. Overall, the
rapid and complete recovery of power and isometric torque following a high-velocity
protocol that induced substantial muscular fatigue suggests a robust resilience of the
neuromuscular system in this group of healthy but sedentary older women.

Limitations. We assessed age-related differences in voluntary activation in response to
fatiguing contractions using changes in the MVIC:80Hz ratio. Although our observations
are consistent with recent work (222), the 80-Hz stimulated contractions were delivered
at an intensity eliciting 50% MVIC torque at baseline. This approach may underestimate
voluntary activation because not all motor units are recruited at 50% MVIC, and different
motor units may be recruited at baseline and fatigue due to changes in the threshold for
activation.
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Conclusions. This study shows that the greater muscle fatigue observed in older
compared with young muscle during high-velocity contractions was not related to
differences in muscle architecture, deficits in voluntary activation, failure of excitationcontraction coupling, or an exaggerated, fatigue-induced slowing of contractile
properties. We have shown that baseline T1/2 is inversely associated with greater muscle
fatigue in older women, which might be explained by selective atrophy of fast-twitch
muscle fibers, slowed crossbridge kinetics, or changes in muscle-tendon unit stiffness
with age. Overall, our results suggest that the cause of age-related differences in muscle
fatigue reside within the myofibers in healthy older adults; recent work suggests that
intracellular metabolism may be important in this process (223).
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Table F.1. Group characteristics

Age (yr)
Height (cm)
Body mass (kg)
BMI (kg.m-2)
PA (counts.d-1000)
MVPA (min.d-1)
Gait speed (m.s-2)
Chair rise time (s)
TUG (s)
SPPB-A

Young
Older
95% CI
(n=8)
(n=8)
23.4 ± 1.8
69.6 ± 1.1 -50.8, -41.6
164.5 ± 1.9 164.3 ± 2.6
-6.6, 7.1
65.3 ± 5.9
66.4 ± 3.8
-16.2, 14.0
24.1 ± 2.2
24.6 ± 1.3
-6.0, 5.0
286.0 ± 29.2 162.6 ± 10.4 52.8, 193.8
47.3 ± 6.5
11.2 ± 2.3
20.5, 51.8
1.20 ± 0.04 1.17 ± 0.07
-0.1, 0.2
14.1 ± 1.1
19.5 ± 1.6
-9.5, -1.3
8.3 ± 0.2
9.0 ± 0.6
-2.1, 0.7
2.9 ± 0.1
2.5 ± 0.1
0.02, 0.6

P

Effect
size

0.942
0.877
0.851
0.005
0.001
0.740
0.140
0.382
0.037

0.03
0.08
0.10
1.99
2.62
0.18
1.41
0.59
1.57

Values are mean±SE. 95% CI, 95 % confidence intervals for the difference between group
means; BMI, body mass index; PA, physical activity; MVPA, moderate- to vigorous-intensity
physical activity; TUG, timed up-and-go; SPPB-A, advanced short physical performance
battery.

Table F.2. Effects of aging on properties of the vastus lateralis

Muscle architecture
Pennation angle
(°)
MT (mm)
eFL (mm)
eFL/thigh length
Contractile properties
MVDC (W)
MVIC (Nm)
RTD (%pk.ms-1)
T1/2 (ms)

Young
(n=8)

Older
(n=8)

95% CI

P

Effect
size

13.5 ± 0.4

13.0 ± 0.6

-1.1, 2.1

0.524

0.33

26.1 ± 1.5
113.7 ± 8.8
3.1 ± 0.3

23.0 ± 1.8
102.7 ± 8.0
2.7 ± 0.2

-2.0, 8.1
-14.5, 36.5
-0.4, 1.1

0.209
0.371
0.330

0.66
0.46
0.50

349.8 ± 31.5
134.7 ± 12.0
1.33 ± 0.12
118.8 ± 4.4

202.3 ± 24.9 61.5, 233.6
93.8 ± 6.5
11.7, 70.3
1.08 ± 0.10
-0.1, 0.6
151.9 ± 6.0 -49.0, -17.2

0.002
0.01
0.119
0.001

1.84
1.50
0.83
2.20

Values are mean±SE. 95% CI, 95% confidence intervals for differences in group means; MT,
muscle thickness; eFL, estimated fascicle length; MVDC, maximal voluntary dynamic
contraction; MVIC, maximal voluntary isometric contraction; RTD, maximum rate of torque
development; T1/2, torque half-relaxation time.
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Table F.3. Recovery of voluntary and stimulated isometric torque production
Young
(n=8)
MVIC (% baseline)
0R
76.3 ± 4.0
5R
95.6 ± 2.0
10R
94.6 ± 2.3
20R
91.7 ± 3.5
30R
94.7 ± 1.8
80Hz (% baseline)
0R
79.6 ± 2.8
5R
83.4 ± 3.7
10R
77.6 ± 4.3
20R
77.7 ± 4.3
80.3 ± 4.1
30R
10Hz (% baseline)
0R
58.9 ± 6.4
5R
77.5 ± 3.0
10R
63.5 ± 4.3
56.1 ± 4.9
20R
30R
60.5 ± 4.6

Older
(n=8)

95% CI

P

Effect
size

68.5 ± 1.7
96.0 ± 1.7
97.4 ± 1.2
95.8 ± 1.9
94.9 ± 1.0

1.3, 14.3
-6.8, 6.2
-9.3, 3.8
-10.7, 2.4
-6.6, 6.4

0.019
0.921
0.403
0.210
0.976

0.89
0.08
0.53
0.51
0.05

72.4 ± 3.1
78.6 ± 4.0
72.0 ± 3.6
70.6 ± 3.5
68.2 ± 4.4

-3.6, 17.9
-6.0, 15.5
-5.1, 16.4
-3.7, 17.8
1.3, 22.8

0.191
0.381
0.301
0.196
0.029

0.86
0.44
0.50
0.64
1.01

51.6 ± 3.1
81.7 ± 3.7
65.3 ± 2.5
62.8 ± 3.1
61.3 ± 2.7

-4.1, 18.5
-15.6, 7.1
-13.1, 9.5
-18.0, 4.6
-12.1, 10.6

0.208
0.458
0.750
0.240
0.895

0.51
0.44
0.18
0.57
0.07

Values are mean±SE. 95% CI, 95% confidence intervals for differences in group means;
MVIC, maximal voluntary isometric contraction; 80Hz, high-frequency stimulation; 10Hz,
low-frequency stimulation.
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Figure F.1. Ultrasound image from a representative young woman showing estimated
fascicle length (eFL), muscle thickness (MT), and pennation angle (ϴ).

Figure F.2. Representative baseline series of contractions. Data are from one young
woman.
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Figure F.3. Age-related differences in muscle fatigue and recovery. Older women
experienced greater fatigue (*p=0.005), but both groups fully recovered within 5 min
following contractions (†p=0.005). Data are mean±SE.
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Figure F.4. Fatigue and recovery of contractile properties in young and older women. A)
10:80-Hz torque at baseline, fatigue, and throughout recovery. The 10:80-Hz torque
ratio decreased with fatigue (#p=0.001) and increased over the first 5 minutes of
recovery in both groups (#p≤0.01). B) T1/2 at baseline, fatigue, and throughout recovery.
Relaxation was slower in older compared with young women at baseline, fatigue, and
following 5 minutes of recovery (*p≤0.04). In both groups, T1/2 slowed with fatigue and
recovered within 5 minutes of recovery in both groups (#p=0.001), with no groupxtime
interactions. Data are mean±SE. The dark and light grey shaded boxes represent the
contraction protocol and recovery period, respectively.
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Figure F.5. Associations between half relaxation time and fatigue. Fatigue (peak power,
% initial) was plotted against half relaxation time (T1/2) at baseline. Linear regression
analysis revealed an association between these variables for older (r2=0.591, p=0.043),
but not young women (r2=0.145, p=0.351), suggesting the age-related slowing of T1/2
may prevent excessive muscle fatigue in older women.
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